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by Andy L. Cox 
The Developmental Origins of Health and Disease (DOHaD) hypothesis proposes that 
embryonic  environment  can  induce  permanent  changes  in  metabolism  during 
development,  increasing  the  risk  of  disease  in  adults.  Adverse  environments  during 
critical stages of gestation are sufficient to induce adaptations in offspring and disease 
susceptibility in later life. Rodent models show that maternal diet exclusively during 
preimplantation  development  induces  cardiovascular  and  metabolic  disease  in  adult 
offspring. Changes must therefore occur within the distinct cell populations of the early 
embryo and be maintained throughout development. Determining adaptive mechanisms 
has been challenging due to the small size of the early embryo, and genetic variability in 
outbred strains previously used. We generated mouse embryonic stem (ES) cells from 
inbred  C57BL/6  mice  as  a  model  to  overcome  these  problems.  These  were  used  to 
characterise mechanisms associated with the embryo’s adaptive responses to maternal 
diet. 
ES  cell  lines  were  derived  from  blastocysts  of  C57BL/6  mice  assigned  to  either  an 
isocaloric low protein diet (LPD), or a control diet exclusively through preimplantation 
development. ES cell lines were characterised for karyotype, sex, gene expression, and 
functional characteristics including proliferation, death, and metabolism at standardised 
passages. 
LPD had no impact on blastocyst formation in vivo or blastocyst cell lineage allocation. 
Experimental  conditions  did  affect  blastocyst  outgrowth  development  in vitro.  LPD-
outgrowths  cultured  with  less  feeder  fibroblasts  showed  slower  development  than 
controls. Although LPD blastocyst outgrowth was comparable to controls under high 
feeder growth conditions, there was a significant reduction in the capacity for ES cell 
derivation. There was a prominent sex bias towards male ES cell lines. These ES cells  
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retained  similar  levels  of  gene  expression  related  to  pluripotency,  housekeeping  and 
developmental functions irrespective of diet. LPD did not affect growth or metabolism. 
These  cells  however  showed  increased  basal  apoptosis,  and  reduced  levels  of 
phosphorylated Extracellular signal-regulated kinase (ERK).  
The reduced ES cell isolation efficiency may indicate a reduced number of pluripotent 
cells present within the early embryo or increased sensitivity of these cells in response to 
maternal LPD. Increased apoptosis in ES cells derived from LPD-blastocysts reveal that 
these  cells  are  indeed  more  sensitive.  Reduced  activated  ERK  may  suggest  that 
dysregulated  ERK-mediated  survival  signalling  causes e nhanced  apoptosis.  Such 
adaptations  in  the  early  embryo  may  impact  on  lineage  allocation  as  differentiation 
occurs.  These  ES  cell  lines  may  provide  a  model  to  investigate  such  mechanistic 
adaptations in post-implantation tissues providing further insight into foetal responses to 
poor nutrition and the induction of adult onset disease.  
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Chapter 1:  Introduction 
1.1 The Developmental Origins of Health and Disease 
Modern lifestyle changes have caused a significant rise in daily calorie intake and a 
reduction in physical activity, which has been linked with a rapid increase in a range of 
adult  onset  diseases.  These  diseases  have  been  grouped  under  the  term  metabolic 
syndrome, a range of medical disorders including cardiovascular disease (CVD), type 2 
diabetes  (T2D),  chronically  elevated  blood  pressure  (hypertension),  raised  serum 
cholesterol, and obesity. The incidence of these diseases increases with age and weight. 
1.1.1 The DOHaD hypothesis 
The ‘developmental origins of health and disease’ (DOHaD) hypothesis proposes that 
many  adult  onset  diseases  are  not  just  influenced  by  direct  adult  environment  and 
genetics but that environmental conditions during development and in early life may also 
play a role (Hanson and Gluckman, 2008; McMillen and Robinson, 2005). This model 
was developed from epidemiological studies of human populations relating incidences of 
CVD (Barker and Osmond, 1986a) and T2D (Hales et al., 1991) to birth weight. Initial 
evidence came from geographical studies in England and Wales showing geographic 
relationship between infant and adult death rates and nutrition in early life (Barker and 
Osmond, 1986a; Barker and Osmond, 1986b). Studies with large British cohorts (Barker 
et al., 1990; Barker et al., 1993; Osmond et al., 1993), showed that men with low birth 
weight, had higher death rates and vice versa. This led to the hypothesis that poor foetal 
environment  and  infant  growth  determines  high  risk  for  ischemic  heart  disease.  The 
association between low birth weight and coronary heart disease has been confirmed in 
studies of men in Uppsala, and Caerphilly, (Frankel et al., 1996) and among women in 
the United States (Rich-Edwards et al., 1997). 
From this, it was proposed that there might be a direct link between abnormal foetal 
growth and permanent changes in structure and function of developing tissues. These 
apparently irreversible changes to physiology and metabolism were considered to heavily 
influence  the  risk  of  later  disease.  Subsequent  studies  have  shown  that  many 
environmental  cues  acting  during  development  can  induce  structural  and  functional 
adaptations in tissues that are independent of birth size. It was therefore proposed that 
birthweight is not necessarily the main indicator of the DOHaD response, but that the Chapter 1 
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intrauterine environment is more important (reviewed by Barker, 1998; Gluckman et al., 
2007; McMillen and Robinson, 2005). 
1.1.2 Models of the DOHaD response 
It  was  hypothesised  that  the  embryo  responds  to  environmental  signals  in utero in  a 
number of ways, dependent on the severity or magnitude of the environmental challenge. 
Some responses may be developmentally disruptive, causing structural defects, which 
confer no adaptive advantage, for example responses to teratogens. Alternatively, it has 
been proposed that the embryo may modulate the normal program of development in an 
attempt  to  improve  its  immediate  or  future  survival  chances.  For  example,  if  foetal 
growth is restricted in response to extreme nutritional deficit it may respond by induction 
of physiological adaptations that reduce the plasma and tissue concentrations of growth 
promoting factors such as insulin and insulin-like growth factor (IGF-1), and by reducing 
anabolic demand (Gluckman, 1995). In addition, redistribution of foetal blood flow and a 
capacity to lose structural units within developing organ systems may affect their life-
long functional capacity in an attempt to maintain the development of critical organs 
such  as  the  brain  (Gluckman  et  al.,  2007;  McMillen  and  Robinson,  2005).  These 
immediate adaptive responses occur to ensure short-term survival at a possible cost to 
postnatal  health.  A  further  level  of  adaptive  response,  termed  a  predictive  adaptive 
response (PAR), has also been considered as a mechanism of developmental plasticity. 
Subtle  modifications  occur  within  the  developing  embryo  that  do  not  confer  an 
immediate advantage, but are induced in expectation of the future postnatal environment. 
These changes are made to obtain an adaptive advantage, but the advantage is delayed. 
Essentially  the  ‘choice’  of  adult  phenotype  is  predetermined  by  environmental  cues 
throughout  development.  These  intrauterine  signals  are  predictive  of  the  later  life 
environment and regulate the appropriate physiological homeostatic settings. This would 
enhance the fitness of the organism if the suggested environment occurs, ensuring an 
optimal chance of postnatal survival (Gluckman and Hanson, 2004; Gluckman et al., 
2005c). 
PARs  can  only  be  beneficial  if  the  forecast  environment  is  correct.  This  becomes 
apparent when conditions vary to the predicted postnatal environment, and challenge the 
organism’s  induced  physiological  range.  This  ‘mismatch’  response  may  then  be 
maladaptive and increases the susceptibility to disease. For example, an impaired foetal 
environment  due  to  placental  or  maternal  disease  may  be  sensed  in  the  foetus  as  a Introduction 
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compromised  nutrition.  The  physiology  is  adjusted  accordingly  in  expectation  of  a 
nutritionally deprived future environment. Therefore if the offspring is then placed in an 
enriched postnatal environment a mismatch is generated. This is evident when observing 
modern human populations. The enriched environment seen in the developed countries 
generates  mismatch  irrespective  of  developmental  conditions.  This  is  particularly 
relevant  to  the  increasing  obesity  epidemic  (Gluckman  et  al.,  2007)  and  is  most 
graphically observed in populations experiencing rapid dietary alterations such as India 
and results in a large increase in the incidence of metabolic syndrome (Gluckman et al., 
2005a) (Figure 1.1). 
Whether the response is immediate or predictive, disruptive, or adaptive, the ability to 
alter  the  developmental  program  provides  a  mechanism  to  improve  embryo  survival 
chances under environmental stress but can have long-term detrimental effects on adult 
health. 
 
Figure 1.1: Model of developmental mismatch.  
The developing organism senses maternally transmitted environmental signals, such 
as undernutrition, during prenatal and early postnatal life. Developmental plasticity in 
response to these cues modifies the default trajectory defined by the inherited foetal 
genome according to whether the environment is perceived as adequate or deprived. 
This results in adjustment of metabolic setpoints. Mismatch between the predicted 
and actual mature environments, particularly if the mature environment is richer than 
anticipated enhances disease risk (Gluckman et al., 2007). 
 
The  DOHaD  concept  is  supported  by  several  lines  of  evidence,  which  are  discussed 
briefly  below  (reviewed  by  Gluckman  et  al.,  2007;  McMillen  and  Robinson,  2005): 
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Undernutrition during gestation can result in long-term effects that are independent of 
birthweight (Roseboom et al., 2001). Experimental manipulation of the periconceptional 
environment leads to altered cardiovascular and metabolic function in the adult organism 
(Gluckman et al., 2005b; Kwong et al., 2000; Langley-Evans et al., 1996b), and shows 
organ specific alterations in gene expression and function (Lillycrop et al., 2007; Watkins 
et al., 2010; 2008a). This suggests that multiple interacting mechanisms are likely to 
affect developmental patterning by altering expression patterns of key regulatory genes. 
In evolutionary terms, plasticity throughout development acts to increase an individual’s 
fitness in ways that are faster and more sensitive to transient environmental changes than 
pure genetic changes.  
1.1.3 Nutrition and DOHaD 
Nutrient  availability  has  been  identified  as  a  major  regulator  of  the  developmental 
program  (Barker,  1994).  In  the  context  of  the  DOHaD  hypothesis,  there  are  many 
nutritional models that have been generated in animals. These studies show that the type, 
the timing and the duration of the nutritional insult are crucial determinants of embryo 
development and long-term postnatal physiological function and health status. 
Reducing maternal nutrient consumption, altering the intake of specific macronutrients, 
or  maternal  overnutrition  all  impose  negative  effects  on  postnatal  phenotype.  For 
example, modest maternal protein restriction during pregnancy in the rat (Bertram et al., 
2001; Kwong et al., 2000; Langley-Evans et al., 1996b; Torrens et al., 2003) and mouse 
(Watkins  et  al.,  2010;  2008a),  leads  to  low  birthweight,  hypertension  (Langley  and 
Jackson,  1994)  vascular  dysfunction  (Torrens  et  al.,  2006),  and  behavioural  diseases 
(Watkins  et  al.,  2008b).  This  is  also  associated  with  impaired  lipid  and  glucose 
homeostasis (Fernandez-Twinn et al., 2005; Ozanne et al., 1996), increased fat deposition, 
and altered feeding behaviour (Bellinger et al., 2004; Bellinger et al., 2006). Maternal 
nutrient  restriction  or  foetal  growth  restriction  have  also  been  shown  alter  postnatal 
glucose homeostasis and insulin sensitivity in the pig and sheep (Owens et al., 2007b; 
Poore and Fowden, 2002). Reducing global nutrient intake in rats by up to 30% (Woodall 
et  al.,  1996),  and  uterine  ligation  experiments  (Jansson  and  Lambert,  1999)  led  to 
intrauterine  growth  restriction  and  induced  raised  blood  pressure,  hyperinsulinemia, 
hyperleptinemia, reduced locomotion, and obesity in the offspring; This was exacerbated 
by feeding a high-fat diet after weaning (Vickers et al., 2000). The offspring of sheep 
exposed to global nutrient restriction during early-to-mid pregnancy exhibit increased Introduction 
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blood pressure (Gilbert et al., 2005; Gopalakrishnan et al., 2004). In addition maternal 
overnutrition  and  high-fat  diets  in  rats  produces  offspring  with  increased  adiposity, 
hyperglycaemia, hyperinsulinemia (Bayol et al., 2008), and hypertension (Khan et al., 
2005; Taylor et al., 2005). Surprisingly, offspring from protein overnutrition studies have 
similar  changes  as  those  that  have  reduced  protein  intake.  Increased  protein  (40% 
compared to 20% control) led to a reduction in birth weight of male offspring, followed 
by accelerated postnatal growth. This was associated with increased adiposity (Daenzer 
et al., 2001), and significantly higher blood pressure in adult mice (Thone-Reineke et al., 
2006). 
1.1.4 Developmental plasticity 
It is proposed the altered physiological and homeostatic set points in response to these 
adverse  developmental  cues  are  achieved  through  ‘developmental  plasticity’.  This  is 
defined as the ability of a single genotype to produce more than one alternative form of 
physiological  state  or  behaviour  in  response  to  environmental  conditions  or  stimulus 
(Barker, 2004). Many organisms undergo adaptations during development in response to 
cues about the future environment that alter the developmental program in a manner that 
generates alternative phenotypes. For example, the amount of daylight to which meadow 
voles (Microtus pennsylvanious) are exposed during gestation determines coat thickness 
in the offspring in anticipation of winter or spring temperatures (Lee and Zucker, 1988).  
Although a diverse range of nutritional insults can elicit similar responses in offspring 
health, the timing and duration of the insult affects the severity and nature of the response. 
It has been suggested that ‘windows of plasticity’ at specific stages of development may 
exist  throughout  gestation  where  the  developmental  program  is  more  sensitive  to 
environmental signals (reviewed by Gluckman et al., 2007; McMillen and Robinson, 
2005). For example, Roseboom et al. (1999) investigated the effects of timing of foetal 
undernutrition from data based on the children born during the Dutch winter famine of 
1944–1945. This showed that foetal undernutrition affected adult physiology depending 
on  different  phases  of  development.  Perinatal  exposure  to  famine  conditions  led  to 
overweight adult offspring with increased risk for insulin resistance and impaired glucose 
tolerance.  Those  conceived  during  the  famine  had  increased  risk  for  high  serum 
cholesterol  and  heart  disease  as  adults  (Painter  et  al.,  2006;  Roseboom  et  al.,  2001; 
Roseboom et al., 1999). Chapter 1 
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1.2 The preimplantation embryo as a mediator of the DOHaD 
response 
1.2.1 Critical stages of sensitivity 
There is now much evidence that associates the concept of plasticity during development 
with embryo ‘reprogramming’ and determination of the subsequent pathologic outcomes. 
Recent data shows very early development, periods of organogenesis, and late gestation 
may  be  particularly  sensitive  time  points  and  have  been  the  primary  focus  for 
investigating the impact of dietary manipulation on offspring health (Figure 1.2). 
 
Figure 1.2: Critical periods during early mouse development.  
Nutrient  deprivation  during  early-  and  mid-  development  tend  to  result  in  altered 
cardiovascular development and hypertension, whereas nutritional insult during late 
gestation  and  early  postnatal  development  effects  risk  of  obesity  and  diabetes 
hypothalamic–pituitary–adrenal activity, growth hormone and insulin metabolism, and 
reproductive development (modified from Nagy et al., 2003). 
 
Rodent  and  sheep  models  allow  manipulation  of  maternal  diet  at  specific  points  in 
embryonic  and  foetal  development.  Initial  dietary  manipulation  studies  where  a  low 
protein diet (LPD) was fed to pregnant rats throughout gestation resulted in increased 
blood  pressure  in  the  offspring  (Langley-Evans  et  al.,  1994).  Langley-Evans  et  al. 
(1996c),  also  demonstrated  that  the  severity  of  the  hypertensive  phenotype  could  be 
differentially  influenced  by  restricting  maternal  protein  to  specific  periods  of 
development.  The  magnitude  of  hypertension  was  greatest  when  mothers  were 
undernourished during the last trimester of gestation. Further, a LPD targeted exclusively 
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to the preimplantation stage of development in rodents alters foetal and postnatal growth 
and  results  in  increased  systolic  blood  pressure  (SBP)  and  hypertension  postnatally 
(Kwong et al., 2000; Watkins et al., 2008a). In sheep, nutrient deficiency during late 
gestation leads to increased levels of obesity and insulin resistance (Gardner et al., 2005) 
and a hypertensive phenotype in adult offspring (Edwards et al., 2001; Edwards and 
McMillen,  2001).  Maternal  protein  restriction  in  sheep  during  the  periconceptional 
period of development leads to changes in maternal and foetal growth, and increased 
foetal  blood  pressure  (Edwards  and  McMillen,  2002a;  2002b;  Gardner  et  al.,  2004; 
Gilbert et al., 2005). These studies provide evidence to suggest that different windows of 
sensitivity exist during development in which phenotypic adaptations can be induced in 
response to environmental adversities. However, the mechanisms by which such changes 
are transmitted postnatally are still poorly understood.  
There is significant interest in the impact of maternal dietary deficiencies during the 
preimplantation stage of development and their long-term consequences. This period is 
perhaps the most susceptible to environmental cues as significant epigenetic patterning 
occurs  during  preimplantation  development.  The  epigenetic s tatus  established  here 
determines gene expression patterns within cells, which are maintained throughout foetal 
and postnatal development and in adult life (Hochberg et al., 2011). In addition, the 
preimplantation embryo is well known for its environmental sensitivity (Fleming et al., 
2004) and may therefore act as a mediator of the DOHaD response.  
This sensitivity has been observed in vitro by preimplantation embryo culture (Ecker et 
al., 2004; Watkins et al., 2007) and in vivo from studies of long-term effects in response 
to  maternal  diet  (Fleming  et  al.,  2004;  Langley-Evans  et  al.,  1996c;  Watkins  et  al., 
2008a). Many experimental studies have attempted to link maternal nutrition during the 
preimplantation period of gestation and long term developmental potential. Reduction                      
macronutrients, particularly the levels of protein, have caused changes in development of 
the embryo to compensate this. In particular, a LPD, fed exclusively to rodents during the 
preimplantation period (Kwong et al., 2006; 2000; Watkins et al., 2007; 2008a) or during 
the  periconceptional  period  (Kwong  et  al.,  2007;  Watkins  et  al.,  2007;  2008b)  is 
associated with significant postnatal phenotypes (Watkins et al., 2007; 2008b). These are 
gender  specific  and  adaptations  include  a  reduced  birth  weight,  subsequent  over-
compensatory adolescent growth, onset of adult hypertension, and disproportionate organ 
growth (Kwong et al., 2006; 2000). Abnormal postnatal phenotype as a consequence of Chapter 1 
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in vitro manipulation during the periconceptional period has also been associated with 
irreversible  alterations  in  adult  physiology,  revealing  increased  SBP,  altered  organ 
allometry as well as behavioural and cardiovascular defects (Watkins et al., 2007; 2008b). 
In other mouse studies, maternal diets containing high fat and high cholesterol during 
pregnancy  initiate  pathogenic  events  in  the  developing  foetus  and  induce  obesity, 
hypertension, impaired skeletal muscle development and aberrant behavioural responses 
in the offspring (Elahi et al., 2008). Such mild maternal dietary manipulations do not 
compromise foetal viability but affect growth and developmental patterning, which can 
induce late onset metabolic diseases.  
Collectively, these in vitro and in vivo studies of early development indicate a foetal 
strategy  to  protect  future  development  with  possible  subsidiary  effects  on  mature 
physiological and metabolic systems. The long-term effects of maternal diet in these 
studies  suggest  that  the  induced  phenotypic  changes  in  the  offspring  of  dietary 
challenged mothers must be occurring in cell populations of the preimplantation embryo. 
These changes must be maintained throughout development in derivate cells and tissues, 
becoming evident in the mature organs and biological systems.  
1.2.2 The preimplantation embryo  
Development  of  the  preimplantation  embryo  is  characterized  by  the  formation  of 
specialised cell lineages that enable implantation into the uterus. During fertilisation, the 
haploid gametes combine to form a single diploid cell, the zygote, which then travels to 
the uterus for implantation. The zygote undergoes cleavage; a set of synchronous cell 
divisions  and  at  8-cells  compaction  occurs.  Here  blastomeres  flatten  and  undergo 
intracellular adhesion mediated by the calcium-dependent E-cadherin/ catenin system, 
components of the adherens junction (Fleming et al., 2000). Polarisation of blastomeres 
at  this  stage  and  asynchronous  cell  division  results  the  first  cellular  differentiation 
forming  two  distinct  cell  types  in  the  16-cell  morula.  The  outer  blastomeres  form  a 
monolayer of polar epithelial cells, the trophectoderm (TE), which encloses the non-polar 
inner cell mass (ICM) (Johnson and McConnell, 2004). The blastocyst is formed as fluid 
is transported across the TE generating a blastocoelic cavity (Figure 1.3). Introduction 
  9 
 
Figure 1.3: Schematic of mammalian preimplantation development. 
Following  fertilisation,  three  synchronous  cell  divisions  occur  during  cleavage  to 
generate  an  8-cell  embryo  where  cells  are  loosely  associated.  The  initiation  of 
compaction  occurs  at  the  8-cell  stage  where  distinct  cells  are  no  longer  visible. 
Differentiated  cell  lineages  (TE  and  ICM)  emerge  in  the  subsequent  cell  divisions. 
Cavitation completes blastocyst morphogenesis and degradation of the ZP enables 
the invasive TE cells to implant. 
 
The pluripotent ICM cells give rise to all of the future foetal tissues and a proportion of 
the  extraembryonic  membrane  (allantois  and  the  amnion).  The  multipotent  TE 
contributes only to cell types of the trophoblast (TB) layers of the placenta. Prior to 
implantation,  the  ICM  cells  differentiate  to  form  the  epiblast  (EPI),  and  an 
extraembryonic  precursor  lineage,  the  primitive  endoderm  (PE).  The  PE  forms  the 
endoderm layers of the yolk sac, whilst the EPI are the progenitors of the three germ 
layers: the ectoderm, mesoderm, and definitive endoderm, each of these contributing to 
specific foetal tissues (Rossant and Cross, 2001; Tam and Rossant, 2003) (Figure 1.4). 
Changes induced within the three progenitor cell lineages of the blastocyst could have 
implications for the future development of the whole organism and demonstrates why the 
preimplantation period appears critical for foetal and adult health. 
 Chapter 1 
  10
 
Figure 1.4: Allocation of preimplantation cell lineages.  
The three cell lineages of the preimplantation embryo, the ICM/EPI, the PE and the 
TE (a, day 4.5), give rise specific cell lineages in the postimplantation embryo (b, day 
6.0; c, day 7.0) and are fate restricted to form specific tissues in the conceptus. (d) 
Showing a summary of cell lineage allocation throughout early development.  The EPI 
gives rise to ectoderm, mesoderm and definitive endoderm. The PE differentiates into 
the  parietal  and  visceral  endoderm  (both  contribute  to  foetal  extraembryonic 
membranes).  The  TE  gives  rise  to  the  ectoplacental  cone  (EPC),  extraembryonic 
ectoderm  (ExE)  and  the  trophoblast  giant  cells  (modified  from  Tam  and  Rossant, 
2003). Introduction 
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1.2.2.1 Molecular regulators of early lineage commitment 
Cell lineage fate is dictated by a well-defined transcriptional network, which functions to 
regulate differentiation processes during patterning of the embryo. There are a number of 
key transcription factors (TF) that specify blastocyst lineage and also their derived stem 
cells.  In  the  morula,  an  established,  self-sustaining  network  of  regulatory  TFs  are 
involved in cell fate decisions. Oct4 (Octamer binding protein) (Nichols et al., 1998), 
Sox2 (SRY (Sex-determining region)–box 2) (Avilion et al., 2003; Nichols et al., 1998) 
and Nanog (NK2-class homeobox TF) (Chambers et al., 2003; Mitsui et al., 2003) are 
required for specification of pluripotent cells. These are expressed in every cell during 
cleavage, but become restricted to ICM/ EPI cells. Initially, caudal-like homeobox 2 TF 
(Cdx2)  and  eomesodermin  (Eomes)  are  activated  in  the  outer  cells,  which  drive  the 
repression of ICM determinants (Niwa et al., 2005; Ralston and Rossant, 2008; Strumpf 
et al., 2005). Reciprocal repression of TE lineage markers by Oct4/ Nanog/ Sox2 in 
pluripotent cells ensures correct lineage segregation (Niwa et al., 2005). Additionally, 
existing  reports  indicate  a  role  for  Sall4,  a  TF  belonging  to  the  Splat  family,  as  an 
activator of Oct4, and modulator of Nanog transcription (Wu et al., 2006) (Figure 1.5). 
 
Figure  1.5:  Transcriptional  regulators  of  ICM/  TE  specification  in  mouse 
preimplantation mouse embryos 
TE specification relies on TEAD4, Cdx2, Eomes and Elf5 TFs. Due to inactive HIPPO 
signalling  in  TE  cells,  TEAD4  binds  Yap1  which  activates  Cdx2.  Cdx2  in  turn 
upregulates Eomes and Elf5 and suppresses Nanog and Oct4 expression promoting 
TE  cell  fate.  Oct4,  Sox2,  and  Nanog  form  the  core  machinery  that  regulates 
pluripotency  in  ICM  cells.  Further,  Sall4  activates  Oct4  and  modulates  Nanog 
expression. Oct4 negatively controls Cdx2 expression to repress TE differentiation. 
Nanog  suppresses  Gata6  and  brachyury  preventing  PE  formation  (modified  from 
Suwinska and Ciemerych, 2011). 
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TE Specification 
Cdx2 is initially expressed at the 8-cell stage in the embryo, and becomes restricted to the 
outside cells at the morula stage inducing expression of Eomes and elf5 (Dietrich and 
Hiiragi, 2007; Ralston and Rossant, 2008). Embryos lacking Cdx2 form blastocysts, but 
do not undergo TB differentiation indicating its role in maintenance of the TE (Strumpf 
et al., 2005). TEA domain/ transcription enhancer factor family member 4 (TEAD4) and 
the coactivator Yes-associated protein 1 (YAP) (Vassilev et al., 2001; Zhao et al., 2008) 
are  required  for  Cdx2  transcription  (Nishioka  et  al.,  2008;  Yagi  et  al.,  2007). 
Phosphorylation  on  YAP  in  the  ICM  inhibits  Cdx2  expression  when  the  entire  cell 
surface is subject to cell-cell contact (Nishioka et al., 2009; Sasaki, 2010) (Figure 1.5). 
Primitive endoderm formation 
Cell position appears to drive cell fate in ICM and TE segregation. However, during the 
final cell fate decision in the blastocyst, formation of the PE and EPI, cell fate precedes 
and helps drive cell position. At E 3.5, ICM cells show exclusive expression of either the 
pluripotent  EPI  marker  Nanog,  or  the  PE  specific  Gata  factors  in  a  random  mosaic 
pattern prior to presence of the PE layer (Chazaud et al., 2006; Gerbe et al., 2008). At 
this  stage,  cells  are  restricted  to  one  fate  or  the  other.  Interestingly,  the  Gata6 gene 
possesses Nanog binding sites in its enhancer region, and Gata6 is upregulated in Nanog-
deficient cells (Mitsui et al., 2003). Correct specification of these lineages is subject to 
extrinsic  signalling  pathways,  likely  via  FGFR  signalling.  In  particular,  signalling 
through  Growth  receptor  bound  protein  2  (Grb2)  (downstream,  of  the  Ras-MAPK 
signalling  pathway),  is  required  for  PE  segregation  (Koutsourakis  et  al.,  1999)  by 
repression  of  Nanog  (Chazaud  et  al.,  2006),  and  consequently  the  Nanog-mediated 





Figure 1.6: Transcripts involved in lineage specification in the mouse blastocyst  
Oct4, Cdx2, Nanog and Gata6, are key TFs generating the first three lineages in the 
blastocyst.  In  the  early  embryo  expression  is  not  restricted.  Lineage-restriction  is 
established in association with the maturation of cellular structures, such as apical-
basolateral  cell  membrane  domains,  and  intercellular  junctions,  and  of  cross 
regulatory  interactions  between  the  TFs  themselves.  Oct4  is  observed  in  all 
blastomeres throughout early cleavage stages due to maternally encoded protein. At 
the blastocyst stage, Oct4 is downregulated in the outer TE cells by Cdx2 through 
direct physical interaction and transcriptional regulation. Cdx2 is detected beginning at 
the  eight-  to  16-cell  stage.  Initial  expression  is  stochastic.  In  the  morula,  Cdx2  is 
ubiquitous but higher in outer,  polarized cells. Restricted expression in  TE cells is 
established by the blastocyst stage. Nanog and Gata6 are detected from the eight-cell 
stage. Both proteins are expressed uniformly until the early blastocyst stage. Nanog 
expression is downregulated in outer cells by Cdx2 and in a subpopulation of the ICM 
by  Grb2-dependent  signalling.  Gata6  expression  is  maintained  by  Grb2-dependent 
signalling.  By  the  late  blastocyst  stage,  ICM  cells  express  either  Nanog  or  Gata6 
(modified from Rossant and Tam, 2009). 
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1.3 Potential mechanisms of the DOHaD response 
Until recently, the focus in DOHaD research has been on defining the consequences of 
environmental challenges during development, on the adult phenotype. The emphasis of 
this  work  is  now  to  attempt  to  determine  the  initiating  physiological,  cellular,  and 
molecular mechanisms by which environmental cues can influence the developmental 
program. 
The most obvious mediator of plasticity within the developmental program, particularly 
during the preimplantation embryo, is by regulation of gene expression. Many studies 
demonstrate that alterations can be induced by epigenetic changes in the DNA, where 
gene  expression  is  regulated  by  mechanisms  that  do  not  involve  changes  in  the 
underlying DNA sequence. However, it is unlikely that causal mechanisms for these 
plastic  responses  reside  exclusively  at  the  epigenetic  level.  Many  studies  focus  on 
identifying changes in physiological function that are associated with increased disease 
risk,  and  alterations  in  expression  and  activity  of  the  systems  regulating  such 
physiological function. In addition it is postulated that metabolic and proliferative status 
of  cells  in  the  developing  organism  can  also  influence  foetal  development  through 
changes  in  signalling  pathways  or  cell  cycle  kinetics.  It  is  probable  that  long-term 
phenotypic  changes  are  a  result  of  complex  interactions  between  numerous  factors 
resulting in an amplification of an adaptive response. Determination of these mechanisms 
will help to explain the etiology of adult disease. 
1.3.1 Epigenetic modifications 
Gene expression can be regulated without altering the nucleotide sequence of DNA (Bird, 
2002) by modifying chromatin structure (Berger, 2007; Reik et al., 2003b). This level of 
gene regulation is important to enable dynamic interpretation of genetic information. In 
the nucleus, DNA is wrapped around a histone complex forming the nucleosome, the 
basic unit of chromatin. Epigenetic modifications of these structures determine whether 
parts of chromosomes are tightly or loosely packaged, and thus whether a gene becomes 
active  (Grunstein,  1997). P ost-translational  modifications  of  histones  by  acetylation, 
methylation,  phosphorylation,  and  ubiquitination  of  specific  amino  acids  can  alter 
chromatin structure. These modifications can promote a compact conformation, blocking 
access of TFs and repressing gene expression, or an open active conformation (Berger, 
2007).  Epigenetic  regulation  is  best  characterized  by  DNA  methylation,  whereby 
modifications  of  cytosine  residues,  particularly  within  CpG  dinucleotides  define  the Introduction 
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proximal gene expression (McMillen and Robinson, 2005). Hypermethylation of CpG 
rich regions can mediate transcriptional repression, whereas gene activation occurs in 
areas  of  hypomethylation  (Lillycrop  et  al.,  2005)  Different  cells  and  tissues  have  a 
unique epigenetic signature, determining the gene expression pattern. Epigenetic patterns, 
acquired  during  development  are  stable  in  all  somatic  cells  throughout  adult  life. 
However, somatic epigenetic patterns undergo “reprogramming” in germ cells and in 
early embryos (Figure 1.7). 
 
Figure 1.7: Transcriptional activity and DNA methylation status in mammalian 
embryos. 
Embryonic  demethylation  leads  to  substitution  of  methylated  sites  (red  circles)  by 
nonmethylated sites (yellow circles). Two alternative fates are then envisaged: either 
transcription persists, leading to restoration of the unmethylated CpG islands and their 
flanking  methylated  regions  (RHS);  or  transcription  is  extinguished  during  the 
demethylation process (LHS). This allows de novo methylation of the CpG islands and 
its  flanking  regions.  In  this  way,  the  embryonic  promoters  are  imprinted  and  gene 
activity is determined for the duration of the cells lifetime (Bird, 2002). 
 
In primordial germ cells, erasure of epigenetic marks and parental imprints occur in order 
to restore totipotency and remove “epimutations” that could otherwise be inherited across 
generations. Epigenetic marks are re-established during gametogenesis (Figure 1.8). This 
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results in differences in methylation on chromosomes that are inherited from the oocyte 
versus sperm. This epigenetic asymmetry is termed “genomic imprinting”. The erasure of 
methylation marks at imprinted genes in the germ line is a key developmental event 
ensuring  that  gender-specific  methylation  is  imposed  during  subsequent  germ  cell 
development (Reik and Walter, 2001). Upon fertilization, genome-wide demethylation 
occurs (Howell et al., 2001; Mertineit et al., 1998; Morgan et al., 2005), and around the 
time of implantation (blastocyst stage) there is a wave of global de novo methylation 
(Figure 1.8). This occurs mainly in the ICM cells of the expanded blastocyst and is likely 
connected with the process of lineage decision and cell differentiation (Monk, 1995; Reik 
et al., 2001). It is crucial for development that imprinted genes maintain their methylation 
marks through early embryo reprogramming to ensure the inheritance of parental-specific 
epigenetic  information.  Thus  DNA  demethylation  and  remethylation  is  resisted  at 
imprinted loci in embryos (Brandeis et al., 1993; Olek and Walter, 1997). 
Figure 1.8: Alterations in methylation status during development 
During embryonic development and sex determination, primordial germ cells undergo 
genome-wide  demethylation,  which  erases  previous  parental-specific  methylation 
marks  that  regulate  imprinted  gene  expression.  In  the  male  germ  line,  paternal 
methylation marks in imprinted genes are laid down in developing gonocytes that will 
develop into spermatogonia. The female germ line establishes maternal methylation 
marks in imprinted genes at a later stage. After fertilization, the paternal genome is 
more rapidly demethylated than the maternal. Genome-wide remethylation occurs on 
both parental genomes before implantation. However, imprinted genes maintain their 
methylation  marks  throughout  this  reprogramming,  allowing  for  the  inheritance  of 
parental-specific  monoallelic  expression  in  somatic  tissues  throughout  adulthood 
(Surani et al., 2007). 
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The inherent flexibility of the epigenome to respond to certain stimuli and modulate gene 
expression is critical for this reprogramming procedure and in reestablishment of the 
epigenome.  However  this  process  also  makes  the  genome  vulnerable  to  epigenetic 
modifications at this stage, especially as some environmental factors or cues can act on 
the epigenetic machinery with potential long-term outcomes (Sinclair and Singh, 2007). 
This process is sensitive to environmental changes demonstrating that early embryonic 
maintenance of epigenetic status is particularly important for normal development. 
Epigenetic modifications of key developmental genes and the effects imposed on the 
metabolic state by altering expression patterns suggest a plausible mechanism for the 
association of foetal plasticity and metabolic disease. In particular, the DNA methylation 
status  of  imprinted  genes,  and  genes  explicitly  involved  in  metabolic  regulation  is 
proposed to play a significant role in embryonic adaptations (Reviewed Fleming et al., 
2004; Kwong et al., 2006). 
Growth regulated epigenetic changes in imprinted genes  
Imprinted genes are highly involved with the regulation of foetal growth, development 
and function of the placenta, and also postnatal behaviour (Reik et al., 2003a).  
Interestingly,  foetal  growth  is  enhanced  by  many  paternally  expressed  genes  and 
suppressed  mainly  by  maternally  expressed  genes.  Most  imprinted  genes  contain 
differentially methylated regions (DMRs), due to epigenetic modifications at regulatory 
CpG islands on one gene copy. After fertilisation, DMRs of imprinted genes must be 
maintained in the adult for the desired gene expression. As imprinted genes can regulate 
expression of foetal and placental growth, as well as nutrient supply, they are prime 
targets  for  adaptive  epigenetic  changes;  especially  during  the  process  of  epigenomic 
remodelling prior to implantation. Various studies have looked for epigenetic changes in 
a  cluster  of  imprinted  genes  that  are  associated  with  the  IGF  signalling  pathway 
(Hochberg et al., 2011; Khosla et al., 2001; Kwong et al., 2006; Young et al., 2001). This 
includes genes encoding insulin-like growth factor and its receptor (Igf2, Igf2R) and also 
the H19 gene, a regulator of IGF2. Loss of imprinting in these genes induces bi-allelic 
expression whereas silencing of both alleles results in complete loss of gene function.  
Environmental stress, such as those that result from in vitro culture, can interfere with the 
maintenance of imprinting. Assisted reproductive technologies (ART) in humans is a 
stressor of particular interest because in vitro culture of embryonic cells and embryos can 
perturb the genomic imprinting, affecting foetal growth and development (Arnaud and Chapter 1 
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Feil, 2005; Cox et al., 2002; Mann et al., 2003). It had been shown that ART leads to loss 
of methylation at multiple imprinted genes including Kcnq1ot and Igf/H19 (Azzi et al., 
2009; Gicquel et al., 2003). 
In cattle and sheep, epigenetic changes result large offspring syndrome (LOS) (Young et 
al.,  1998)  where  animals  exhibit  various  phenotypes  including  oversized  offspring  at 
birth. In both species, the syndrome occurs after in vitro culture of embryos between 
fertilization and the blastocyst stage and is often related to the loss of imprinting of the 
Igf2-receptor gene which ensures internalization and degradation of IGF2 and exerts an 
anti-proliferative  effect  (Young  et  al.,  2001).  In vitro  mouse  embryo  culture,  in  the 
presence of bovine serum, showed altered expression patterns of imprinted genes Igf2 
and H19, and reduced growth (Khosla et al., 2001). In sheep, serum exposure leads to 
hypermethylation of the normally active maternal allele for the IGF2R and decreased 
expression. Further, embryonic stem (ES) cell-derived foetuses often show changes in 
methylation status of Igf2 and Igf2R resulting in aberrant gene expression and leading to 
abnormal foetal growth and perinatal death (Dean et al., 1998). Rats fed a LPD show 
reduced H19 expression in male blastocysts (Kwong et al., 2003) and altered levels of 
H19 and Igf2 transcripts in foetal liver (Kwong et al., 2006). 
These experiments demonstrate that changes in imprinted gene expression as a result of 
an adverse intrauterine environment or culture conditions induce subtle changes, which 
in most cases are manifest only in adult life. This corresponds well with the concepts of 
the  DOHaD  paradigm.  Interestingly,  recent  cloning  experiments  in  cattle  and  mice 
demonstrate  that  phenotypic  changes  induced  at  least  in  part  by  epigenetic  changes 
during in vitro culture and nuclear transfer, become corrected upon transmission through 
the germ line and do not affect phenotype across multiple generations (Thuan et al., 
2010). This is contradictory to some data, which show trans-generational effects of the 
DOHaD response (Drake and Walker, 2004; Mahsoudi et al., 2007). 
Epigenetic changes in genes linked with metabolic control 
Several  studies  have  analysed  the  epigenetic  status  of  other  non-imprinted  genes 
involved in regulating developmental and metabolic processes. Undernutrition impacts 
significantly  on  methylation  patterns  at  promoter  regions  of  both  the  peroxisomal 
proliferator-activated  receptor  alpha  (PPAR )  and  the  glucocorticoid  receptors  (GR), 
which  are  central  to  lipid  and  carbohydrate  homeostasis,  and  in  regulation  of  blood 
pressure (Lillycrop et al., 2005; 2007; Michalik et al., 2002). Hypomethylation of the Introduction 
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PPAR  promoter and enhanced activation of its target gene acyl-CoA oxidase (AOX) has 
regulatory  consequences  on  the  metabolism  of  lipids  and  carbohydrates  and  is 
consequently implicated as a cause of dyslipidemia in adults (Michalik et al., 2002). The 
GR is an important regulator of blood pressure, and changes in gene expression levels 
may  contribute  to  postnatal  hypertension  and  CVD.  Protein  restriction  at  the 
preimplantation stage also induces other metabolic changes demonstrated by an enhanced 
capacity  for  gluconeogenesis  and  peroxisomal  fatty  acid   -oxidation  in  response  to 
increased expression of hepatic GR and PPAR  (Lillycrop et al., 2007). This is likely to 
result in the onset of hyperglycaemia. Furthermore, the offspring of mice fed a LPD 
exhibit decreased expression of Dnmt1 (Lillycrop et al., 2007), which is important in 
maintaining  patterns  of  DNA  methylation  throughout  mitosis.  Failure  to  maintain 
methylation results in activation of genes that are not normally expressed (as shown 
above).  The  effects  of  reduced  expression  of  Dnmt1  can  be  prevented  by  folic  acid 
supplementation (Lillycrop et al., 2007). 
Nutritionally induced epigenetic modification of key developmental genes and the effects 
imposed on metabolic state by these changes are a possible mechanism for inducing 
adaptive responses and the associated metabolic disease in the adult.  
1.3.2 Physiological and metabolic adaptations 
Early proliferative capability effects on adult physiology and metabolism 
The  stem  cell  pool  for  foetal  and  extraembryonic  development  is  limited.  Metabolic 
stress during development can restrict embryo proliferation and blastocyst cell numbers 
in  both  the  ICM  and  TE  lineages  (Fleming  et  al.,  2004;  Thompson  et  al.,  2007). 
Consequently, the allocation of the appropriate number of cells during progression of 
gastrulation and organogenesis can be compromised. Such changes if they persist would 
inevitably impact on tissue structure. A depleted ICM may result in altered physiological 
activity of derivative foetal lineages, whereas extraembryonic lineages derived from both 
TE and ICM lineages may affect placental function and may therefore indirectly regulate 
foetal nutrition and growth (Fleming et al., 2004).  
Studies suggest a major role for the proliferative ability of early cell lineages in setting 
the  developmental  trajectory,  particularly  during  the  preimplantation  period,  and 
evidence  associates  embryo  environment  and  blastocyst  cell  numbers  to the  onset  of 
adult disease (Kwong et al., 2000). Decreased proliferation compromises the generation 
of appropriately sized stem cell lineages (with less ICM cells) in the blastocyst following Chapter 1 
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LPD and indeed early adaptations to have been shown to exert long-term effects on adult 
physiology and development (Kwong et al., 2000; Mitchell et al., 2009; Watkins et al., 
2007).  Proliferative  potential  during  development  may  act  as  a  general  adaptive 
mechanism that considerably influences hormonal regulation, physiological parameters 
and developmental potential of many organ systems. This may provide a mechanistic 
framework  for  the  effects  of  developmental  plasticity  and  in  concurrence  with  other 
regulatory  mechanisms  may  amplify  the  effects  of  nutrient  deprivation  and  induced 
phenotype.  
The effects of early physiological adaptations during development  
Many  studies  have  focussed  on  identifying  physiological  changes  associated  with 
enhanced disease risks due to in response to early embryo environment. For example, a 
reduction in nephron number has been seen following a prenatal LPD in rodents (Hoppe 
et al., 2007; Langley-Evans et al., 1999; Vehaskari et al., 2001; Woods et al., 2004). This 
has also been observed in offspring of sheep exposed to reduced nutrition during early-
mid gestation (Gilbert et al., 2005; Langley-Evans and Langley-Evans, 2003). Reduced 
nephron  number  is  likely  to  contribute  to  a  decline  in  renal  function  and  onset  of 
hypertension (Brenner and Chertow, 1993). Likewise, LPD has been shown to reduce 
pancreatic weight, islet cell mass, and the relative contribution of  -cells to the islets 
(Petrik et al., 1999; Snoeck et al., 1990). This may be due to an altered ratio of precursor 
cells that contribute to  - and  -cell lineages (Joanette et al., 2004) and may contribute to 
impaired glucose homeostasis (Fernandez-Twinn et al., 2005). LPD in rats alters the 
density of capillaries in the cerebral cortex (Bennis-Taleb et al., 1999) and reduces the 
density  of  neurons  expressing  appetite  regulatory  systems  (Plagemann  et  al.,  2000). 
Collectively,  these  studies  suggest  that  maternal  dietary  effects  on  proliferation  and 
differentiation can alter physiology in later life. 
Extraembryonic  lineages  are  likely  mediators  of  responses  to  maternal  diet  as  they 
regulate maternal-foetal nutrient transport. LPD treatment during early development in 
mice results in a smaller visceral yolk sac (VYS), a derivative of the ICM (Watkins et al., 
2008a). This is critical as the VYS contributes to early foetal growth as an important 
source of nutrient (Beckman et al., 1998b; Lloyd, 1990; 1998). The VYS surrounds the 
conceptus from early postimplantation development and is in direct apposition with the 
uterine  wall.  Its  rich  blood  supply  is  continuous  with  the  foetus  and  it  functions  in 
endocytotic uptake and lysosomal digestion of maternal proteins supplying amino acids Introduction 
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needed for foetal growth (Beckman et al., 1998a). A maternal LPD acts to stimulate VYS 
transport  capacity  by  increasing  expression  of  endocytotic  vesicles  and  receptors 
involved in VYS endocytotic activity (Watkins et al., 2008a), therefore increasing the 
supply  of  nutrients  during  a  critical  stage  of  foetal  development  (Figure  1.9).  This 
response  may  partially  stabilise  foetal  growth  and  enhance  competitive  fitness  in 
conditions of poor nutrient availability.  
Together these studies demonstrate that maternal nutrition can impact key processes of 
proliferation and differentiation in a way that negatively alters offspring physiology in 
adult life. 
 
Figure 1.9: Nutrient supply to the mouse embryo via the VYS 
(A)  The  development  of  important  placental  structures  in  the  mouse.  (B) 
Representative ultrastructure of VYS (from Watkins et al., 2008a). (C) Mechanism of 
nutrient uptake and supply in the endoderm of the VYS. Nutrients are endocytosed 
from the yolk sac and when inside they are digested in the cells lysosomes. After 
digestion the products are secreted into the mesenchymal cell layer of the VYS where 
they enter the vitelline circulation to be delivered to the embryo. Abbreviations: VE – 
visceral endoderm, AC – amniotic cavity, ECC - exocoelomic cavity, VYS – visceral 
yolk sac (Zohn and Sarkar, 2010). 
 Chapter 1 
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Many imprinted genes are involved with placental development and function, placental 
H19 and Igf2 transcripts are likely to regulate the supply of nutrients available to the 
foetus (Reik et al., 2003a). Consequently, alterations in expression of these genes as seen 
in the rat following maternal LPD treatments during preimplantation development may 
induce abnormalities in postnatal growth (Kwong et al., 2006). Therefore regulation of 
imprinted genes via maternal diet may have a major role in the DOHaD effect. 
1.3.3 Homeostatic changes 
Changes in adult phenotype may also be induced by homeostatic control mechanisms 
based around maternal-foetal neuroendocrine signalling. Attention has been drawn to the 
specific metabolic and endocrine pathways that are known to be deregulated in metabolic 
diseases such as CVD and T2D. Serum angiotensin-converting enzyme (ACE) converts 
angiotensin I (AT1) to angiotensin II (AT2) - a potent vasoconstrictor and regulator of 
blood pressure. Overexpression of this enzyme has been associated with hypertension 
and CVD in adults. In addition, overexpression of phosphoenolpyruvate carboxykinase 
(PEPCK), the rate-limiting enzyme in gluconeogenesis, results in insulin resistance and 
is a major contributor to T2D (Desai et al., 1997). Mouse embryo culture (Watkins et al., 
2007)  and  maternal  LPD  treatment  exclusively  during  preimplantation  development 
(Kwong et al., 2007; Langley-Evans et al., 1996b) induces increased hepatic expression 
of both ACE and PEPCK. Glucocorticoids (GC) are potent regulators of foetal growth 
and development and are known to affect glucose metabolism and hypertension in adults 
(Bertram et al., 2001). GC hormones bind to the cytosolic GC receptor (GR) to mediate 
their  action.  The  activity  of  GCs  is  regulated  by  two  isoforms  of  the  enzyme,  11 -
hydroxysteroid  dehydrogenase  (11 -HSD1  and  11 -HSD2).  Foetal  overexposure  to 
maternal GC induces life-long increases in GC action, which can lead to hypertension 
(Langley-Evans et al., 1996b). Changes in gene expression of these enzymes indicate 
foetal adaptations in response to nutrient availability where a maternal LPD appears to 
readjust the metabolic setpoints of PEPCK and 11 -HSD enzymes to the direction of 
enhanced glucose production. Alterations in GC regulation are a critical component in 
linking  nutrition,  foetal  growth  and  the  induction  of  impaired  glucose  tolerance  and 
hypertension in adults. Enhanced foetal exposure to these regulatory hormones can alter 
the  hypothalamus-pituitary-adrenal  (HPA)  axis.  Elevated  activity  can  modify  the 
expression of many downstream genes controlling growth and metabolism and overall 
physiological  structure.  There  is  clearly  genetic  regulation  of  these  hormones  during Introduction 
 23 
early development in response to nutrition, and these changes in gene expression can 
initiate the subsequent metabolic reprogramming (Lillycrop et al., 2005; 2007). 
The observations from these many studies demonstrate a conceivable molecular basis for 
maternal diet driven metabolic disease in the long-term. 
 
In  summary,  a  broad  range  of  animal  models,  have  utilised  a  number  of  nutritional 
interventions,  in  an  attempt  to  model  the  assosciations  between  developmental 
environment  and  long-term  physiological  function  and  health  as  described  by  the 
DOHaD hypothesis. The bulk of studies have been of a descriptive nature, characterising 
postnatal  phenotype,  and  although  this  diversity  of  nutritional  insults  in utero  across 
many strains and species exists, the range of phenotypic endpoints is generally consistent 
and narrow, with an enhanced risk of hypertension, glucose, and obesity reported in most 
models (summarised in Table 1.1). This suggets a small number of common mechanisms 
are active in response to foetal nutritional imbalance. Focus has now switched to identify 
these mechanims underlying the relationships observed, and experiments have shown 
that developing organisms act in response to the immediate environment by a complex 
array of evolutionary-conserved adaptive changes. These changes enable a multitude of 
epigenetic, metabolic and physiological states to exist. Interaction of these regulatory 
adaptations may act as a general mechanism that functionally alters homeostatic setpoints 
under  adverse  conditions.  This  enhances  the  initial  developmental  program  but  may 
enhance  disease  risk.  Importantly,  evidence  of  specific  associations  is  not  always 
consistent.  Differences  and  inconsitencies  between  models  can  reflect  differences  in 
species or strains of animals used, and composition/ timing of the nutritional insult. Such 
studies have shown critical and sensitive periods of development exist, where the embryo 
is particularly vulnerable to programming.  
 
Table 1.1: Summary of the common animal models and nutritional interventions utilised to 






Disease phenotype  Associated cellular/ molecular changes 
GLOBAL NUTRIENT RESTRICTION 
Rat  Gestational    BP 
(Woodall et al., 1996) 
Vascular dysfunction 
(Torrens et al., 2009a) 
  glomeruli 
(Tafti et al., 2011) 
  BP 
(Edwards and McMillen, 2002b)    Gestational 
Impaired glucose homeostasis 
(Owens et al., 2007a)   
  BP 
(Edwards and McMillen, 2001)   
Late gestation  Glucose intolerance 
Insulin resistance




  BP 
(Gilbert et al., 2005; Gopalakrishnan et al., 2004; Hawkins 
et al., 2000) 
  nephron number  
  ACE expression |   AT2 expression 
(Gilbert et al., 2005) 
Sheep 
Periconceptional    BP 
(Edwards and McMillen, 2002b; Gardner et al., 2004) 
Vascular dysfunction 
(Torrens et al., 2009b) 
 
Pig      BP 
(Poore and Fowden, 2002)   
INTRAUTERINE GROWTH RESTRICTION/ UTERINE LIGATION 
Rat      BP 
(Jansson and Lambert, 1999)   
Guinea pig  Mid-late gestation    BP 
(Persson and Jansson, 1992)    nephron number 
(Briscoe et al., 2004) 
Rabbit        nephron number 
(Bassan et al., 2000) 
LOW PROTEIN DIET 
  BP 
(Bertram et al., 2001; Langley-Evans et al., 1994; 1999; 
Torrens et al., 2006) 
Vascular dysfunction 
(Torrens et al., 2006; 2003) 
  nephron number 
(Langley-Evans et al., 1999; Woods et al., 2004) 
hypomethylation/ altered histone acetylation and   
GR expression 
(Bertram et al., 2001; Lillycrop et al., 2005; 2007) 
  11 -HSD expression 
(Bertram et al., 2001)  Gestational 
Insulin resistance 
(Fernandez-Twinn et al., 2005) 
Impaired glucose homeostasis 
Obesity 
(Bellinger et al., 2004; 2006) 
   -cell mass/ activity 
(Petrik et al., 1999; Snoeck et al., 1990) 
hypomethylation and  PPAR  expression 
(Lillycrop et 
al., 2005) 
Mid-late gestation    BP  
(Langley-Evans et al., 1999)    nephron number 
(Vehaskari et al., 2001) 
  BP 
(Kwong et al., 2000)    11 -HSD expression |   ACE expression 




Impaired glucose homeostasis 
  H19 and Igf2 expression 
(Kwong et al., 2006) 
  PEPCK expression 
Gestational      nephron number 
(Hoppe et al., 2007)  
  BP 
(Watkins et al., 2008a)    nephron number 
(Watkins et al., 2008b)  Mouse 
Preimplantation 
    VYS mass 
(Watkins et al., 2008a) 
Sheep  Mid-gestation    BP 
  GR expression 
  ACE expression 
(Whorwood et al., 2001) 
HIGH PROTEIN DIET 
Rat  Gestational  Obesity 
(Daenzer et al., 2002)   
Mouse  Gestational    BP 
(Thone-Reineke et al., 2006)   
HIGH FAT DIET 
  BP | Vascular dysfunction 
(Khan et al., 2005; 
2003; Taylor et al., 2005) 
 
Rat  Gestational 
Obesity, Glucose intolerance 
(Chen et al., 2008) 
Insulin resistance 
(Bayol et al., 2008) 
 
MICRONUTRIENT RESTRICTION 
  BP 
(Gambling et al., 2003)   
Rat  Gestational 
Obesity   Introduction 
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1.4 Stem cells as a model for embryonic development 
The above studies show that the pre-implantation period of development appears to be a 
decisive window of plasticity for setting permanent genetic, physiological and metabolic 
homeostatic  controls.  It  seems  that  changes  are  occurring  within  the  early  stem  cell 
lineages  of  the  blastocyst  prior  to  implantation  and  major  lineage  specification. 
Permanent imprinting of genetic features in these cells must be maintained in derivative 
cells as differentiation occurs. This would enforce permanent changes in the structure of 
specific tissues and impact on tissue function through metabolic regulation. Adaptive and 
maladaptive  changes  within  the  embryo’s  stem  cell  populations  therefore  have  the 
potential to integrate into the entire foetal and placental tissues. While potential candidate 
mechanisms  exist  to  explain  the  physiological  and  metabolic  changes  that  occur  in 
response to developmental environment, there has been little attempt to elucidate the 
changes that must occur within the stem cells populations of the preimplantation embryo. 
1.4.1 Embryonic stem cells as a model for embryonic development and the 
DOHaD response 
1.4.1.1 Stem cells of the preimplantation embryo – The ICM 
Stem  cells  are  defined  by  two  properties:  long-term  self-renewal  and  the  ability  to 
differentiate (Gardner and Beddington, 1988). Only the early embryo and the embryonic 
germ line possess truly pluripotent cells that can give rise to all adult cell types. True 
totipotency,  i.e.  the  capability  to  form  all  cell  types,  is  lost  during  early  cleavage 
divisions. The potential of each individual cell becomes restricted as the TE (outer cells) 
differentiates and envelope the ICM, which remains relatively undifferentiated. At this 
critical point, two distinct sources of stem cells are transiently produced which retain the 
capability to form multiple cell types (Hadjantonakis and Papaioannou, 2001; Smith, 
2001a).  These  stem  cell  populations  do  not  exist  for  long  due  to  the  rapid  rate  of 
development, but it is possible to capture these cells by in vitro culture techniques. 
ES cells can be isolated from the ICM, and trophoblast stem (TS) cells can be derived 
from the TE. The ICM cells are restricted in fate at an early stage of development where 
they are unable to form TE cells or any of their derivatives. In vivo, ICM cells can form 
all foetal cell types and extraembryonic tissues apart from the trophoblast. Initially the 
ICM differentiates to form the postimplantation EPI and extraembryonic endoderm (EE). 
The EPI cells are pluripotent cells that rapidly differentiate to form the three germ layers 
of the foetus during gastrulation. The developmental potential of all cell types gradually Chapter 1 
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becomes more restricted as differentiation occurs (Hadjantonakis and Papaioannou, 2001) 
(Figure 1.4). 
1.4.1.2 Origin and characteristics of ES cells 
In the early 1980s the first stem cell lines, termed ES cells, were derived from mouse 
blastocysts (Evans and Kaufman, 1981; Martin, 1981). These stem cells retained the 
pluripotent characteristics of the ICM cells in culture and were able to participate fully in 
embryogenesis, generating an ideal model to study aspects of embryonic development, 
which are otherwise difficult to examine in vivo. Whilst ES cells are able to differentiate 
into  cells  from  each  of  the  three  germ  layers,  to  form  all  tissues  of  the  foetus  and 
extraembryonic placental membranes, they will not contribute to the TB. This has been 
shown in vitro and after reintroduction into the blastocyst (Bradley et al., 1984), and is 
consistent with their origin from the ICM/ EPI of the embryo proper. Isolation of ES cells 
is  now  a  well-established  technique  and  cell  lines  can  be  derived  routinely  by  the 
dissociation of ICM cells from blastocyst outgrowths. The disaggregated ES cells can be 
maintained in culture and still retain pluripotent characteristic when cultured on mouse 
embryonic  fibroblasts  (MEFs)  and/  or  in  the  presence  of  leukaemia  inhibitory  factor 
(LIF).  
A complex system of cell-surface proteins, their molecular signalling pathways, and the 
TFs initiating or modulating target gene transcription that maintain pluripotency have 
been discovered demonstrating how the cells environment can be transmitted to the cell. 
This forms a stable system that sustains self-renewal and pluripotency, but will lead to 
differentiation under the correct signals, a process that is crucial during development in 
vivo. 
1.4.1.3 Extrinsic pluripotency factors 
Signalling cascades triggered by interleukin LIF 
Molecular analysis of ES cell cultures identified LIF as the active constituent capable of 
supporting  self-renewal  (Murray  and  Edgar,  2001;  Smith,  2001a;  Smith  et  al.,  1988; 
Williams et al., 1988).  
LIF, a member of the IL6 family of cytokines acts via its interaction with a heterodimeric 
receptor  LIFR   (LIF  receptor   )-gp130  (glycoprotein  130)  localized  on  the  cell 
membrane.  Ligand  binding  induces  activation  of  three  important  signalling  cascades: 
Janus  kinase ( JAK)/  Stat3  (signal  transducer  and  activator  of  transcription-3),  the 
phosphatidylinositol  3-kinase  (PI3K)-mediated  pathway,  and  the  mitogen-activated Introduction 
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protein kinase (MAPK) cascade. In the regulation of pluripotency JAK/ Stat3 is triggered 
solely by LIF, whereas multiple molecular signals are required to activate the PI3K and 
MAPK pathways (Niwa et al., 2009). Co-activation of these pathways is essential for 
regulation of the biological responses in ES cells 
LIF/ JAK/ Stat 
Several groups have shown the importance of Stat3 in the maintenance of pluripotency in 
ES cells (Boeuf et al., 1997; Matsuda et al., 1999; Niwa et al., 1998). In particular, 
inducible  expression  of  Stat3  revealed  that  Stat3  activation  was  sufficient  for  self-
renewal in the presence of foetal bovine serum (Matsuda et al., 1999). 
LIF  mediated  activation  of  LIFR -gp130  causes  JAK  recruitment  to  the  intracellular 
domain  of  gp130  (Boulton  et  al.,  1994).  Signal  transduction  occurs  via  Stat3 
phosphorylation causing its dimerization, translocation to the nucleus and transcription of 
genes involved in self-renewal (Niwa et al., 1998; Yoshida et al., 1994). 
MAPK/ ERK Cascade 
Active  gp130  receptor  can  associate  with  the  protein  tyrosine  phosphatase  SHP-2 
(Fukada et al., 1996), a positive effector of the MAPK signalling cascade, and lead to 
recruitment  of  Gab1.  The  complex  gp130/SHP-2/Gab1,  initiates  a  phosphorylation 
cascade that culminates in the activation of the ERK1 and ERK2 kinases (Takahashi-
Tezuka  et  al.,  1998)  (Figure  1.10).  The  ERK/  MAPK  pathway  along  with  the  FGF 
pathway regulates cell differentiation in mouse ES cells (Boeuf et al., 2001; Kunath et al., 
2007). Suppression of SHP-2/ ERK enhances ES cell self-renewal (Burdon et al., 1999) 
suggesting that ERK activation is necessary for differentiation processes. It was recently 
shown that ES cells could be cultured in the absence of extrinsic signals (feeders, serum 
and cytokines) by using a combination of small chemical inhibitors that target ERK/ 
MAPK and glycogen synthase kinase 3 (GSK3) pathways (Ying et al., 2008), and that 
ES cells lacking Fgf4 or ERK2 fail to differentiate under differentiation cues (Kunath et 
al., 2007). Interestingly Stat3 can prevent ERK from being activated and it is thought that 
the ERK pathway can also inhibit the JAK/ Stat3 pathway. ES cells carrying a knockout 
of  Shp2  phosphatase  show  increased  phosphorylation  of  Stat3  (Chan  et  al.,  2003) 
demonstrating that the two pathways converge to determine cell fate. ERK activation 
may  occur  downstream  of  PI3K,  which  is  also  important  in  ES  cell  self-renewal 
(Armstrong et al., 2006). Chapter 1 
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PI3K pathway 
PI3Ks mediate signal transduction through downstream effector molecules including the 
serine/threonine protein kinase B (PKB, also known as AKT) and 3-phosphoinositide-
dependent protein kinase (PDK1). PDK1 activates AKT, p70 ribosomal S6 kinase (S6K) 
and p90 ribosomal S6 kinase (RSK) (Williams et al., 2000). AKT has been implicated in 
many cellular processes like regulation of the cell cycle progression, cell death, adhesion, 
migration,  metabolism  and  tumorogenesis  (reviewd  by  Brazil  et  al.,  2004).  AKT 
regulates  many  downstream  targets  including  GSK3   (glycogen  synthase  kinase  3 ) 
(Alessi et al., 1996) and mammalian target of rapamycin (mTOR) (Hay and Sonenberg, 
2004).  These  pathways  control  GSK3   phosphorylation  thereby  regulating  its 
inactivation  (Figure  1.10).  PI3K  activity  appears  crucial  for  self-renewal  of  ES  cells 
(Takahashi  et  al.,  2005).  It  has  been  reported  that  the  inhibition  of  PI3K  and  AKT 
induces differentiation of mouse and human ES cells in the presence of LIF and feeder 
cells,  respectively  (Kim  et  al.,  2005a;  Paling  et  al.,  2004).  Loss  of  self-renewal  and 
differentiation following chemical inhibition of PI3K results in increased activity of ERK. 
Dual inhibition of PI3K and ERK restored self-renewal in these cells demonstrating a 
functional role for PI3K in negative regulation of ERK to promote self-renewal (Paling et 
al.,  2004).  Further, c onstitutive  expression  of  AKT  can  confer  LIF  independence 
(Watanabe et al., 2006).  -catenin (a transcriptional activator of pluripotency associated 
genes)  signalling  appears  to  be  involved  in  AKT-mediated  maintenance  of  the 
pluripotent  state  (Watanabe  et  al.,  2006).  This  is  independent  of  the  Wnt-signalling 
pathway, which is also a key regulator of  -catenin signalling. 
BMP signal pathway 
LIF is not sufficient to support self-renewal. Without serum, cells differentiate even in 
the presence of LIF. However, in the presence of Bone Morphogenic Protein (BMP4) 
differentiation is blocked by activation of SMADs, which induce expression of inhibitor 
of differentiation (Id) factors (Ying et al., 2003), promoting ERK inactivation (Burdon et 
al., 1999; Lodge et al., 2005; Qi et al., 2004) (Figure 1.10). Introduction 
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Canonical Wnt signalling 
In addition, the Wnt signalling pathway is involved in the short-term maintenance of 
pluripotency of both human and mouse ES cells (Aubert et al., 2002). The Wnt/ -catenin 
signal cascade is the key pathway involved in the regulation of ES cell differentiation 
(Figure 1.10). In the canonical pathway, Wnt protein combines with receptors Frizzled 
and LRP5/6 resulting in disassembly of a proteosomal complex composed of glycogen 
synthase kinase-3  (GSK3 ), adeomatosis polyposis coli (APC) and casein kinase I (CKI) 
(Liu et al., 2005). This complex normally promotes the proteolytic degradation of the  -
catenin intracellular signalling molecule. Therefore, degradation of the GSK3  complex 
will result in an accumulation of  -catenin in the cytoplasm, and translocation to the 
nucleus. Here, it acts as a transcriptional activator regulating expression of a series of 
genes including: Oct4, Nanog, Id and Stat3, thus inhibiting the differentiation (Reya and 
Clevers,  2005).  Wnt  signalling  is  endogenously  activated  in  ES  cells  and  is 
downregulated  upon  differentiation  (Sato  et  al.,  2004).  Wnt  signalling  activation  can 
upregulate Stat3 expression, suggesting that it has synergistic effect with LIF-Stat3 (Hao 
et al., 2006). 
1.4.1.4 Intrinsic pluripotency factors 
In  addition  to  these  extrinsic  factors,  a  network  auto-  and  cross-regulatory  TFs  are 
involved in self-renewal and anti-differentiation. Oct4, Nanog and SOX2 are considered 
essential to maintain pluripotency (Avilion et al., 2003; Chambers et al., 2003; Chambers 
and Smith, 2004; Niwa, 2007; Pesce and Scholer, 2001). These determinants of ES cell 
identity  perform  essential  roles  in  lineage  allocation  during  blastocyst  development 
(section 1.2.2.1). Chapter 1 
  30 
 
Figure  1.10:  Signalling  pathways  regulating  self-renewal  and  pluripotency  in 
mouse ES cells 
Pluripotency  is  regulated  by  LIF-dependent  JAK/  Stat  and  PI3K/  AKT  signalling 
pathways;  BMP-mediated  activation  of  Id  protein  transcription  and  suppression  of 
MAPK/ ERK; and WNT/ GSK3 signalling cascades. 
 
Oct4 is central to pluripotency  
Oct4 is a member of the POU-transcription factor family and is expressed in pluripotent 
cells  in  the  early  embryo  (Palmieri  et  al.,  1994).  Oct4  knockout  embryos  develop 
normally until the blastocyst stage but fail to give rise to ES cells (Nichols et al., 1998). 
ES cells derived from the ICM maintain expression of this TF and require continuous 
expression in conjunction with gp130 activation (Chambers and Smith, 2004) to maintain 
pluripotency. Expression levels are critical as RNAi-mediated knockdown results in TE 
cell  formation  (Hay  et  al.,  2004;  Hough  et  al.,  2006),  and  overexpression  causes 
differentiation to PE (Niwa et al., 2000). 
Sox2 interplay with Oct4 
SOX2,  a  member  of  the  HMG  DNA-binding  proteins,  is  a  cofactor  of  Oct4,  and  is 
required for expression of Oct4 and its target genes (Ambrosetti et al., 1997; Masui et al., 
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2007; Nishimoto et al., 1999). Like Oct4, Sox2 expression maintains pluripotency in the 
early  embryo  and  ES  cells.  Knockdown  stops  proliferation  and  self-renewal,  and 
promotes  TE  differentiation  (Avilion  et  al.,  2003;  Li  et  al.,  2007).  Similar  to  Oct4 
expression levels are critical for maintenance of pluripotency. Overexpression of Sox2 
causes differentiation towards neuroectoderm, mesoderm and TE (Kopp et al., 2008). 
Nanog  
Nanog may be a major downstream target for extrinsic factors as Nanog overexpression 
overcomes LIF-dependence for self-renewal (Chambers et al., 2003; Mitsui et al., 2003). 
Mouse embryos lacking Nanog fail to develop beyond the blastocyst stage due to the 
absence of EPI (Mitsui et al., 2003). Surprisingly, however, Nanog is not one of the TFs 
needed  for  reprogramming  of  somatic  cells  to  a  pluripotent  state  (Maherali  and 
Hochedlinger,  2008;  Okita  et  al.,  2007;  Takahashi  and  Yamanaka,  2006).  However, 
Nanog is expressed weakly or not at all in incompletely reprogrammed cells that fail to 
activate the endogenous pluripotent transcriptional circuitry (Silva et al., 2008; Sridharan 
et  al.,  2009),  and  induced  Nanog  enhances  the  efficiency  of  full  pluripotent 
reprogramming (Silva et al., 2009). Nanog appears to inhibit Gata factors (Chambers and 
Smith, 2004; Mitsui et al., 2003), preventing differentiation towards a PE fate and is 
thought to be reliant on formation of transcriptional networks with Oct4 and Sox2 (Boyer 
et al., 2005; Liang et al., 2008). It may be that Nanog is not required for establishment of 
pluripotency, but is necessary for generating ground state pluripotency and maintenance 
of self-renewal. 
A synergistic pluripotency network 
Oct4  and  Sox2  directly  interact  and  bind  to  mutual  promoter  regions,  activating 
expression of other stemness factors including the key pluripotency gene Nanog (Chew 
et al., 2005; Rodda et al., 2005; Tomioka et al., 2002), demonstrating a cooperative role 
in  maintenance  of  ES  cells.  Many  other  target  genes  which  function  in  maintaining 
pluripotency  and  also  in  promoting  differentiation  and  development,  are  bound  by 
combinations of these core pluripotency factors suggesting roles in positive and negative 
regulation of transcriptional activity (Boyer et al., 2005; Ivanova et al., 2006; Loh et al., 
2006; Wang et al., 2006). Hence, the key pluripotency-associated TFs positively regulate 
theirs,  and  each  other’s  expression  to  generate  a  stable  feed-forward  loop,  whilst 
repressing genes associated with differentiation to maintain pluripotency (Figure 1.11). 
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Figure  1.11:  Regulatory  interactions  between  the  TF  triad  Oct4,  Sox2,  and 
Nanog.  
The master regulators of pluripotency cooperate to block lineage commitment. They 
form  intrinsic  self-regulatory,  feed-forward,  and  feed-back  loops  that  ensure  high 
expression  levels  and  provide  self-stabilizing  system  of  the  factors  for  the 
maintenance of pluripotency (modified from Kim et al., 2008). 
 
Core transcription factors in reprogramming 
Differentiated  cells  can  be  induced  to  a  pluripotent  state  by  forced  expression  of 
particular  core  regulatory  TFs  demonstrating  their  importance  in  establishing  and 
maintaining pluripotent characteristics. Recent success in reprogramming somatic cells 
was  achieved  with  ectopic  expression  of  Oct4,  Sox2,  c-Myc  and  Klf4  to  reprogram 
mouse and human fibroblast cells to a pluripotent state (Okita et al., 2007; Takahashi and 
Yamanaka, 2006; Wernig et al., 2007). Yu et al (2007) showed that Oct4, Sox2, Nanog 
and LIN28 were sufficient to establish pluripotent cells from human somatic cells. These 
exogenous  reprogramming  factors  are  thought  to  activate  the  core  endogenous 
transcriptional circuitry for pluripotency as well as the expanded network TFs to remodel 
the cells expression profile. Pluripotent transcriptional profiles are not fully activated in 
partially reprogrammed cells. Here, binding of Oct4, Sox2, and Klf4 are compromised 
probably due to absent expression of other factors such as Nanog (Sridharan et al., 2009). 
In search of other essential pluripotency regulators, reprogramming has been achieved 
using other combinations of TFs with greater efficiency (Han et al., 2010). 
1.4.1.5 Epigenetic control of pluripotency 
TFs involved in maintaining pluripotency also work in concert with epigenetic factors 
and together maintain homeostasis in ES cells. 
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Epigenetic control of gene expression is, in part mediated by histone proteins, (Jenuwein 
and Allis, 2001; Margueron et al., 2005). These modifications act to repress or activate 
gene  expression  by  controlling  accessibility  of  RNA  polymerases  and  TFs  to  gene 
promoter regions. For example, tri-methylation of lysine 9 and lysine 27 of histone 3 
(H3K9 and H3K27) induces an gene repressive chromatin conformation, whereas H3K4 
tri-methylation, and acetylation of H3 and H4 are associated with active transcription 
(Jenuwein  and  Allis,  2001).  DNA  methylation  generally  represses  gene  expression 
(Santos and Dean, 2004).  
ES cells possess a unique chromatin landscape containing ‘bivalent domains’ (Bernstein 
et  al.,  2006)  which  is  thought  to  maintain  ES  cells  in  a  highly  dynamic  and 
transcriptionally permissive pluripotent state, primed for differentiation under the correct 
conditions.  This  is  achieved  by  applying  both  activating  and  repressive  chromatin 
modifiers at the same location within a gene’s promoter region.  
Using affinity purification followed by mass spectrometry, Oct4, Sox2, Nanog and other 
pluripotency  TFs  have  been  shown  to  directly  interact  and  regulate  many  chromatin 
regulators (Chen and Zhang, 2012). In addition, chromatin regulators also participate in 
regulating expression of core pluripotency factors (Chen and Zhang, 2012; Loh et al., 
2007). 
Cell cycle of mES cells: A role in preventing differentiation 
Like the cells of the epiblast in the preimplantation mouse embryo, mouse ES cells in 
vitro have an unusual cell cycle dynamic. Specifically, the G1 (gap phase 1) checkpoint 
is truncated in proliferating epiblast and ES cells (Savatier et al., 1996; Wianny et al., 
1998). Consequently these cells spend the majority (~60%) of their time in the S-phase 
(period  of  chromosome  replication)  (MacAuley  et  al.,  1993;  Stead  et  al.,  2002) 
accounting for their rapid rate of proliferation (Savatier et al., 1994; Stead et al., 2002; 
White and Dalton, 2005). It is not possible to induce quiescence—withdrawal from the 
cell cycle to a G1 or G0 state in undifferentiated ES cells (Smith, 2001a). 
Cell  cycle  progression  is  regulated  by  cyclin  dependent  kinases  (CDKs).  Usually, 
completion of each phase of the cell cycle requires activation of at least one phase-
specific CDK complex (Nurse, 1990; 2000). This complex consists of the CDK subunit, 
and a regulatory cyclin subunit. The cell cycle progresses with overlapping waves of 
phase-specific CDK activity, defining the order of the cell cycle. Chapter 1 
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ES cells exhibit increased levels of cyclins and CDKs throughout the cell cycle, and lack 
the CDK periodicity described for somatic cells (Faast et al., 2004; Stead et al., 2002) . 
As well as this unusual CDK activity, ES cells do not express CDK inhibitory (CDKI) 
molecules (Faast et al., 2004; Savatier et al., 1996) , which are usually involved in cell 
cycle  arrest.  Together  these  can  account  for  their  rapid  cell  division  rates.  ES  cell 
differentiation is associated with increased expression of cyclin D and establishment of a 
fully formed G1 phase, and the rate of cell division slows (Savatier et al., 1996). This can 
occur if LIF or feeder layers are withdrawn from mouse ES cell cultures. Then, cell 
division continues for only a few days as the process of differentiation begins (Smith, 
2001a). 
1.4.1.6 ES cell Potential 
The isolation of stem cell populations of the early embryo has deeply influenced the 
study of embryonic development. ES cells, due to their ICM origin have huge potential in 
determining the processes of foetal and extra embryonic development and therefore have 
been useful for studies of cell fate and lineage specification. Genetic manipulation of ES 
cells and subsequent generation of transgenic mice in chimeras (Robertson, 1991) has 
enabled  insight  into  gene  function.  ES  cells  also  have  remarkable  developmental 
potential in vitro. They are able to form cell types of all three embryonic germ layers 
under appropriate culture conditions. This has been utilized to determine differentiation 
pathways for many cell types (Keller, 1995). ES cells provide an invaluable model for 
studying developmental potential and genetic and epigenetic characteristics of these early 
founder  lineages,  from  which  informative  parallels  can  be  drawn  for  in  vivo 
embryogenesis. 
1.4.2 Trophoblast stem cells as a model for placental development 
The  TB  lineages  form  the  bulk  of  the  placenta  and  are  central  to  maternal-foetal 
interactions  and  nutrient  transport.  Placental  disorders  have  adverse  effects  on  foetal 
growth and although only a temporary organ, incur long-term costs (Godfrey, 2002). 
IUGR as a result of placental or maternal disease restricts nutrients supply to the foetus 
reducing  foetal  growth  (Constancia  et  al.,  2002;  Reik  et  al.,  2003a).  CVD  and 
behavioural  responses  in  offspring  are  associated  with  these  placental  insufficiencies 
(Baschat and Hecher, 2004; Constancia et al., 2002; Reik et al., 2003a). Placental growth 
and  nutrient  supply  are  regulated  in  part  by  epigenetic  control  of  imprinted  gene 
expression  (Constancia  et  al.,  2002).  Alterations  in  imprinted  gene  expression  are Introduction 
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associated with changes in foetal and placental endocrinology. TS cell can be captured in 
vitro from the blastocyst by the supplementation of FGF4 and its cofactor heparin (Oda 
et al., 2006; Tanaka et al., 1998). They are restricted in their differentiation potential to 
placental lineages confirming their identity as a TE derivative (Kunath et al., 2001). 
Using TS cells to study the characteristics of extraembryonic lineages may be useful in 
determining mechanisms of foetal adaptations in response to poor intrauterine conditions. 
1.4.3 Stem cells as a model for embryo adaptive responses 
It  seems  that  the  initiating  factors  for  foetal  adaptations  in  response  to  immediate 
environment may reside primarily in the early cell lineages of the blastocyst (Fleming et 
al., 2004; Kwong et al., 2000; Watkins et al., 2010; 2007), and that there are long-term 
consequences of changes in these cells that impact on the adult tissues. 
The three types of stem cells of the preimplantation embryo, give rise to all feto-placental 
tissues. Adaptive changes to these cells by their direct environment have a potentially 
great  impact  on  future  development.  Although  the  effects  of  preimplantation 
undernutrition on offspring can be investigated relatively easily, it is much more of a 
challenge to determine the mechanisms that cause these changes. The small number of 
cells within the blastocyst and their rapid rate of differentiation under normal conditions 
make it difficult to quantify metabolic, physiological, or genetic changes. It is possible 
that stem cells isolated from ‘adapted’ embryos may also display changes in response to 
the  environment  and  provide  a  novel  tool  to  study  the  mechanisms  behind  adaptive 
responses during development.  Assuming that these cells retain the characteristics of 
their  founder  cells,  gene  expression  characterization  and  functional  analysis  of  these 
undifferentiated  stem  cells,  or  in  vitro  differentiation  into  specific  developmental 
lineages, provides a scalable model to compare the effects of nutritional treatments. 
It  should  be  noted  however  that  the  ES-cell  precursors  only  exist  transiently  during 
development; ES cells can therefore be defined as a cell type existing only in cell culture. 
The origin of these cells provides a window into the processes of early development, yet 
the artificial conditions in which ES cells exist must be considered. It is possible that the 
process of ES cell derivation and in vitro culture conditions change the properties of the 
original cells (Chambers and Smith, 2004; Smith, 2001b). However the transcriptome 
analysis of mES cells and embryos reveal a very similar gene expression profile (Sharov 
et al., 2003), and the fact that ES cells reintroduced into the blastocyst never give rise to 
extraembryonic tissues (Rossant et al., 2003) suggests that they do in fact correspond to Chapter 1 
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the epiblast cells. However, ES cells can be induced to form TB by downregulation of 
Oct4 (Niwa et al., 2000) or forced expression of CDX2 (Niwa et al., 2005). Spontaneous 
differentiation to PE cells types occurs in culture and can be induced by overexpression 
of Gata4/ 6 (Fujikura et al., 2002) or by downregulation of Nanog (Mitsui et al., 2003). 
These differentiation conditions however do not occur in vivo, and may just represent 
relaxation of developmental constraints as a consequence of in vitro culture on the cells. 
Another cause for concern is loss of genomic imprinting in ES cells. It’s known that 
disrupting imprinting patterns in blastocysts in vivo may result in foetal abnormalities, 
and as discussed, maternal diet can alter genomic imprinting with potential long-term 
consequences. In vitro culture of embryos or ES cells grown may disrupt normal patterns 
of  imprinting.  For  example,  foetal  calf  serum  in  human  ES  cell  cultures  decreases 
expression  of  certain  imprinted  genes  (Khosla  et  al.,  2001).  However,  in  mES  cell 
cultures the parental imprinting patterns persist (O'Shea, 1999; Rohwedel et al., 1996).  
In summary ES cells constitute the model most similar to the preimplantation embryo, 
retaining the ability of the ICM cells to generate all cell types of the foetus (Beddington 
and Robertson, 1989). The potential of ES cells to maintain additional characteristics of 
their in vivo counterparts provide a valid model for understanding early developmental 
adaptations that cannot be easily studied in vivo. In addition, ES cells can generate a 
multitude of differentiated cell types (reviewed by Keller, 2005) useful for studying the 
DOHaD response. In particular, formation of cardiomyocytes and vascular endothelial 
cells, insulin producing cells, hematopoietic cells and a variety of neurons may provide 
some insight into the onset of DOHaD related disorders.  
1.5 Cell death 
Cell  death  plays  an  important  role  in  peri-implantation  development,  eliminating 
abnormal cells and regulating embryo cell number (Pampfer and Donnay, 1999). Both 
rapid  proliferation,  and  cell  death  occur  from  as  early  as  the  8-cell  stage  and  their 
interplay  is  crucial  for  normal  development  (Huppertz  and  Herrler,  2005).  There  are 
growth changes connected with suboptimal embryo environment, some of which may be 
linked  with  cell  death.  Maternal  undernutrition  during  preimplantation  development 
generates a hyperglycemic intra-uterine environment (Eckert et al., 2012; Kwong et al., 
2000), and embryos from diabetic mice or cultured under hyperglycaemic conditions 
show a decreased number of ICM cells of the preimplantation embryo (Beebe and Kaye, 
1991; Pampfer et al., 1990; Vercheval et al., 1990), associated with increased cell death Introduction 
 37 
restricted largely to the ICM (Gareskog et al., 2007; Moley et al., 1998; Pampfer et al., 
1997b). This was coincident with reduced levels of IGF-I in the uterus (Zakaria et al., 
2007) which is known to inhibit apoptosis and stimulate blastocyst cell proliferation in 
vitro  (Harvey  and  Kaye,  1992;  Kaye  et  al.,  1992).  Indeed  mouse  preimplantation 
embryos cultured with IGF-I showed decreased spontaneous apoptosis (Kurzawa et al., 
2001). Studies in the rat fail to show an increase in apoptosis upon maternal dietary 
restriction,  however,  as  this  is  a  rapid  process  and  there  are  few  cells  present, 
demonstrating an increased rate of cell death may be challenging (Kwong et al., 2000). 
This has not been studied in the mouse. 
As  cell  death  was  studied  in  some  depth  in  and  this  thesis  some  of  the  important 
pathways regulating cell death are discussed here: Healthy development not only relies 
on regulated proliferation and differentiation processes, but also controlled elimination of 
unwanted cells by cell death. Interplay between these processes, and the mechanisms of 
cell death are particularly important during early embryo development. Cell death can 
occur in many ways but can be broadly categorised into two main types; unprogrammed, 
or programmed (Melino et al., 2005). Unprogrammed cell death, necrosis, can result 
from cellular infections/ injury, or from toxins. Necrosis is characterised by uncontrolled 
swelling  and  rupture  of  the  cell  and  release  of  cellular  contents,  provoking  an 
inflammatory  response  and  loss  of  surrounding  cells  (Majno  and  Joris,  1995). 
Programmed cell death (PCD), minimises inflammation by following a controlled set of 
pathways which prevents release of harmful cellular components (Green, 2011). 
Apoptosis is the most common and extensively studied form of PCD, recognised by 
stereotypical  morphological  changes;  cell  shrinkage,  chromatin  condensation,  nuclear 
fragmentation, and membrane blebbing (Kerr et al., 1972; Wyllie et al., 1980). These 
changes are a consequence of a complex, energy-dependent cascade of biochemical and 
molecular events, which culminates in activation of cytoplasmic endonucleases, causing 
degradation of nucleic acids (Nagata, 2000), and proteases that degrade cytoskeletal and 
nuclear protein substrates (Luthi and Martin, 2007). Degraded cellular components are 
reorganised  into  membrane-bound  apoptotic  bodies  and  phagocytised  preventing  an 
inflammatory response (Elmore, 2007; Kurosaka et al., 2003). 
To  ensure  a  tightly  regulated,  yet  efficient  system  of  events,  the  apoptotic  process 
requires the interplay of a multitude of factors. A diverse range of apoptotic stimuli, from 
either outside or inside the cell, can initiate a number of pathways. These death signals Chapter 1 
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converge to activate common cell death machinery which is involved in the initiation, 
mediation, execution, and regulation of apoptosis (Reviewed by Adams, 2003). 
1.5.1 The Executioners of apoptosis – Caspases 
Caspases, cysteine proteases are the central executioners of apoptosis and are activated in 
most  cases  of  cell  death  (Bratton  et  al.,  2000;  Earnshaw  et  al.,  1999).  They  can  be 
divided into two groups; the initiator, and effector caspases. To prevent unwarranted cell 
death, each member is maintained as an inactive precursor, a zymogen. Initiator caspases 
(-2, -8, -9, -10) are found as inactive monomers. Activation can occur by recruitment to a 
multi-protein  complex,  leading  to  dimerization  of  the  zymogen  and  autocatalysis 
(Boatright and Salvesen, 2003; Stennicke and Salvesen, 1999). The initiator caspases 
then cleave the pro-caspase form of their target executioner caspases (-3, -6, -7) into their 
active forms (Riedl and Shi, 2004). These active caspases then proteolytically cleave 
their distinct cellular substrates (Slee et al., 2001). Caspase-3 is considered the most 
important as it is activated by any of the initiator caspases and has a wide  array  of 
cellular substrates (Walsh et al., 2008). 
1.5.2 Mechanisms of Apoptosis: Intrinsic vs. Extrinsic. 
Two principle pathways of caspase activation have been determined (Reviewed by Fulda 
and  Debatin,  2006).  The  extrinsic  pathway  is  triggered  by  engagement  of  the  death 
receptors  by  ligands  such  as  tumour  necrosis  factor  (TNF)- ,  TRAIL,  and  FAS-L. 
Recruitment, and activation of the adaptor molecule, FADD, and initiator caspases -8, or 
-10, enables direct cleavage and activation of downstream effector caspases (Walczak 
and Krammer, 2000).  
The intrinsic pathway is induced by various intracellular stress signals, and is regulated 
by the Bcl-2 family of proteins (Reviewed Adams, 2003; Strasser et al., 2000). These 
mediate  release  of  apoptogenic  factors  from  the  mitochondrial  intermembrane  space, 
which triggers activation of caspase 9 and cell death (Earnshaw, 1999; Saelens et al., 
2004) (Figure 1.13). The Bcl-2 family contains both pro- and anti-apoptotic members. 
The antagonistic functional properties of these proteins enable tight regulation of cell 
death responses in the cell. There are three major subfamilies of these proteins. The BH3-
only  proteins,  BOPs  (tBid,  Noxa,  Puma,  Bik,  Bim,  Hrk,  Bmf,  Bad),  are  essential 
initiators of apoptosis, and primarily antagonise the anti-apoptotic Bcl-2 members (Bcl-2, 
Bcl-xL,  Bfl-1,  Mcl-1,  Bcl-w).  The  other  pro-apoptotic  members,  the  ‘pore-formers’ Introduction 
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(BAX,  BAK,  BOK)  are  normally  antagonised  by  anti-apoptotic  members  to  prevent 
apoptosis (Figure 1.12 ) (Bouillet and Strasser, 2002a; 2002b; Oltvai et al., 1993).  
 
Figure 1.12: Mechanisms of controlling apoptosis by Bcl-2 family proteins. 
The  Bcl-2  family  consists  of  proapoptotic  and  anti-apoptotic  members.  The  anti-
apoptotic members share a number of Bcl-2 homology (BH) domains (BH1-4). BH1-3 
domains of the Bcl-2-like proteins (yellow) form hydrophobic pockets to which BH3-
only proteins (BOPs; orange) can bind and inhibit the anti-apoptotic function of these 
proteins.  The  multi-domain  pro-apoptotic  proteins  (BAX/  BAK,  BOK;  red)  also  use 
BH1-3 to form hydrophobic pockets, and in viable cells, form a complex with Bcl-2 
proteins inhibiting initiation of apoptosis (modified from Adams, 2003).  
 
Individual BOPs transduce specific death signals and can be activated by sensing cellular 
stresses such as DNA damage. BOPs are either expressed or activated to inhibit anti-
apoptotic  factors,  enabling  release,  translocation  of  the  BAX/  BAK/  BOK  to  the 
mitochondria, and permeabilisation of the outer mitochondrial membrane (Eskes et al., 
2000; Martin, 2010). This results in efflux of apoptogenic proteins, formation of the 
apoptosome (Chinnaiyan, 1999) and initiation of the caspase cascade (Figure 1.13).  
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Figure 1.13: Regulation of cell intrinsic apoptosis by Bcl-2 proteins.  
In healthy cells caspases are present as zymogens, and BOPs are sequestered away 
from Bcl-2-like proteins. Intrinsic apoptosis is initiated under stress, inducing BOPs to 
associate with Bcl-2-like proteins at the mitochondrial membrane. BAX/BAK are freed 
and oligomerise leading to permeabilisation of the mitochondrial outer membrane and 
release of apoptogenic factors such as cytochrome c, AIF, Smac /DIABLO, Omi/HtrA2 
and endonuclease G from the mitochondrial intermembrane space.  The release of 
cytochrome c into the cytosol triggers caspase-3 activation through formation of the 
cytochrome c/Apaf-1/caspase-9-containing apoptosome complex. Smac/DIABLO and 
Omi/HtrA2 promote caspase activation through neutralizing the inhibitory effects of the 
inhibitors of apoptosis (IAPs) whereas AIF causes DNA condensation (modified from 
Adams, 2003). 
 
The levels at which these proteins are expressed relative to one another, their location in 
the cell, and whether they are post-translationally modified contributes greatly to the 
balance of active agonistic to active antagonistic Bcl-2 proteins. 
1.5.3 Survival signalling - Inhibition of apoptotic processes. 
In order to accurately determine whether cells live or die, cells are required to interpret 
and integrate external signals on a continuous basis. These cell fate decisions are made 
by  a  limited  number  of  cognate  signalling  pathways,  controlled  by  kinases.  The 
PI3K/AKT, Raf/MEK/ERK, JAK/ Stat, and stress-induced JNK and p38 MAPK signal 
transduction pathways are integral in this cell fate processing, regulating cell survival by 
controlling  cell  death  mechanisms.  Cell  survival  is  achieved  by  active  inhibition  of 
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apoptosis, using various strategies to target apoptotic machinery at a number of points in 
the apoptotic pathway. There are many examples where activation of the cell survival 
pathways regulates expression or activity of pro-survival and pro-apoptotic Bcl-2 family 
members, caspases, or function of the death receptor pathway. This can be controlled 
either directly by phosphorylating components of the cell machinery, or indirectly by 
changing  the  expression  levels  of  genes  that  encode  these  apoptotic  proteins.  The 
mechanisms  by  which  these  pathways  inhibit  apoptosis  are  complicated  and  vary 
depending on cell type and the stimulus the cell receives. 
Transcriptional and translational control of apoptotic protein function 
mediates cell survival. 
The cell survival pathways cooperate in promoting survival by regulation of common 
targets  (Figure  1.14).  Stimulation  of  ERK  and  AKT  acts  principally  to  attenuate 
activation of the intrinsic apoptotic pathway, by preventing dimerization and activation 
of  the  ‘pore-formers’  (BAX/  BAK),  thus  blocking  activation  of  the  caspase  cascade. 
Activation  of  apoptosis  requires  upregulation  of  proapoptotic  genes.  ERK/AKT  can 
protect cells by interfering with the apoptotic transcriptional programme. For example, 
upon ERK/ AKT- mediated phosphorylation, FOXO TFs bind to 14-3-3 proteins causing 
its  sequesterisation  in  the  cytoplasm, preventing  association  with  pro-apoptotic  target 
genes in the nucleus (Brunet et al., 1999; Dijkers et al., 2000; Fu and Tindall, 2008). 
Mechanisms also exist to also upregulate anti-apoptotic Bcl-2-like proteins and caspase 
inhibitors to block cell death (Wang et al., 1998; Zong et al., 1999) (Table 1.2).  
Regulation of cell survival/ death via AKT/ ERK can occur without requirement for new 
protein synthesis, by direct post-translational modifications cell death machinery. For 
example  phosphorylation  of  pro-apoptotic  BOPs  causes  sequesterisation  by  14-3-3 
proteins, preventing them from targeting and inhibiting the protective function of Bcl-2-
like proteins, to promote cell death. In other examples, phosphorylation of BOPS can 
lead to their degradation (Ley et al., 2003) (Table 1.2). 
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Figure 1.14: Cell Survival pathways. 
The  PI3K/AKT,  ERK  MAPK,  and  JAK/  Stat  pathways  mediate  the  expression  and 
function  of  many  proteins  that  are  essential  for  cell  survival.  Via  these  signal 
transduction  pathways,  activity  and  expression  of  pro-apoptotic  proteins  can  be 
altered to block apoptosis. In addition, cells can promote cell survival by enhancing 
activity or expression of anti-apoptotic molecules. 
 
1.5.4 Mechanisms of apoptosis induced by stress-related MAP kinases 
Whilst ERK MAPK is generally considered to have a cytoprotective role, the stress-
related MAPKs, JNK and p38 MAPK function in promoting apoptosis in response to cell 
stress  (Wagner  and  Nebreda,  2009;  Xia  et  al.,  1995).  Normally,  MAPK-dependent 
apoptosis is supressed by the survival pathways mentioned above. Activation of these 
pathways is complicated and may require parallel activation of other pathways.  
As  with  the  survival  signalling  pathways,  JNK  and  p38  can  regulate  apoptosis  by 
targeting  TFs  that  control  expression  of  apoptotic  proteins,  or  by  direct  directly 
modulating activities of these proteins through distinct phosphorylation events (Aoki et 
al., 2002; Schroeter et al., 2003) (Figure 1.15; Table 1.2). For example, JNK promotes 
cell  death  by  phosphorylation  of  pro-apoptotic  BOPs,  releasing  them  from 
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sequesterisation and enabling activation of BAX/ BAK, and initiation of the caspase 
cascade (Lei and Davis, 2003; Letai et al., 2002). JNK also neutralises the activity of pro-
survival  BCL2  proteins  (Cai  et  al.,  2006;  Puthalakath  et  al.,  1999;  Puthalakath  and 
Strasser, 2002; Sunayama et al., 2005). JNK activation also leads to phosphorylation and 
translocation of a number of TFs enabling upregulation of pro-apoptotic proteins. c-Jun 
and p53 are the most extensively studied transcriptional substrates of JNK (Cai and Xia, 
2008; Fan et al., 2001) Importantly, JNK can negatively regulate ERK and there may be 
crosstalk  between  these  signalling  pathways  (Black  et  al.,  2002;  Shen  et  al.,  2003; 
Zuluaga et al., 2007) (Table 1.2). 
 
Figure 1.15: Mechanisms involved in JNK and p38 MAPK-mediated apoptosis. 
JNK  and  p38  increase  expression  of  pro-apoptotic  genes  through  targeted 
phosphorylation and transactivation of a number of TFs. In addition, activated MAPKs 
can  directly  target  and  inhibit  anti-apoptotic  activity  of  Bcl-2  proteins  and/  or 
phosphorylate BOPs, which can antagonize the Bcl-2 proteins. This enables release 
of apoptogenic factors from the mitochondria, initiation of the Caspase cascade and 
cell death. ERK and AKT survival pathways are also negatively regulated by activation 
of stress-related MAPKs.  
  
 
Table 1.2: Regulation of apoptotic machinery by intracellular signalling pathways 
  ERK  AKT  JAK/STAT  p38 MAPK  JNK 
Transcriptional 
Regulation 
ERK-activated RSK activates 
CREB  » upregulates Bcl-2, 
Bcl-xl, Bcl-1 (Ballif and Blenis, 2001; 
Bonni et al., 1999) 
Activates TF NFkB which upregulates 
Bfl1 (Zong et al., 1999), c-IAP1, c-IAP2 (Wang et 
al., 1998),  Bcl-2 (Kurland et al., 2001) 
Stat3 upregulates 
Mcl-1, Bcl-2, c-IAP 
(Bhattacharya et al., 2005) 



















increasing activity (Domina et al., 
2004) 
Phosphorylates Mcl-1 increasing activity 
(Longo et al., 2008) 
Stabilizes Bcl-w (Garofalo et al., 2008) 
- 
Phosphorylates Bcl-2 causing 
degradation (Markou et al., 2009) 
NGF inactivates p38 preventing 
Bcl-2 phosphorylation (Torcia et al., 
2001) 
Phosphorylates Bcl-2 on Ser70 
causing dissociation from BAX 
(Ishikawa et al., 2003) 
Phosphorylates Bcl-xL »  abrogates 
ability of  
to bind to Bax (El Fajoui et al., 2011) 
Phosphorylates Bcl-2 on Ser70 » 
dissociation from Bax (Shitashige et al., 2001) 
Blocks ERK activation (Black et al., 2002; 
Shen et al., 2003) 
Transcriptional 
Regulation 
NGF causes ERK activation 
and downregulation of Bim 
(Biswas and Greene, 2002) 
Phosphorylates TF FOXO3A  » 
Sequesterisation by 14-3-3  » prevents 
Bim (Brunet et al., 1999; Dijkers et al., 2000; Fu and 
Tindall, 2008; Gilley et al., 2003)/ PUMA 
transcription (You et al., 2006) 
Downregulates Bad (Cowburn et al., 2002).
 
Phosphorylates TF FOXO1  » 
Sequesterisation by 14-3-3  » prevents 
Bax transcription (Kim et al., 2005b) 
-  Activates TF FOXO3A » 
upregulates Bim (Cai and Xia, 2008) 
Caused degradation of TF p53 »  
Upregulates Bax, Puma (Fuchs et al., 1998; 
Wong et al., 2005) 
Phosphorylates c-jun  » increases 
expression of pro- TNF- , Fas-L, and 


















Phosphorylates Bad » 
Sequesterisation by 14-3-3 
(Eisenmann et al., 2003) 
Phosphorylates Bim causing 
dissociation from Mcl-1 and 
Bcl-xL (Ewings et al., 2007a; 2007b) 
Phosphorylates BimEL 
»causes ubiquitnation and 
degradation (Ley et al., 2003) 
Phosphorylation of  
procaspase 9 (Allan et al., 2003) 
Phosphorylates Bad, » Sequesterisation 
by 14-3-3 (Datta et al., 1997; Gottlieb et al., 2000; Zha et 
al., 1996). 
Phosphorylates Bax Ser184 
sequesterisation in cytoplasm by pro-
survival members (Gardai et al., 2004) 
Phosphorylates Bim » Sequesterisation 
by 14-3-3 (Qi et al., 2006) 
Phosphorylation of  procaspase 9 (Cardone et 
al., 1998) 
- 
Phosphorylates BimEL (Cai et al., 
2006) 
Phosphorylates Bax causing 
activation and mitochondrial 
translocation (Kim et al., 2006) 
Phosphorylates Bim (Lei and Davis, 2003; 
Puthalakath et al., 1999) / Bmf (Letai et al., 2002; 
Puthalakath et al., 2001) » releases from 
myosin V motor complex enabling 
interaction with Bax/ Bak 
Phosphorylates Bad at Ser128 » 
inhibits14-3-3 sequesterisation » Bad 
inhibits Bcl-2 (Sunayama et al., 2005) 
Cleaves Bid to jBid » Translocates to 
mitochondria releasing Smac/ 
DIABLO (Deng et al., 2003) 
Phosphorylates Bax causing 
mitochondrial translocation (Kim et al., 
2006) Introduction 
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1.6 Project Rationale 
As outlined above, periconceptional maternal undernutrition alters embryo environment, 
affecting  foetal  growth  and  metabolic  function,  and  enhancing  the  risk  of  metabolic 
disease.  This  suggests  that  significant  changes  must  occur  within  the  stem  cell 
populations of the early embryo, before lineage specification. However such changes 
have not been extensively studied.  
Altered blastocyst cell numbers in response to in vitro culture or maternal LPD suggests 
that there is a significant effect on cell proliferation and lineage allocation. Evidence of 
epigenetic  changes  and  loss  of  developmental  potential  in  ES  cells  cultures  also 
demonstrates  significant  reprogramming  in  response  to  unfavourable  conditions. 
Previous studies have used MF-1 mice to study preimplantation maternal undernutrition. 
The genetic variability in this strain has makes it difficult to pinpoint subtle embryonic 
changes  that  may  occur  as  a  result  of  a  LPD  challenge.  Further,  studying  molecular 
changes  in  the  very  early  embryo  is  difficult  due  to  ethical  and  cost-related  issues. 
Limitations in embryo availability, the small size, and the rapid rate of development at 
this stage, make it challenging to study in detail. Therefore molecular changes induced 
within the blastocyst have not been investigated in detail and thus provides a basis for the 
study of these stem cell populations. 
We  aim  to  define  mechanisms  by  which  environmental  factors  influence  blastocyst 
potential  in  inbred  mice  (to  remove  genetic  variability)  with  a  major  focus  on  the 
embryo’s  stem  cell  populations.  Generating  ES  cell  lines  from  environmentally 
challenged embryos enables the study of functional and molecular characteristics of these 
early foetal progenitor cells in more detail than in the blastocyst. As progenitors of all 
fetal  cells,  ES  cells  may  be  useful  for  investigating  embryonic  plasticity  in  fetal 
development and the consequences of changes to these stem cells on development of 
derivative lineages. This ES cell model may improve our ability to address complex 
interactions between embryo environment and early development. Chapter 1 
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1.6.1 Project objectives 
Therefore this thesis has several research objectives: 
1. To analyse the effects of maternal diet on pluri-potential and cell lineage allocation in 
the blastocyst. 
2. To assess the effects of maternal diet on pluripotency and cell lineage allocation in 
blastocyst outgrowths in vitro. 
3. To analyse the effects of maternal diet on the ability to isolate ES cells from blastocyst 
outgrowths. 
4. To  characterise  the  ES  cells  isolated  from  nutritionally-challenged  and  control 
blastocysts 
5. To investigate the sex-specific effects of maternal diet on proliferation, cell cycle and 
metabolism in these ES cell lines. 
6. To investigate the effects of maternal diet on cell death. 
7. To investigate the molecular pathways involved in these processes  
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Chapter 2:   General methods and materials 
2.1 Animal Procedures 
2.1.1 Animals 
All mice and experimental procedures were conducted using protocols approved by, and 
in accordance with, the UK Home Office Animal (Scientific Procedures) Act 1986 and 
local ethics committee at the University of Southampton under UK Home Office Project 
License PPL30/2467.  
C57BL/6 mice (University of Southampton Biomedical Research Facility) were housed 
on  a  controlled  07.00-19.00  h  light  cycle  at  21°C  and  fed  standard  laboratory  chow 
(Special  Diet  Services),  and  water  ad  libitum,  except  where  mentioned  below.  For 
experiments, 7-10 week old females were naturally mated with sexually mature males. 
Mating  was  confirmed  the  following  morning  (0.5  days  post-coitum;  dpc)  by  the 
presence of a copulation plug. 
2.1.2 Blastocyst (3.5 dpc) collection 
Mice were killed by cervical dislocation and intact uteri were removed by cutting each 
horn below the oviduct, and across the cervix. Preimplantation embryos (3.5 dpc) were 
recovered following uterine flushing with warm H6 medium containing 4mg ml
-1 bovine 
serum albumin (BSA) (Appendix I). These blastocysts were either cultured for ES cell 
isolation, or processed for immunolabelling. 
2.2 Cell culture 
2.2.1 Feeder cell (MEF) preparation 
Primary mouse embryonic fibroblasts (MEFs) were isolated from 13.5 dpc MF1 foetuses 
(Nagy et al., 2003). Foetuses were surgically removed from maternal tissue. The bodies 
were  finely  minced  using  a  sharp  razor  blade  and  incubated  in  trypsin: 
Ethylenediaminetetraacetic acid (EDTA) (0.05%; Gibco, Cat. No. 25300) at 37°C for 30 
min and further dissociated by thorough pipetting. Cells were centrifuged at 1000 rpm for 
5 min. The resulting pellet was treated with DNase (500  g) in MEF culture medium 
((Dulbecco  modified  Eagle  medium  (DMEM)  [Sigma]  supplemented  with  10%  FBS 
[Sigma],  2  mM  glutamine  and  penicillin  [50  U/ml]/  streptomycin  [50   g/ml])  and 
resuspended. Cells were plated onto 15cm tissue culture dishes (Nunc), and grown at Chapter 2 
  48 
37°C/  5%  CO2.  Once  confluent  the  cells  were  frozen  at  -80°C  in  MEF  medium 
supplemented with 10% FBS (foetal bovine serum) and 10% dimethyl sulfoxide (DMSO; 
Sigma, D5879). Cells were stored in liquid nitrogen. 
For ES cell culture, MEFs were thawed and cultured for at least one passage, but not 
more  than  three  passages.  Prior  to  plating  ES  cells,  MEFs  treated  with  10   g/ml 
mitomycin C (Sigma) for 2 h, mitotically inactivating the cells. The treated MEF cells 
were  washed  thoroughly  in  PBS  (phosphate  buffered  saline)  and  re-plated  at  high 
densities on gelatin-coated culture dishes. 
2.2.2 ES Cell Culture 
ES cell lines were grown to a maximum 70-80% confluency on mitotically inactivated 
feeder  cells  in  ES  medium  (knockout-DMEM  supplemented  with  15%  serum 
replacement  (SR)  [Gibco,  10828],  non-essential  amino  acids  [Gibco,  11140],  1  mM 
sodium pyruvate [Gibco, 11360], 100  M 2-mercaptoethanol [Sigma, M7522], 2 mM 
glutamine, penicillin [50 U/ml]/ streptomycin [50  g/ml] (Gibco, 10378) and 1000 U/ml 
of leukaemia inhibitory factor (LIF)) and incubated at 37 °C in 5% CO2. Cells were 
passaged every 2-3 days by incubating with 0.05% trypsin-EDTA (Gibco, 25300) for 
~5mins at 37ºC and further dissociated by vigorous pipetting before spinning at a low 
speed (~1000rpm), resuspending, and seeding onto freshly prepared MEFs. Medium was 
changed daily. 
2.2.3 Feeder-free ES cell culture 
ES cell purification was achieved by differential adhesion preplating (Nagy et al., 2003). 
ES cells, cultured on a MEF feeder layer, were harvested, re-plated onto gelatinized 
dishes and incubated at 37°C for 30 min in MEF culture medium (without LIF), allowing 
MEFs  to  attach.  ES  cell  suspension  was  centrifuged  (300g  for  5  min)  and  cultured 
fibroblast-free on gelatin treated plates in ES medium. Medium was replaced daily. ES 
cells were maintained by trypsin passaging confluent cultures every 2 days. 
2.2.4 Freezing and thawing ES cells 
Confluent  ES  cells,  expanded  up  to  a  100  mm  dish,  were  trypsinised,  pelleted  and 
resuspended in cold ES freezing medium (ES medium supplemented with 10% SR and 
10%  DMSO).  The  ES  cell  suspension  was  aliquoted  into  1.8mm  cryovials  (Nunc, 
377267) and frozen slowly at -80ºC overnight before storing in liquid nitrogen. Cell 
stocks were quick-thawed in a water bath at 37ºC, spun (~300g), resuspended in ES General methods and materials 
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medium, and seeded onto fresh mitotically inactivated MEFs on a 60 mm sterile dish 
(Nunc, 150288). ES cells were cultured on feeders for at least one passage. 
2.3 Immunocytochemistry 
Samples were washed in PBS and fixed in 4% paraformaldehyde (PFA) solution for 15 
min. Cells were either stained immediately after fixation, or stored 4°C in PBS-Tween-20 
(PBS-T, 0.05%) until required. Prior to immunostaining, cells were washed twice with 
PBS.  Cells  were  permeabilised  with  0.3%  Triton  X-100,  and  non-specific  antibody 
binding was blocked with 5% normal serum (in PBS) from the same host-species as the 
secondary antibody (45 min at room temperature). Cells were incubated with primary 
antibodies  (in  1%  BSA,  0.3%  Triton  X-100)  either  overnight  at  4°C,  or  at  room 
temperature for 1 h. Cells were then washed three times with PBS-T (0.1%; Sigma) over 
30  min,  and  incubated  with  the  appropriate  with  Alexa-Fluor  conjugated  secondary 
antibody (Molecular probes) in 1% BSA, 0.3% Triton X-100 (1:200) for one hour in the 
dark.  Nuclei  were  counterstained  with  4’,  6-diamino-2-phenylindole  dilactate  (DAPI, 
0.2 g/ml PBS-T; Sigma) in a final washing step. Samples were mounted with anti-fade 
Vectashield® mounting medium (Vector laboratories) onto microscope slides and images 
were captured by fluorescence microscopy. 
2.4 Polymerase chain reaction analysis of genomic DNA 
2.4.1 Genomic DNA extraction 
Confluent cells were washed with PBS and lysis buffer containing 10 mM Tris, pH 8, 
100 mM NaCl, 10 mM EDTA, pH 8, 0.5% sodium dodecyl sulphate (SDS), and 1 mg/ml 
proteinase  K  was  added  fresh.  Plates  were  incubated  overnight  at  55°C  in  a  humid 
environment  to  avoid  evaporation  (Ramirez-Solis  et  al.,  1992).  The  following  day, 
lysates were taken and two volumes of cold ethanol (absolute) added to precipitate. A 
genomic  DNA  pellet  was  obtained  by  centrifugation,  washed  in  70%  ethanol,  and 
allowed to air-dry. DNA was resuspended in nuclease-free water and quantified using the 
Nanodrop ND-100- spectrophotometer. 
2.4.2 Polymerase chain reaction 
Polymerase chain reaction (PCR) samples containing final concentrations of 1 x PCR 
buffer (20 mM Tris–HCl, pH 8.4, 50 mM KCl), 2.5 mM MgCl2 (Invitrogen), 250  M of 
each dNTP (Invitrogen), 250 nM of each oligonucleotide primer, 0.625 U HotStart Taq Chapter 2 
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(Qiagen), and 50 ng sample DNA were prepared in a total volume of 25  l. The PCR was 
performed  on  a  DNA  Engine®  Peltier  Thermal  Cycler  (BioRad,  UK).  Reaction 
conditions were as follows: Initiation by HotStart Taq activation at 95°C for 15 min, 
followed  by  35  cycles  each  consisting  of  a  denaturation  step  at  94°C  for  60  sec, 
annealing at 55°C for 30 sec, and extension at 72°C for 60 sec. After the last cycle, 
samples were kept at 72 °C for 10 min. 
2.4.3 Gel electrophoresis 
Amplified DNA products were separated by gel electrophoresis through 3% agarose gel 
in 1 X TBE buffer (50 mM Tris, 100mM Borate, 10 mM EDTA, pH 8.2) at 70 V and 
visualised by ethidium bromide staining under ultraviolet (UV) illumination.  
2.5 Quantitative PCR (qPCR) analysis 
2.5.1 RNA extraction and reverse transcription 
Total  RNA  from  ES  cells  was  isolated  using  the  RNeasy  mini  kit  (Qiagen,  UK) 
according to the manufacturers’ instructions. Briefly, cells were lysed in Buffer RLT and 
homogenized using a QIAshredder spin column (Qiagen, UK). RNA was precipitated 
using 70% ethanol and mixed by pipetting. Lysates was transferred to an RNeasy spin-
column, allowing selective binding of RNA to a silica-based membrane. Contaminants 
were washed away by centrifugation with buffers provided (outlined in the RNeasy mini 
handbook). RNA was finally eluted in 30-50  l of water. On-column DNase I digestion 
was  performed  using  the  RNase-free  DNase  kit  (Qiagen,  UK)  according  to  the 
manufacturers’  instructions.  RNA  was  quantified  using  the  Nanodrop  ND-1000 
spectrophotometer.  
First-strand cDNA was synthesized by using 250 ng of RNA combined with 0.5  g 
random  primers  in  an  Improm-  II
TM  Reverse  Transcriptase  System  (Promega,  UK) 
reaction (20 u Recombinant RNasin® Ribonuclease Inhibitor, 0.5 mM of each dNTP, 
and 3 mM MgCl2), prepared in a final 20  l volume in thin-walled, nuclease-free tubes. 
Tubes were transferred to a DNA Engine® Peltier Thermal Cycler (BioRad, UK) for 
reverse transcription where primer/templates were annealed at 25°C for 5 min, extended 
at 42°C for 1 min, and finally incubated at 70°C for 15 min for RT inactivation. Reverse 
Transcriptase negative (RT-) controls were also prepared as a control for genomic DNA. General methods and materials 
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cDNA was diluted to a concentration equivalent to 5 ng/  l RNA and stored at -20°C for 
use in qPCR. 
2.5.2 Quantitative PCR 
Amplification  of  each  target  gene  was  quantified  using  the  SYBR-green  detection 
method, following the SYBR-green precision mastermix (PrimerDesign, UK) protocol. 
SYBR-green dye detects PCR products by intercalating between double stranded DNA 
present in samples and fluorescing. During the PCR, the DNA polymerase amplfies the 
target sequence. SYBR-green then binds to each new copy of double-stranded DNA. As 
the  PCR  progresses,  more  PCR  product  is  created.  The  fluorescene  intensity  is 
proportionate to the amount of PCR product produced (gene expression). Samples were 
analyzed in duplicate using clear 96-well plates (Axygen). Absence of genomic DNA 
was confirmed by analysis of RT- samples and no template controls (water only) were 
also included in each assay. Thermal cycling was performed using a DNA engine thermal 
cycler  and  Chromo4  Real-time  Detector  (BioRad,  UK)  with  Opticon  Monitor  v3.1 
software under the following conditions: 95°C for 10 min (enzyme activation), then 40 
cycles of 95°C for 15 s (denaturation) followed by 60°C for 1 min (annealing), and a 
final extension step at 72°C for 10 min. Melting curves were generated for each sample 
to confirm target specific amplification by fluorescence detection at 0.2°C steps between 
60°C and 95°C.  
2.6 Death assays and cell cycle analysis 
2.6.1 Cell cycle analysis 
Propidium iodide (PI) staining provides a precise measure of cell cycle distribution in a 
population of cells. PI fluoresces red when it intercalates between the bases of DNA, thus 
distinct phases of the cell cycle can be determined by measuring fluorescence intensity 
(DNA content) of individual PI-stained cells. 
To assess cell cycle distribution, cells were grown on a feeder layer and harvested by 
trypsinisation  after  24  h  of  culture.  Cells  were  fixed  overnight  with  cold  70%  (v/v) 
ethanol and stained with 10  g/ml PI (Sigma) containing 250  g/ml RNase (Sigma). 
Cells were analysed by flow cytometry. Chapter 2 
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2.6.2 Bromodeoxyuridine (BrdU) incorporation 
To analyse cell cycle kinetics, a combined BrdU-incorporation and PI staining protocol 
was used. BrdU, a thymidine analog, is incorporated into cells undergoing replication in 
the  S-phase  of  the  cell  cycle.  Combination  with  DNA  markers  such  as  PI  allows 
characterization of cells that are actively synthesizing DNA (BrdU incorporation) relative 
to their phase in the cell cycle defined by PI staining intensities. 
Prior to analysis, cells were incubated with 10  M BrdU (Sigma) at 37°C for various 
incubation  times  (5  min  –  24  h),  harvested,  washed  in  cold  PBS,  and  fixed  in  70% 
ethanol at 4 °C overnight. Fixed cells were then incubated in 2 N HCl containing 0.5% 
TX-100  for  30  min  to  denature  DNA  strands  and  neutralised  with  0.1 M  sodium 
tetraborate (Na2B4O7) for 10 min at room temperature. To detect BrdU incorporation, 
samples were labelled with mouse anti-BrdU (1:100; Vector labs, VPB209) in 5% goat 
serum-PBS overnight at 4 °C, washed extensively in PBS-T (0.1%) and incubated with 
Alexa Fluor 488 goat anti-mouse IgG secondary antibody (1:200, Molecular probes) for 
30 min at room temperature. Cells were washed as above, incubated with 10  g/ml PI 
containing 250  g/ml RNase for 20-30 min, and analysed by flow cytometry. 
2.6.3 Apoptosis assay 
Basal levels of cell death were measured using the Annexin V assay. During the early 
stages of the apoptotic pathway there is an initial loss of plasma membrane asymmetry. 
Phosphatidylserine (PS) phospholipids, which are normally present only on the inner 
leaflet of the plasma membrane are externalised, exposing PS to the external cellular 
environment. Annexin V is a phospholipid-binding protein with a high affinity for PS, 
and when conjugated with a fluorescent tag, such as Fluorescein-5-isothiocyanate (FITC), 
can be used to detect these early-apoptotic cells. Further, loss of membrane integrity 
occurs  during  the  later  stages  of  cell  death.  Dead  cells  can  therefore  be  detected  by 
inclusion of DNA dyes such as propidium iodide (PI), which permeates cells in which 
the plasma membrane has been compromised, but is excluded from viable cells. 
Cells were seeded in triplicate onto freshly prepared feeders in 12 well plates. To assess 
cell  viability,  floating  cells  were  collected  and  adherent  cells  were  harvested  by 
trypsinisation. Cells were centrifuged and incubated with FITC-conjugated Annexin V 
(Patrick Duriez, Protein core facility, University of Southampton) and 100  g ml
-1 PI  in 
Annexin V binding buffer (10 mM HEPES pH 7.4, 140 mM NaCl, 2.5 mM CaCl2) for 30 General methods and materials 
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min  at  4°C  in  the  dark.  Cells  were  analysed  by  flow  cytometry  immediately  after 
incubation.  
2.6.4 Flow cytometry 
Data acquisition was performed using a FACSCalibur flow cytometer (BD Biosciences) 
and data were assessed using Cell Quest Pro software (BD Biosciences) unless otherwise 
stated.  To  analyse  cell  samples,  live  ES  cell  populations  were  first  identified  from 
plotting forward scatter (FSC; indicating cell size) vs. side scatter (SSC; indicating cell 
granularity)  and  gated  to  exclude  cell  debris  and  MEF  cell  populations.  To  format 
fluorescence parameters for dual-colour analysis, singly stained samples were used and 
appropriate  compensation  levels  were  set  in  order  to  eliminate  spectral  overlap  and 
bleed-through  between  fluorophores.  This  was  achieved  by  adjusting  median 
fluorescence of the positive population so that it was parallel with median fluorescence 
of the negative population. ES cell populations were further analysed by generating dot 
plots to examine levels of fluorescently labelled markers. The percentage of cells in each 
population and gate of interest were quantified. 
2.7 Western blotting 
2.7.1 Sample preparation  
Preparation of ES cell protein lysates 
ES cells were grown feeder-free as described in section 2.2.3. Cells were collected by 
trypsinisation, pelleted, snap-frozen in liquid nitrogen and stored at -80°C. Samples were 
thawed on ice, and whole cell lysates were prepared by 30 min incubation with Onyx 
lysis  buffer  (20  mM  Tris-HCl,  pH  7.4,  135  mM  NaCl,  1.5  mM  MgCl2,  1  mM 
ethyleneglycoltetraacetic  acid  (EGTA),  1%  TX-100,  10%  glycerol,  protease  inhibitor 
cocktail (Sigma. 1:100,), 2 mM Na3VO4, and 50 mM NaF) followed by centrifugation at 
13,000 rpm at 4°C for 15 min. Lysates were quantified using a bicinchonic acid (BCA) 
protein assay (described in section 2.7.2). Equal quantities of the protein samples were 
either resolved immediately by SDS-PAGE, or stored at -80°C until required. 
2.7.2 Sample quantitation (BCA protein assay) 
Protein concentrations in whole cell lysates were measured using Pierce BCA protein 
assay (Thermo Fisher Scientific Inc., Rockford, IL) to ensure that equal quantities of 
protein were loaded for SDS-PAGE. 200  l of a working BCA reagent was prepared by Chapter 2 
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combining 50 parts of reagent A (consisting of Na2CO3, BCA detection reagent, and 
C4H4O6Na2 in 0.2N NaOH) with 1 part reagent B (4% (w/v) CuSO4 solution). The BCA 
working solution was added to 10  l duplicates of cell samples or BSA standards (0.0625 
–  2  mg/ml)  in  a  96  well  microtitre  plate.  Following  incubation  at  37°C  for  30  min, 
absorbance at 570 nm was measured using a microplate reader. A representative standard 
curve from which protein concentrations for ES cell lysates were determined is shown in 
Appendix II.i. 
2.7.3 SDS-Polyacrylamide gel electrophoresis 
Prior  to  fractionation  by  sodium  dodecyl  sulphate  polyacrylamide  gel  electrophoresis 
(SDS-PAGE),  cells  were  lysed  as  described  in  section  2.7.1  and  diluted  to  25ug  in 
ultrapure water to achieve 65% of total loading volume. Samples were suspended in 4X 
sample buffer (0.25 M Tris.HCl, 40% (v/v) Glycerol, 2.8 M SDS, 0.1% Bromophenol 
Blue) at 25% of the final volume, and 10% (v/v) 2-Mercaptoethanol was added fresh to 
lysates to generate reducing conditions. Samples were heated at 95°C for 5 min. Proteins 
were separated by electrophoresis (~1.5 h at 100 V) on pre-cast 4-12% NuPAGE® Bis-
Tris  polyacrylamide  gels  (Invitrogen)  in  NuPAGE®  MOPS-SDS  running  buffer 
(Invitrogen)  using  the  NuPAGE®  Xcell  Surelock®  Mini-cell  electrophoresis  module 
(Invitrogen).  
2.7.4 Immunoblotting 
After separation, proteins were transferred from the SDS-gel to a methanol activated 
Polyvinylidene  Fluoride  (PVDF)  membrane  (Immobilon-FL,  0.45   m;  Millipore)  by 
electro-elution (300 mA overnight (with cooling), using a mini tank wet transfer system 
(Hoefer), in buffer containing 25 mM Tris, 150 mM glycine, 20% methanol, 0.01% SDS. 
Membranes were blocked with 5% (w/v) non-fat dry milk in Tris-Buffered Saline (TBS) 
+  0.05%  Tween20  (TBS-T)  for  1  h  at  room  temperature  with  constant  agitation. 
Membranes were washed with TBS-T and probed with primary antibodies overnight at 
4°C in 5% BSA, 0.05% sodium azide in TBS-T. 
Protein  bands  were  visualised  by  fluorescence-based  immunodetection.  Following 
primary  antibody  labelling,  washed  blots  were  incubated  in  secondary  antibody 
conjugated  to  IRDye™  800CW  (Rockland  inc.  Molecular  probes)  near-infrared  (IR) 
fluorochrome (diluted 1:10000 in 5% BSA in TBS-T) for 1 h at room temperature in the 
dark. Following further washing steps over 30 min at room temperature, western blots General methods and materials 
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were scanned using the LI-COR Odyssey IR imaging system (LI-COR Biosciences). 
Integrated density values (IDVs) were obtained using the Odyssey software based on 
pixel intensity, and normalised to  -Tubulin loading controls.  
If membrane stripping was required between antibody probing the blot was incubated in 
stripping buffer (200 mM glycine, 3.5 mM SDS, 1% (v/v) Tween20, pH 2.2) for 10 min 
room temperature, and then subsequently washed in PBS for 20 min, TBS-T for 10 min 
and then blocked for an hour in 5% (w/v) non-fat dried milk in TBS-T.  
2.8 Statistical Analysis 
All  statistical  analysis  was  performed  using  Minitab  16.1.0.  Data  was  checked  for 
assumptions of normality using the Anderson-Darling test. Data was considered normal 
where p>0.05 (significance level).  Variance homogeneity was analysed using the F-test. 
Variance  was  similar  where  p 0.05.    Unless  otherwise  stated,  differences  between 
dietary  treatment  groups  or  between  genders  were  performed  using  the  independent 
Student’s t-test (for normally distributed data), or Mann–Whitney rank sum test (for non-
normal data sets). All data are expressed as means ± SEM.  P 0.05 was considered 
statistically significant.   
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Chapter 3:  Effect of LPD-challenge on the 
blastocyst and the derivation of ES cells 
3.1 Introduction 
It has been shown that altering maternal nutrition exclusively during preimplantation 
development leads to a wide range of physiological outcomes in offspring (Bertram et al., 
2001; Gardner et al., 2005; Kwong et al., 2000; Langley-Evans et al., 1996b; Watkins et 
al., 2007; Watkins et al., 2008b). These studies suggest that changes within the stem cells 
of the blastocyst are induced early in development, which becomes apparent later on.  
Characterising  the  changes  occurring  in  the  preimplantation  embryo  is  technically 
difficult because of the small number of cells at this stage and generates ethical issues 
due to the number of animals that would be required to generate meaningful data. 
In the late blastocyst, three cell lineages exist, which are restricted in their future fate 
(Rossant et al., 2003). The ICM gives rise to all foetal cell types, whilst the TE and PE 
generate the extraembryonic tissues. Stem cells lines have been derived from each of the 
three blastocyst lineages: embryonic, trophoblast, and extraembryonic endoderm stem 
cells (ES, TS, and XEN) (Figure 3.1). Each stem cell type exhibits features of the lineage 
from which it is derived, including tissue-specific developmental potential, morphology, 
transcription factor expression and growth factor requirements. These stem cells provide 
an expandable source of cells and studying these cells have provided an opportunity to 
understand the cells from which they originate. 
Deriving  stem  cells  from  blastocysts  of  mothers  that  have  received  a  dietary 
manipulation, such as LPD, during preimplantation development may provide a source to 
investigate  the a lterations  occurring  within  the  blastocysts  as  a  result  of  these 
environmental conditions. Isolation of ES cells may be most relevant as they provide a 
means to study the cells that give rise to all foetal tissues. 
The  ICM  can  be  manually  isolated  from  blastocysts  and  cultured  continuously  as 
homogenous ES cell cultures (Evans and Kaufman, 1981; Martin, 1981). This involves 
culture of blastocysts on MEFs, allowing the embryo to hatch from the ZP. TE cells 
attach  to  the  underlying  MEF  cells  forming  a  cluster  of  ICM  cells.  ES  cells  can 
subsequently be derived by dissociation of the ICM and culture of the disaggregated cells 
in the presence of LIF (Smith et al., 1988). Chapter 3 
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ES cells possess physical and molecular characteristics that are uniquely comparable to 
ICM and EPI cells of the blastocyst and early post-implantation embryo (Smith, 2001a). 
They represent the in vitro model most similar to preimplantation development in vivo. 
Importantly, these cells can be extensively manipulated and cultured over many passages, 
yet still retain pluripotency. This is best demonstrated by this ability to reintegrate into 
embryogenesis (Wobus and Boheler, 2005). With the exception of the EE lineages, ES 
cells contribute to all other cell types (Beddington and Robertson, 1989). In addition, ES 
cells have extraordinary developmental potential in vitro and are able to form cell types 
of all three germ layers when induced to differentiate under varying culture conditions 
(Keller, 1995; Smith, 2001b). These features of ES cells present a useful in vitro model 
to  investigate  cellular  characteristics  during  self-renewal,  cell  commitment  and 
differentiation of their in vivo counterparts within the embryo. 
 
Figure 3.1: Cell lineage segregation in the early embryo 
Showing  distinctions  between  the  blastocyst’s  stem  cells.  The  first  cellular 
differentiation  occurs  in  the  morula  as  inner  and  outer  cells  are  formed.  During 
blastocyst formation, three distinct cell types are formed which are restricted in fate. 
The TE cells, surrounding the ICM, form the TB layers of the placenta. The inner cell 
populations are heterogeneous, forming EPI and PE cell types as the ICM cells begin 
to segregate. The EPI forms all foetal tissues whilst the PE is restricted to form only 
the extraembryonic endoderm lineages. At E4.5 the EPI and PE are relocated to their 
appropriate positions to prepare for gastrulation. All three cell types of the blastocyst 
can be captured and maintained in culture. TS cells, ES cells and XEN cells express 
markers of their derivative cells and only form cell types of their founder cells when 
reintroduced into the embryo (modified from Rossant and Tam, 2009).  
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The majority of mouse ES cell lines described are derived from the 129/Sv strain (Smith, 
2001a)  and  the  efficiency  of  ES  cell  isolation  variably  decreases  in  other  strains 
suggesting a strong genetic influence on ES cell derivation (Brook and Gardner, 1997; 
McWhir  et  al.,  1996).  However,  mice  derived from  129  ES  cell  lines  exhibit  highly 
variable phenotypes due to variation in genetic background (Sigmund, 2000). Backcross 
breeding  diminishes  overall  genetic  heterogeneity  and  therefore  isolation  of  ES  cells 
from  highly  inbred  mouse  strains  is  preferable  for  comparison  between  experimental 
treatments. However, ES cells derived from inbred strains are more difficult to propagate 
and have been described to generate chimeras less efficiently (Baharvand and Matthaei, 
2004; Bryja et al., 2006a; Schoonjans et al., 2003). They also contribute less frequently 
to the germ line in comparison to ES cell lines from the 129 strains (Auerbach et al., 
2000; Brook and Gardner, 1997). 
To study the effects of maternal diet on the characteristics of the embryos’ stem cell 
populations, we analysed in vitro growth characteristics of blastocysts from from inbred 
C57BL/6  mice,  following  maternal  undernutrition,  and  the  effects  of  this  protein 
undernutrition  on  cell  lineage  allocation.  We  then  derived  ES  cell  lines  from  the 
blastocysts of mice subjected to our protein undernutrition model during preimplantation 
development.  The  physical,  functional  and  molecular  characteristics  of  these 
undifferentiated  ES  cells  can  be  evaluated  between  treatments.  The  differentiation 
potential  of  these  cells  can  also  be  analysed  as  a  model  of  early  post-implantation 
development. Chapter 3 
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3.2 Materials and methods 
3.2.1 Animals treatments 
Subsequent  to  mating,  plug-positive  C57BL/6  females  were  assigned  at  random  to 
receive either a control normal protein diet (18% casein; NPD) or a low protein diet (9% 
casein; LPD) (Table 3.1), and fed ad libitum throughout the preimplantation period of 
gestation  (3.5  dpc).  At  3.5  dpc  blastocysts  were  collected  for  embryonic  stem  cell 
isolation ( Figure  3.6).  Animal  procedures  were  conducted  in  accordance  with  the 
Animals Scientific Procedures act 1986, and local ethics committee at the University of 
Southampton, under provisions of UK Home Office License PPL30/2467.  
Table 3.1: Composition of isocaloric experimental and control diets used (g per kg) 
  9% protein diet (g)  18% protein diet (g) 
Casein  90  180 
Starch Maize  485  425 
Cellulose  50  50 
Sucrose  243  213 
Choline chloride  2  2 
DL-Methionine  5  5 
AIN-76 mineral mix1  20  20 
AIN-76 vitamin mix2  5  5 
Corn oil  100  100 
Gross Energy, MJ/kg  18.27  18.39 
 
Embryo collection and culture  
Following dissection and uterine flushing using warm H6 medium containing 4mg ml-1 
bovine serum albumin (BSA), preimplantation embryos were collected and washed in 
drops  of  potassium  simplex  optimised  medium  (KSOM)  submerged  in  paraffin  oil 
(Sigma). Blastocysts were either fixed immediately for immunofluorescence analysis, or 
cultured.  For  in vitro  culture,  blastocysts  were  immediately  transferred  into  separate 
wells on twenty-four well plates and cultivated on a freshly prepared feeder layer of 
mitotically inactivated MEFs in ES medium. Blastocysts were incubated at 37 °C in 5% 
CO2. Derivation of ES cells 
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3.2.2 Morphology analysis of diet-derived blastocysts 
To  assess  the  effects  of  diet  on  early  pre-  and  post-implantation  growth,  blastocyst 
development in ES cell culture conditions was evaluated at 0.5 d intervals between the 
day of blastocyst collection and the day of ES cell isolation (2.5 d). Individual blastocyst 
morphology was scored (Gardner and Lane, 1993; Lane and Gardner, 1997; Sakkas and 
Gardner,  2005)  according  to  appearance  at  each  0.5  d  time-points,  and  separated  by 
treatment  group  to  enable  a  comparison  of  early  blastocyst  development.  The 
morphology  assessment  was  based  on  the  expansion  state  of  the  blastocyst  and 
development of the embryo after hatching from the ZP and attaching to MEFs before 
ICM dissociation for ES cell derivation (Figure 3.2). 
The Pearson’s Chi-Square test for independence was used to test for association between 
diet  treatment  and  blastocyst  outgrowth  morphology  at  each  time-point.  Chi-square 
values were based on multiple-category contingency analysis of morphological stage for 
each diet treatment group giving an overall association between diet and developmental 
stage. Therefore in cases where statistical differences were observed, a post-hoc analysis 
was conducted to analyse the nature of the association. Standardized residuals (z) were 
generated in SPSS statistical analysis software (IBM) for each individual category, in 
order to determine its overall contribution to the difference observed. A standardized 
residual of ±1.96 or higher at the alpha level of 0.05 indicates a significant contribution 
to the association seen between variables. Chapter 3 
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Image  Blastocyst morphology description 
Stage 
allocation 
A  Early Blastocyst – Blastocoel <    total embryo  1 
B  Mid Blastocyst – Blastocoel >    total embryo  2 
C 
Late Blastocyst – Blastocoel fully occupies embryo. 
Distinguishable ICM from TE. ZP thinning  3 
D  Elongating Blastocyst  4 
E  Hatching – Herniation of TE from ZP  5 
F 
Hatched and Spreading – Escaped from ZP. Attached to 
feeders. No visible ZP.  Spreading of outer cells.  6 
G 
ICM Outgrowth – Blastocoel no longer visible. Tight ICM 
clump on top of TB  7 
H 
Outgrowth Spreading – ICM with flatter, stretched 
appearance. Some signs of differentiated cells  8 
 
Figure  3.2:  Distinct  stages  of  blastocyst  development  used  for  morphology 
analysis 
(A-H)  Development  of  the  blastocyst  in  ES  cell  culture  conditions  after  blastocyst 
collection at 3.5 dpc (A-C) through to ICM dissociation for ES cell isolation (F-H). At 
0.5 d intervals, blastocyst morphology was evaluated and attributed a score (I; table). 
Scale bar = 50  m. 
 Derivation of ES cells 
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3.2.3 ES cell isolation, expansion and culture  
A standardized protocol was generated for ES cell isolation from C57BL/6 mice using 
our  undernutrition  model  (modified  from  Nagy  et  al.,  2003).  Following  collection, 
blastocysts were cultured individually in ES medium and allowed to hatch from the ZP 
and attach to underlying MEF cells. After substantial outgrowth of the ICM (2.5 days 
culture; Figure 3.6), ICM -derived clumps from individual embryos were dislodged using 
a finely drawn capillary tube and mechanically dissociated into single-cell and small-cell 
aggregates in 0.05% trypsin-EDTA by thorough mouth pipetting. The disaggregated cells 
were seeded onto fresh feeder layers on 96 well plates and cultured in ES medium at 
37ºC in 5% CO2. Viable ES cell colonies were evident after 2-3 days culture (medium 
changed daily) and were primarily passaged at day 3.5. ES cell colonies were expanded 
by trypsin passaging at three-day intervals to reach confluency on a 100 mm dish. ES cell 
lines  (representing  ICM  cells  of  an  individual  blastocyst)  were  frozen  at  the  earliest 
possible opportunity, which was generally after 24 days in culture (passage number 5-7; 
Figure 3.6b). 
3.2.4 Immunofluorescence analysis of pluripotency markers 
Blastocyst immunofluorescence analysis 
A second cohort of blastocysts were collected by uterine flushing as described in section 
2.1.2,  immediately  fixed  in  4%  PFA,  and  washed  extensively  in  PBS-T  (0.05%). 
Blastocysts  were  processed  by  mouth  pipetting  through  glass  cavity  blocks  in 
approximately  100   l  of  each  solution.  Immunocytochemistry  procedures  were 
performed  as  described  in  section  2.3.  Briefly,  fixed  embryos  were  blocked  and 
permeabilised (PBS with 0.3% TX-100 and 5% donkey serum) for 45 min, washed, and 
incubated overnight (4°C) with primary antibodies (Mouse anti-Oct4 (Santa Cruz C-10, 
SC5279); Rabbit anti-Nanog (Abcam 80892); and Goat anti-Gata4 (Santa Cruz C-20, 
SC1237)) at a 1:200 dilution. Embryos were washed 3 times to remove excess primary 
antibodies and incubated in secondary antibodies conjugated with Alexa Fluor 488-, 546-, 
or 647- (Molecular probes) for 1 h at room temperature. Embryos were washed with 
fresh PBS-T (0.1%) three times; and counterstained with nuclear marker DAPI (1:500) in 
the final wash (30 min). Non-specific staining was determined by processing embryos as 
described above in the absence of primary antibodies. Embryos were mounted on a poly-
l-lysine  coated  slides  with  Vectashield®  mounting  medium  (Vector  laboratories)  to 
prevent photo bleaching and sealed with nail polish. Fluorescent staining was visualized Chapter 3 
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under a Leica TCS SP5 confocal scanning microscope in the University of Southampton 
Biomedical Imaging Unit. Images were analysed using Volocity software (PerkinElmer). 
Blastocyst outgrowth immunofluorescence analysis 
Blastocysts  were  collected  as  described  in  section  2.1.2  and  cultured  in  vitro,  on 
coverslips on 24 well plates, under the same conditions as used for ES cell isolation 
experiments  (section  3.2.3).  Generally,  3-4  embryos  were  grown  in  each  well.  
Outgrowths were monitored as described in section 3.2.2. Blastocyst outgrowths were 
fixed on coverslips after 2.5 d in vitro culture (at the time that ICM dissociation would 
occur for ES cell isolation.Figure 3.5I; Figure 3.6) and fluorescently labelled as described 
above. 
3.3 Results 
Blastocysts were collected at 3.5 dpc and cultured individually on MEFs in ES medium, 
in order to isolate ES cells lines. The average number of blastocysts collected per mother 
was not significantly different between treatments (6.3 ± 0.44 in LPD vs. 6.5 ± 0.29; 
Figure 3.3).  
 
Figure 3.3: Comparison of blastocyst rates following diet treatment. 
(A)  Mean  of  total  embryos  collected  per  mother  at  E3.5  following  either  a  LPD  or 
control diet throughout preimplantation development, and the number of which were 
blastocysts. (B) Compares the mean percentage embryos present as blastocysts at 
collection from LPD-treated mice vs. NPD controls. LPD, n=117 total blastocysts from 
16 mothers; NPD, n= 112 total blastocysts from 16 mothers. Vertical bars represent 
SEM. 
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3.3.1 Morphology analysis of blastocysts from diet-challenged mothers 
During the ES cell isolation procedure blastocyst morphology was monitored in ES cell 
culture  conditions  from  the  day  of  blastocyst  collection  (0  d),  through  to  ICM 
dissociation  (2.5  d),  enabling  a  comparison  of  early  pre-  and  post-implantation 
development between treatments. There was no observable dietary effect on blastocyst 
development  after  2.5  d  in  ES  cell  culture  conditions,  as  determined  by  chi-square 
analysis of blastocyst morphology at 0.5d intervals after collection (Figure 3.4).  
 
Figure  3.4:  Comparison  of  early  embryo  development  in  ES  cell  culture 
conditions. 
Embryo morphology was evaluated from the day of blastocyst collection through to 
the point of ICM dissociation at 0.5 d intervals. The percentage of embryos at each 
morphology stage is shown at (A) 1 d, (B) 1.5 d, and (C) 2 d for each diet treatment. 
(D) Shows the overall percentage of hatched blastocysts at each time-point. Values 
are percentages of 94 LPD-challenged, and 78 control (NPD) blastocysts. 
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3.3.2 Optimization of embryonic stem cell isolation protocol 
It has been shown that production of ES cell lines from different mouse strains requires 
different  culture  conditions  (Baharvand  and  Matthaei,  2004).  In  order  to  assess 
developmental potential of ES cell lines derived from dietary treated blastocysts; it was 
first necessary to optimise conditions for efficient ES cell derivation from the C57BL/6 
mouse  strain.  We  found  it  necessary  to  make  several  modifications  to  the  standard 
protocol to improve the initial low efficiency of ES cell derivation.  
Figure 3.5 compares outgrowth development of blastocysts using the standard protocol 
(Bryja et al., 2006a), against C57BL/6 blastocysts used in these experiments for the first 
6  days  of  ES  cell  culture.  Substantial  ICM  outgrowths  were  formed  from  C57/BL6 
blastocysts after 3 days in ES culture (Figure 3.5G). However, after 5 d culture, when 
ICM clumps were picked for ES cell isolation using the standard protocol, outgrowths 
appeared much flatter and showed a high degree of differentiation (Figure 3.5I). This 
resulted in no ES cell colonies after ICM dissociation.  
As  overgrowth  of  colonies  induces  differentiation,  it  was  felt  important  to  pick  and 
dissociate ICM outgrowths before differentiation of the cells (2.5 d). This improved ES 




Figure 3.5: Steps of mouse ES cell derivation using the ‘standard protocol’. 
(A) Timeline of the ES cell isolation procedure using the standard protocol (Nagy et al., 
2003). (B-I) Compares development of the blastocyst over the first 6 d of ES culture.  
The  left  hand  panel  shows  brightfield  images  of  blastocyst  development  using  the 
standard protocol (images from Bryja et al., 2006a), whereas the right hand panel 
shows phase contrast images of  C57BL/6 blastocyst development using the same 
method of derivation. (B-C) Morphology of E3.5 blastocyst. (D-E) Hatched blastocyst 
2 d after blastocyst collection. (F-G) 3 d ES culture, showing clear ICM outgrowth. (H-I) 
5 d ES culture when ICM outgrowths were picked and trypsinised for ES cell isolation 
and derivation. Using this protocol the C57BL/6 derived blastocyst outgrowth shows 
clear differentiation showing a loss of defined ICM in I. (J-K) Established ES cell lines. 
Scale bar = 50  m. 
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3.3.3 Isolation of embryonic stem cell lines from dietary-treatments 
Optimisation  of  the  standard  protocol  enabled  generation  of  a  consistent  system  for 
isolating ES cells from diet-challenged C57BL/6 mice. This ensured that all ES cells 
were subjected to the same conditions and procedures throughout the ES cell derivation 
process. Our diet treatment model, describing the method used for isolating ES cell lines 
is described in Figure 3.6 and in section 3.2.3. The ES cell lines generated in this study 
were from individual blastocysts cultured and expanded under these conditions. Details 
of the origin of each stem cell line used are shown in Appendix II.ii. 
 
Figure 3.6: Embryonic stem cell isolation procedure 
(A) C57BL/6 mice were naturally mated and assigned a LPD or NPD throughout pre-
implantation development (3.5 dpc) (as shown in schematic). E3.5 blastocysts were 
collected and cultured on fibroblasts in medium containing 15% serum replacement 
and LIF (1000 U/ml). After embryo attachment and outgrowth (2.5 days), the ICM was 
disaggregated  and  transferred  to  new  wells.  ES  cell  colonies  were  expanded  by 
passaging every three days. ES cells were frozen after 24 days of culture (protocol 
optimised from Nagy et al., 2003).  
 
ES  cell  isolation  efficiency  was  significantly  increased  using  the  isolation  procedure 
above. When using this method over 85% of the nutritionally challenged mothers yielded 
at  least  one  competent  ES  cell  line  from  their  cultured  blastocysts  (Table  3.2).  The 
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average number of embryos collected per mother was not influenced by dietary treatment 
(LPD = 7.69 ± 0.29 vs. NPD = 7.33 ± 0.22). 
 
Table 3.2: Total number of ES cell lines isolated per dietary treatment group 
The overall number of females used in this study, and the total number of embryos 
collected at E3.5 for derivation of ES cell lines. Embryos were cultured individually, 
and each ES cell line was generated from an individual blastocyst. 
Diet 






ES cell lines 
isolated 
LPD  13  11  100  18 
NPD  13  11  93  38 
 
However, when comparing the number of ES cell lines isolated from individual mothers 
for  each  treatment  group  (Figure  3.7),  the  success  rate  of  ES  cell  isolation  was 
significantly reduced by maternal LPD against the control NPD (17.37% ± 3.696 vs. 
41.07% ± 7.867, P=0.0155). 
 
Figure 3.7: Diet ES cell isolation success rate. 
The  percentage  of  blastocysts  yielding  ES  cell  lines  isolated  from  dietary  treated 
C57BL/6 females. The number of blastocysts collected per mother was recorded and 
the percentage of those blastocysts yielding ES cell lines during the ES cell derivation 
procedure was calculated. LPD, n=100 total blastocysts from 13 mothers vs. NPD, n= 
93  total  blastocysts  from  13  mothers.  Vertical  bars  represent  SEM.  *  Indicates  a 
significant difference from that of the NPD group, (P = 0.0155). 
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After thawing ES cells for experimental use, several of the isolated cell lines were found 
to be contaminated. The total number of ES cell lines available for comparison was 
reduced to 27 from the NPD treatment versus 17 from the LPD group. In the NPD all cell 
lines from one of the mothers were contaminated. Therefore, to compare maternal dietary 
effects on ES cell properties there are a total of 10 mothers from the NPD group versus 
11 mothers given a LPD treatment. 
There are a number of possible reasons for the reduction in ES cell isolation potential 
from  LPD-challenged  blastocysts.  This  could  be  a  direct  result  of  changes  in  the 
blastocyst itself, a result of the in vitro culture procedure prior to ES cell isolation, or a 
consequence of the ICM dissociation procedure and subsequent cell culture effects on 
these cells. Changes in rate of proliferation, levels of cell death, or the propensity to 
differentiate may occur as a result of the LPD challenge. Such changes at any of these 
stages of the ES cell isolation process would result in fewer cells with the ability to 
generate ES cell lines. 
To investigate further, we were interested to see if the number of pluripotent cells (i.e. 
cells with the potential to form ES cell lines) were altered as a result of a LPD challenge 
during preimplantation development. 
3.3.4 Lineage allocation in diet-challenged blastocysts 
To investigate the effect of LPD on the blastocyst lineage allocation, a second, separate 
cohort of embryos were collected at 3.5 dpc, fixed, and labeled with early cell lineage 
markers of the ICM (Nanog, Oct4) and the primitive endoderm (Gata4) as described in 
section 3.2.4. 
In addition, blastocyst outgrowths were analysed to compare the effects of in vitro ES 
cell culture on lineage allocation and differentiation. Blastocysts were collected, cultured 
on coverslips with MEFs (3-4 embryos per well), and immunolabelled as described in 
section 3.2.4. 
The mean number of blastocysts collected per mother was not significantly different 
between treatments (5.647 ± 0.28 in LPD vs. 4.83 ± 0.37; Figure 3.8) Derivation of ES cells 
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Figure 3.8: Blastocyst rates following diet treatment for cell lineage experiments. 
(A)  Mean  of  total  embryos  collected  per  mother  at  E3.5  following  either  a  LPD  or 
control diet throughout preimplantation development, and the number of which were 
blastocysts. (B) Mean percentage of blastocysts collected from LPD-treated mice vs. 
NPD  controls.  LPD,  n=121  total  blastocysts  from  18  mothers;  NPD,  n=  108  total 
blastocysts from 17 mothers. Vertical bars represent SEM. 
 
Similar to ES cell isolation experiments above, blastocyst morphology was monitored for 
the  first  2.5  days  of  culture  before  fixing  ICM  outgrowths  for  immunolabelling.  To 
enable blastocyst outgrowths to be processed for confocal microscopy analysis of lineage 
allocation it was necessary to grow blastocysts on glass coverslips  
In contrast to the results shown above, there was a significant association between the 
diet-treatment  embryos  received  during  preimplantation  development  in  vivo,  and 
subsequent  blastocyst  development  and  outgrowth  in  vitro  following  blastocyst 
collection at E3.5. Chi-square analysis revealed no difference in blastocyst development 
in vitro after 1.5d. However, there was a significant relationship between diet treatment 
and blastocyst morphology after 2d ( 
2 (4, N = 74) 12.196, P = 0.012) and 2.5d ( 
2 (2, N 
= 74) 16.671, P < 0.001) of culture. Post hoc analysis of each individual morphological 
category by calculating standardized residuals showed that these differences were due to 
delayed development. There was a significantly higher proportion of blastocysts (19.4%, 
z = 2 vs. 0% in LPD) after d2 culture (Figure 3.9D). After 2.5d culture (Figure 3.9 E) 
there  were  significantly  higher  proportions  of  embryos  forming  spreading  ICM 
outgrowths  from  NPD  treatment  (63.2%,  z  =  4.0  vs.  41.7%  in  LPD)  with  a  larger 
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proportion  of  embryos  at  the  earlier  stages  of  embryo  attachment  in  the  LPD  group 
(36.1%, z = 6.7 vs. 0% in LPD). This delayed morphological development in culture was 
further demonstrated with fewer hatched blastocysts at day 1.5 ( 
2 (1, N = 76) 4.945, 
P=0.026) and day 2 of culture ( 
2 (1, N = 76) 12.5, P < 0.001) (Figure 3.9F). 
Figure  3.10  shows  representative  images  of  lineage  marker  localisation  in  E3.5 
blastocysts (A-H), and in blastocyst outgrowths after 2.5 d in vitro culture (Q-X). Gata4 
is  expressed  first  in  the  mid-late  blastocyst;  therefore  E3.5  embryos  were  cultured 
overnight  in  KSOM  to  allow  formation  of  the  primitive  endoderm,  and  stained  with 




Figure 3.9: Morphology analysis of IVC blastocysts in ES cell culture conditions 
for cell lineage experiments. 
Embryo morphology was evaluated from the day of blastocyst collection through to 
the point of ICM dissociation at 0.5 d intervals. The percentage of embryos at each 
morphology stage is shown at (A) 0.5 d, (B) 1 d, (C) 1.5 d, (D) 2 d, and (E) 2.5 d for 
each diet treatment. (F) Shows the overall percentage of hatched blastocysts at each 
time-point. Values are percentages of 36 (from 6 mothers) LPD-challenged, and 39 
(from 7 mothers) control (NPD) blastocysts. 
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Figure 3.10: Cell lineage allocation in diet challenged blastocysts. 
Expression of lineage markers Gata4 (A, E, I, M), Nanog (B, F, J, N), and Oct4 (C, G, 
K, O) in LPD and control NPD E3.5 (A-H) and E4.5 (I-P) embryos. (D, H, L, P) Overlay 
of Gata4, Nanog, Oct4, and DAPI (nuclear) staining. (Q-X) Outgrowths of LPD (Q-T) 
and control (U-X) in vitro cultured blastocysts (2.5 d) stained for Gata4 (Q, U), Nanog 
(R, V), and Oct4 (S, W). (T, X) Overlay of Gata4, Nanog, Oct4, and DAPI staining. 
Scale bars = 50  M. (F)   shows Nanog
high cells,   shows Nanog
low cells. Derivation of ES cells 
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Volocity software (Perkin Elmer) was used to determine the number of cells expressing 
each of the lineage markers. The software accurately identifies expression patterns based 
on a range of selection criteria. For example, background levels are excluded based on 
voxel  intensities  of  each  object.  Threshold  data  can  be  adjusted  to  separate  areas  of 
interest and can include or exclude objects based on selection parameters such as object 
size and shape. 
E3.5 blastocysts were collected as described above, immunofluorescently labelled with 
lineage  markers,  Gata4,  Oct4;  and  Nanog  and  images  were  captured  using  confocal 
microscopy.  An  identical  measurement  protocol  was  applied  to  each  image  using 
Volocity to determine the number of positively stained cells for each fluorescent channel 
used. Significant fluorescent intensities were selected by setting percentage intensity and 
size exclusion thresholds to remove background noise and to separate individual cells. 
The mean numbers of cells expressing each of the markers are shown in Figure 3.11. 
There were no significant differences in the total number of cells (DAPI +) or in lineage 
allocation between diet treatment groups at E3.5. 
 
 
Figure 3.11: Expression of lineage markers in E3.5 diet embryos 
(A) Mean total number of cells (DAPI+) and the number of cells expressing lineage 
specific  markers  (Gata4,  Nanog,  and  Oct4)  in  embryos  collected  at  3.5  dpc  from 
mothers  fed  either  a  LPD  (solid  bars)  or  control  diet  (hatched  bars)  throughout 
preimplantation development. (B) Ratio of lineage markers expression relative to total 
cell number. Values are means for 27 LPD and 29 NPD blastocysts ± SEM from 8 
mothers per treatment. Oct4 values are from 24 LPD (7 mothers) and 21 NPD (6 
mothers) blastocysts ± SEM. Chapter 3 
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Nanog has been suggested as the key participant in maintaining pluripotency and it has 
been suggested that the levels of Nanog expression are crucial in cell fate decisions. 
Levels of expression correlate with the probability of self-renewal versus differentiation. 
High expressing cells are more stable, whereas low expressing cells are more prone to 
differentiation(Chambers et al., 2003; Chambers et al., 2007; Graf and Stadtfeld, 2008; 
Mitsui et al., 2003), although expression levels can fluctuate in any given cell within a 
population. 
Nanog
high  and  Nanog
low  expressing  cells  were  separated  by  setting  a  percentage 
fluorescence  intensity  threshold  using  Volocity  as  described  above.  Nanog
high  and 
Nanog
low expressing cells are depicted by arrowheads in Figure 3.10F. Cells expressing 




low expression levels in E3.5 diet embryos. 
(A)  Confocal  immunofluorescence  analysis  of  Nanog  expression  levels.  Nanog 
expression levels were quantified per cell in arbitrary fluorescence units as described 
above. (B) Shows the percentage of Nanog
high cells. Values are mean cell numbers 
from 19 LPD and 23 NPD blastocysts ± SEM from 4 and 5 mothers respectively per 
treatment. 
 
Blastocyst outgrowths were analysed to compare the effects of in vitro ES cell culture on 
lineage allocation and differentiation in diet-challenged blastocysts and in controls. There 
was no difference in the total number of cells in outgrowths between treatment groups, or 
in the number of cell expressing markers Gata4 or Nanog. However, blastocysts from the 
LPD group did have significantly more cells expressing Oct4 in their outgrowths (46.31 
± 3 21 in LPD vs. 34.66 ± 2.16; P=0.0029) (Figure 3.13A). As a result the mean ratios 
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Oct4:  total  number  of  cells  was  significantly  greater  in  LPD  outgrowths  (0.3259  ± 
0.01709 in LPD vs. 0.2580 ± 0 01637 in controls; P=0.0068), and the number of Gata4-
(0.796 ± 0.067 in LPD, vs. 0.992 ± 0.0698 in NPD; P=0.049), and Nanog-(0.079 ± 0.015 
in  LPD  vs.  0.134  ±  0.027  in  NPD;  P=0.044)  expressing  vs.  Oct4  positive  cells  was 
significantly less (Figure 3.13B). 
 
Figure 3.13: Lineage marker expression in blastocyst outgrowths. 
(A) Mean total number of cells (DAPI+) and the number of cells expressing lineage 
specific  markers  (Gata4,  Nanog,  and  Oct4)  in  blastocyst  outgrowths  of  LPD-
challenged (solid bars) or control (hatched bars) blastocysts cultured for 2.5 d in ES 
cell medium. (B) Ratio of lineage markers expression relative to total cell number/ 
Oct4 cell number. Values are means for 29 LPD and 35 NPD blastocysts ± SEM from 
7 mothers per treatment. **P<0.01, *P0.05. 
 
Nanog expression levels were also assessed in blastocyst outgrowths. The percentage of 
outgrowths  with  any  Nanog-expressing  cells  was  less  in  LPD-challenged  blastocysts 
(61.76% in LPD vs. 88.24% in controls) (Figure 3.14 C). While there appeared to be a 
decrease in the average number of Nanog
high cells this was not statistically significant 
(P=0.097) (Figure 3.14A). 
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Figure 3.14: Nanog expression levels blastocyst outgrowths 
(A)  Confocal  immunofluorescence  analysis  of  Nanog  expression  levels.  Nanog 
expression levels were quantified as described above. (B) Shows the percentage of 
Nanog
high cells. (C) Shows the number of Nanog + outgrowths per treatment group. 
Values are mean cell numbers from 29 LPD and 32 NPD outgrowths ± SEM from 6 
and 7 mothers respectively per treatment. 
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3.4 Discussion 
Undifferentiated stem cells possess almost unlimited self-renewal capabilities and retain 
pluripotent characteristics of their founder cells. This provides a model to investigate the 
properties of the stem cell populations resident within the blastocyst. In addition, the 
ability of ES cells to form cell types of all three germ layers in vitro, and to reintegrate 
into embryogenesis in vivo, can provide valuable information on lineage specification 
and differentiation. This provides the basis for this study where ES cells derived from 
blastocysts of undernourished mothers may be used as a method to assess the effect of 
diet on these founder cells, a process that is difficult to study in vivo. 
Indeed it has been shown that maternal diet during early development has a significant 
impact on short-term development of the preimplantation embryo with fewer ICM cells 
in the E3.5 blastocyst in rodents, as determined by differential-labeling (Kwong et al., 
2000). This has been associated with long-term changes in adult physiology, with an 
increased incidence of metabolic disease. Our study is somewhat contradictory to these 
findings,  as  blastocysts  collected  from  mothers  fed  a  LPD  during  preimplantation 
development show no differences in cell numbers or cell lineage allocation compared to 
controls.  However,  there  does  appear  to  be  a  notable  effect  of  maternal  diet  on  the 
blastocyst as a whole. Blastocyst developmental progression appears to be slowed as a 
result of less favourable culture conditions and there is a significant influence of maternal 
diet on the potential to isolate ES cells. 
Some  of  the  long-term  effects  of  maternal  LPD  have  been,  in  part,  explained  by 
immediate changes in the blastocyst. Cell numbers in the blastocyst are altered following 
LPD  in  rodents.  In  these  studies,  cell  lineage  allocations  were  determined  using  a 
differential  staining  method  based  on  positional  aspects  of  the  cells.  This  method 
distinguishes outside cells from inside cells in the blastocyst, but doesn’t provide any 
information about the individual cells in terms of cell fate. Here we used cell lineage 
specific markers to distinguish cell type by differential expression of these transcription 
factors.  There  was  no  overall  difference  in  the  expression  of  these  markers  at  E3.5, 
showing  that  cell  lineage  numbers  were  equivalent  between  treatments.  We  were 
primarily  interested  in  the  number  of  pluripotent  cells  in  the  blastocyst,  therefore, 
markers  Oct4,  Nanog  (markers  of  pluripotency),  and  Gata4  (a  marker  of  PE 
differentiation)  were  used.  No  specific  markers  for  the  TE  were  used  in  this  study, 
therefore  it  was  not  possible  to  provide  an  accurate  count  of  TE  versus  ICM  cells, Chapter 3 
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especially as expression of the cell markers used becomes restricted to these lineages 
only at the late blastocyst stage (Dietrich and Hiiragi, 2007).  
In addition, C57BL/6 mice were used in this study, which was different to the strain used 
in previous preimplantation maternal undernutrition models, where outbred MF-1 mice 
were used. MF-1 mice are considered more sensitive to changes in embryo environment. 
For example, in vitro culture of MF-1 blastocysts display a higher apoptotic cell number 
than those from C57BL6/CBA mice, both when directly isolated as blastocysts and when 
developed in culture. Further, MF-1 embryos are also generally more affected by in vitro 
culture conditions (Kamjoo et al., 2002). This may explain the differences seen in our 
study, where we saw no effect of a LPD on C57BL/6 blastocyst cell numbers, compared 
with similar studies using MF1 mice, where blastocyst cell numbers were altered. Further, 
comparison of C57BL/6 mice with another inbred mouse strain, A/J, reveals differences 
in many physiological characteristics (Ernest et al., 2005; Singer et al., 2005). Exposure 
of C57BL/6 mice to high-fat diet during early life induces obesity and diabetes, which 
does not occur in A/J mice (Surwit et al., 1995). Dietary restriction causes changes in 
foetal organ allometry in C57BL/6, but not A/J mice, which are associated with increases 
the  risk  for  adult  diseases  including  coronary  heart  disease  and  components  of  the 
metabolic syndrome (Knight et al., 2007a; Knight et al., 2007b; Knight et al., 2009). In 
summary these studies and ours suggest a genetic basis contributing to the degree of the 
DOHaD response, which should be considered. 
Mitchell et al (2009) saw differences in cell numbers of blastocyst lineages following a 
LPD  in  C57BL/6  mice,  however,  these  mice  were  superovulated  and  embryos  were 
cultured  from  the  2-cell  to  blastocyst  stage  following  a  pre-conceptional  dietary 
treatment. Although a valid effect of diet on blastocyst cell numbers, it does not confirm 
changes in blastocyst development in vivo. The changes shown could well be a result of 
additional variables. Superovulation does not affect the ability of blastocysts to form 
(Katayama and Roberts, 2010; Van der Auwera and D'Hooghe, 2001) , but does impose a 
greater degree of lineage restriction, where blastomeres during early cleavage contribute 
predominantly to the abembryonic pole during axis formation , with a preference towards 
ICM  (Katayama  and  Roberts,  2010).  Superovulation  delays  blastocyst  formation  and 
hatching in vivo (Katayama and Roberts, 2010; Van der Auwera and D'Hooghe, 2001). 
Also,  the  suboptimal  environment  associated  with  in  vitro  culture  during  blastocyst 
development has been shown to reduce ICM cell number at the blastocyst stage (Kaye Derivation of ES cells 
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and  Gardner,  1999;  Lane  and  Gardner,  1997).  Reduction  in  cell  number  of  in vitro 
culture blastocysts has been associated marked changes in adult physiology (Eckert et al., 
2012; Watkins et al., 2007). 
Despite these similarities in blastocyst development in our study, we did see a substantial 
effect of maternal diet on the potential to derive ES cells from blastocysts, which was 
significantly  reduced  following  a  LPD.  There  are  a  number  of  potential  reasons  for 
reduced  stem  cell  potential.  This  may  be  a  result  of  reduced  proliferation,  increased 
sensitivity of cells and higher levels of cell death, or alterations in cell lineage allocation 
during  the  process  of  cell  fate  determination  and  differentiation.  These  changes  may 
occur in the blastocyst itself or as a result of in vitro culture of blastocysts prior to ES cell 
isolation,  but  will  ultimately  lead  to  a  reduction  in  the  number  of  pluripotent  cells 
capable of generating ES cell lines. 
Due to the transient existence of pluripotent cells in the embryo and the rapid progression 
into more differentiated cells (Papaioannou and Rossant, 1978), the window to “capture” 
pluripotent cells is small. Even under optimal conditions it is accepted that the ES cell 
isolation is not possible from all blastocysts. It has been shown that the ICM cells of 
some blastocysts downregulate Oct4 expression and cease dividing when explanted in 
culture (Buehr et al., 2003). In addition, there is a strong genetic element to ES cell 
isolation which is highly variable between mouse strains (Brook and Gardner, 1997). 
This was reflected in our study, where ES cell isolation was initially low in C57BL/6 
mice  compared  to  the  more  permissive  129  strain.  A  modified  protocol  showed  that 
reducing the period in culture before dissociating ICM –derived outgrowths was crucial 
in improving ES cell derivation efficiency. When blastocyst explants were cultured for 5-
6 days as described in many other papers (Auerbach et al., 2000; Bryja et al., 2006b; 
Cheng et al., 2004; Nagy et al., 2003; Nagy et al., 1993; Schoonjans et al., 2003), the 
outgrowths  appeared  more  and  stem  cells  were  not  culturable.  This  suggests  that 
blastocysts from this strain develop at a different rate compared to 129 strains and that 
ICM stem cells have passed the through the crucial window to capture pluripotency by 
this  time.  Alternatively,  altered  proliferation  rates,  or  increased  sensitivity  to  culture 
conditions may affect the permissiveness of these blastocysts. Any conditions that alter 
such developmental parameters are will inevitably reduce the chances of isolating these 
cells. Chapter 3 
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Morphology analysis of blastocyst outgrowths in culture, as determined during the ES 
cell  isolation  procedure,  showed  no  obvious  difference  in  the  rate  of  development 
between treatment groups. However, when blastocyst morphology analysis was repeated 
for the experiment designed to determine cell lineage allocation in blastocyst explants, 
there was a significantly slower developmental progression from mothers on a LPD. This 
may have been due to less favorable experimental conditions. In this analysis, explants 
were grown on coverslips and as a result there were circumstantially much less MEFs in 
these co-cultures, as they did not attach well under these conditions. The MEF feeder 
layer is important as they provide the ES cells substratum to which they can attach. The 
feeder cells also release a number of important growth factors and cytokines into the 
culture medium required for ES cells to maintain self-renewal and pluripotency. LIF has 
been discovered to be the important factor produced by feeder cells, and ES cells can be 
successfully cultured without feeders in the presence of LIF (Smith et al., 1988). This is 
less  successful  with  non-129  ES  cell  lines  resulting  in  increased  cell  death  and 
differentiation (Sato et al., 2009). Fibroblasts have been shown to secrete many growth 
factors including FGF2, LIF, and extra cellular matrix proteins such as, activins, Wnts, 
and BMPs (Eiselleova et al., 2008; Villa-Diaz et al., 2009), which support self-renewal 
and proliferation in ES cells. Feeder-free culture conditions without conditioned medium 
have  been  described  (which  requires  LIF  and-defined  media,  and  gelatin),  yet 
background differentiation is high under these conditions and they do not contribute well 
to the germ-line (Chambers et al., 2007; Toyooka et al., 2008). Although the ES cell 
medium  used  in  our  study  contains  LIF,  the  MEF  cells  may  be  providing  important 
growth  support  factors  that  are  not  sufficiently  available  in  the  blastocyst  outgrowth 
cultures  used  for  cell  lineage  experiments.  This  may  explain  the  discrepancies  seen 
between these experiments. LPD may also induce a phenotype in blastocysts that may 
alter the uptake of these growth factors and subsequent activation of pathways regulating 
pluripotency signalling or proliferation. 
It was hypothesized that a potential cause of reduced ES cell isolation potential was due 
to lineage allocation and perhaps a preference to differentiate towards PE during cell fate 
decisions as a result of LPD treatment. Cell lineage expression analysis in our blastocyst 
outgrowths showed significantly more Oct4 positive cells at the time of ICM dissociation 
(2.5  days  culture),  concomitant  with  a  reduced  ratio  of  Nanog:  Oct4  positive  cells. 
Although Oct4 expression is required to maintain pluripotency in ES cells and the EPI Derivation of ES cells 
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(Nichols et al., 1998; Niwa et al., 2000) it has been shown that the balance in the levels 
of Oct4 is crucial in establishing pluripotent status. Whereas downregulation of Oct4 (by 
one half) results in the loss of pluripotency and differentiation into TE, excess Oct4 
activity (< two-fold) results in differentiation into PE-like cells (Hay et al., 2004; Niwa et 
al., 2000; Pan et al., 2006). In addition Oct4 is not sufficient to maintain pluripotency in 
the absence of certain cytokines and growth factors. The mere presence of Oct4 does not 
necessarily indicate pluripotency. The levels of Oct4 expression were not possible to 
quantify by the methods used in this analysis.  
Further, Oct4 positive cells fluctuate between states of high and low Nanog expression. 
Nanog is a key regulator of pluripotency, and Nanog expression alone is sufficient to 
prevent differentiation of ES cells (Chambers et al., 2003; Mitsui et al., 2003; Niwa et al., 
2009). Nanog expression is heterogeneous in ES cells and the blastocyst (Silva et al., 
2009)  and  high  versus  low  Nanog  expression  correlates  with  the  probability  of  self-
renewal versus differentiation (Chambers et al., 2003; Chambers et al., 2007; Graf and 
Stadtfeld, 2008; Mitsui et al., 2003).  The number of Nanog expressing cells in blastocyst 
explants was not different between treatments. One may anticipate an increase in Nanog 
positive cells to coincide with the increase in Oct4. However, although not significantly 
different, there were less Nanog
high cells, and the proportion of outgrowths containing 
Nanog positive cells was less from LPD blastocysts. This suggests that there are subtle 
changes  in  the  pluripotent  potential  of  the  ICM-derived  cells  of  the  preimplantation 
embryo after blastocyst explant in culture, which may in part help to explain the reduced 
ES  cell  isolation  efficiency  from  blastocysts  following  LPD.  A  change  in  Nanog 
expression however does not reflect an irreversible developmental progression. ES cells 
can reversibly change their state and still maintain pluripotency. Nanog negative cells can 
even revert to a Nanog positive state associated with a return to pluripotent capacity 
(Chambers et al., 2007; Osorno and Chambers, 2011). Fluctuations in Nanog expression 
help to control promiscuous activation of lineage specific genes, regulating the flow of 
differentiating cells along specific lineages when the correct cue arises. Simultaneous 
expression of two or more lineage associated transcription factors in an undifferentiated 
stem or progenitor cell is known as lineage priming (Hu et al., 1997). This offers a more 
conclusive perception of cell fate. The data shown in our study provides some indication 
of  stem  cell  potential  based  on  lineage  specific  marker  expression,  however,  more 
sophisticated analyses are required to generate a true account of pluripotent potential. Chapter 3 
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Further,  the  changes  seen  in  cell  lineage  distribution  may  just  be  a  result  of  the 
differences seen in developmental rate. The increased number of cells expressing Oct4 
may  just  be  a  consequence  of  the  slower  development  of  the  outgrowths  overall,  as 
suggested  by  the  morphology  analysis.  Generally,  an  increased  total  cell  number  in 
outgrowths correlated with a decreased number of Oct4 expressing cells and an increase 
in differentiated cells (Gata4 positive) as might be expected. Therefore, outgrowths at 
earlier stages of development would be expected to contain more Oct4+/ Nanog+. 
The  experimental  differences  seen  in  blastocyst  outgrowth  morphology  experiments 
between  the  embryos  used  for  ES  cell  isolation,  and  in  those  used  for  cell  lineage 
experiments, i.e. the culture with and without feeder cells, makes it difficult to draw 
comparisons and conclusions from this experiment. The same can be said for cell lineage 
marker expression analysis in these outgrowths. It is difficult to suggest whether cell 
lineage distribution has or has not changed during our ES cell isolation experiment based 
on the results of the marker analysis, as there appeared to be considerable difference in 
blastocyst response to the culture conditions. Nevertheless, it does seem that blastocysts 
from LPD are affected in less favourable culture conditions suggesting a more sensitive 
phenotype. This is consistent with many of the studies, which demonstrates that foetal 
growth  impairment  as  a  result  maternal  undernutrition  perpetuates  into  adult  life.  A 
slower  proliferative  rate  in  the  rat  blastocyst  is  connected  to  restrictions  in  early 
embryonic growth and generation of appropriately sized stem cell lineages (Kwong et al., 
2000). This can explain reduced birthweight, or slower growth during the early stages of 
gestation, and abnormal organ allometry observed in a number of maternal undernutrition 
studies in rat (Desai et al., 1996; Langley-Evans et al., 1996a; Langley-Evans et al., 1999) 
and mouse models (Langley-Evans et al., 2011; Watkins et al., 2008a). For example, a 
maternal  low-protein  diet  imposed  throughout  rodent  gestation  induces  specific 
alterations in organ growth producing offspring with fewer nephrons (Langley-Evans et 
al., 1996c; Welham et al., 2002) and reduced postnatal pancreatic islet number, size and 
 -cell  ratio  (Chamson-Reig  et  al.,  2006;  Snoeck  et  al.,  1990).  In  rats,  LPD  during 
preimplantation development led to altered postnatal growth, and abnormal kidney/ liver: 
body weight ratios (Kwong et al., 2000), and in mice, there is a comparatively smaller 
heart mass (Watkins et al., 2010; Watkins et al., 2008a). These changes show direct 
associations with postnatal function, particularly with regard to control of blood pressure 
and glucose homeostasis. Derivation of ES cells 
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This notion of increased sensitivity, may explain how ES cell isolation efficiencies are 
substantially reduced despite no apparent differences in blastocyst outgrowths from this 
experiment. 
Data are limited to suggest that LPD affects cell fate decisions in the blastocysts or 
blastocyst explants in culture (at least under optimal culture conditions). Proliferation and 
cell growth were potentially altered in conditions that were less favourable (less MEFs), 
as suggested by the morphology analysis, but again there was no evidence to suggest that 
this  was  a  significant  factor  during  ES  cell  isolation.  Certainly  there  are  unexplored 
factors involved in the response. 
Disaggregation of ICM-derived outgrowths into single cells during the ES cell isolation 
procedure undoubtedly imposes a large amount of stress on the cells and some level of 
cell death, something that is largely immeasurable. However, considering the pool of 
data  collected  here,  increased  sensitivity  of  the  blastocyst’s  stem  cell  populations  in 
response to maternal LPD seems a possible mediator of reduced potential observed in 
vitro. Determining the cellular processes that are driving these apparent changes in stem 
cell  potential  may  provide  insight  into  changes  that  are  occurring  during  early 
development in vivo.  
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Chapter 4:  Characterisation of ES cell lines 
4.1 Introduction 
Validation of our isolated cell lines is essential to confirm ES cell identity. For these cell 
lines to be considered as a model for studying developmental plasticity in the blastocyst 
they must show expression of the expected self-renewal transcription factors present in 
their in vivo counterparts, allowing them to possess the ability to generate cell types of all 
three definitive germ layers. Further, this is dependent on the ES cells maintaining a 
normal diploid karyotype, as transmission of the ES cell genome through the germ line 
requires a normal chromosome number (Longo et al., 1997).  
Pluripotency in ES cells is maintained by the triad of regulatory factors: Oct4, Nanog and 
Sox2,  which  are  essential  for  self-renewal  and  prevent-differentiation  (Avilion  et  al., 
2003; Chambers et al., 2003; Niwa, 2007; Pesce and Scholer, 2001). The importance of 
these markers in maintaining pluripotency is demonstrated in the generation of induced 
pluripotent  stem  (iPS)  cells  (Kim  et  al.,  2009;  Maherali  and  Hochedlinger,  2008; 
Takahashi and Yamanaka, 2006). This technology is used to return differentiated cells 
into  a  pluripotent  ES  cell-like  state  by  exogenously  introducing  a  combination  of 
transcription factors, including Oct4 and Sox2. Nanog surprisingly is not required for 
dedifferentiation, but its activation is essential to generate full pluripotent potential in iPS 
cells (Silva et al., 2009). During differentiation of ES cells or development of the embryo 
in  vivo,  these  transcription  factors  activate  or  repress  genes  involved  in  lineage 
specification.  Altered  expression  of  these  genes  is  reflected  by  the  mRNA  transcript 
levels within cells and is commonly used to characterize ES cell populations.   
ES cell lines carrying major genetic abnormalities have little experimental value in this 
study, as aberrations are likely to affect the developmental potential of the cells. An 
abnormal chromosome number has been shown to affect proliferation (Baker et al., 2007), 
metabolism,  differentiation  (Williams  et  al.,  2008;  Yang  et  al.),  and  alters  gene 
expression of pluripotency and differentiation markers in ES cells (Mitalipova et al., 
2005). It is therefore necessary to validate the stem cells karyotype when assessing cell 
function and molecular profile.  
Here, we therefore characterise expression of pluripotency markers, chromosome number, 
and determine the sex of our isolated cell lines before any further cell analyses. Some of 
the data in this chapter was included in Lucas et al.(2011). Chapter 4 
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4.2 Materials and methods 
4.2.1 Qualitative pluripotency analysis of ES cells by Immunofluorescence 
ES cells were grown on 13mm coverslips at a starting density of 6000 cells per well as 
described in section 2.2. To verify the undifferentiated state of ES cell lines, cells were 
immunolabelled  to  detect  expression  of  the  pluripotency  markers  Nanog,  Oct4,  and 
SOX2 (section 2.3). Confluent cells (2 d) were fixed in 4% paraformaldehyde for 15 min, 
permeabilised, and blocked (PBS with 0.3% Tx-100 and 5% serum) for 30 min. Cells 
were incubated with primary antibodies (Mouse anti-Oct4 (Santa Cruz C-10, SC5279), 
1:200; Rabbit anti-Nanog (Abcam 80892), 1:200; Rabbit anti-Sox2 (Chemicon, AB5603), 
1:50) overnight at 4°C. After three washes in PBS-Tween-20 (PBS-T, 0.1%) over 30 min, 
cells were incubated with Alexa Fluor 488 (to detect rabbit IgG)-/Alexa Fluor 555 (to 
detect mouse IgG)-conjugated secondary antibody (Molecular probes) for 1 h at room 
temperature. Nuclei were counterstained with DAPI (1: 500 in PBS-T) in a final washing 
step.  Samples  were  mounted  with  anti-fade  Vectashield®  mounting  medium ( Vector 
laboratories) onto microscope slides and images were captured using a Zeiss axiofoot-2 
upright fluorescence microscope.  
4.2.2 Quantitative pluripotency analysis by Real-time PCR 
Sample preparation 
ES cells were rapidly thawed to 37°C from vials stored at the earliest passage number 
following line derivation (passage 5-7), and grown on MEFs in ES medium for one 
passage. ES cells were purified (as described in 2.2.3) and cultured fibroblast-free on 
gelatin treated plates in ES medium. This procedure was repeated twice to minimize 
feeder cell content. Medium was replaced daily, and ES cells were maintained by trypsin 
passaging confluent cultures every 2 days. 
After feeder cell depletion, ES cells (passage 9-11) were pelleted, snap frozen in liquid 
nitrogen  and  stored  at  -80°C  in  prior  to  RNA  extraction.  16  ES  cell  samples  (from 
different lines) were prepared from each dietary treatment to allow comparison in gene 
expression. 
Quantitative Real-time PCR 
ES cell RNA was isolated and reverse transcribed as described in section 2.5.1. RNA 
concentration was determined by Nanodrop and purity was assessed based on the 260 nm 
to  280  nm  absorbance  ratio.  Samples  with  a  ratio  >1.90  were  considered  pure  and Characterisation of ES cells 
 89 
protein-free  and  were  considered  permissible  for  inclusion  in  quantitative  gene 
expression  analysis.  RNA  quality  was  assessed  on  a  denaturing  2%  agarose  gel 
containing formamide (Figure 4.1). 
 
Figure 4.1: RNA gel electrophoresis results from ES cell RNA extractions 
A representative 2% agarose gel showing total RNA for randomly selected ES cell 
lines used to make cDNA for gene expression analysis. The numbers marking each 
lane are the individual ES cell line ID numbers. The 18S and 28S ribosomal RNA 
bands are clearly visible, and there are no signs of lower molecular smears (degraded 
RNA) showing that the RNA samples are intact. 
 
Following reverse transcription, cDNAs were diluted to 5 ng/ l before being used as a 
PCR template. Amplification was performed as described in section 2.5.2 following the 
SYBR-green  precision  mastermix  protocol.  Gene  expression  for  each  sample  was 
analysed  in  duplicate  using  clear  96-well  plates.  Each  reaction  contained  1   l  of 
prediluted cDNA in a 20  l final volume. Sample sets also included a no template control, 
containing no cDNA. Primers were used at 300nM each. 
Primers  specific  for  chosen  genes  were  designed  over  the  intron-exon  boundaries  to 
minimize  genomic  DNA  amplification  using  the  Roche  Applied  Sciences  Universal 
Probe Library Design Centre (detailed in Table 4.1).  
Oligonucleotide sequences were synthesized by Invitrogen Custom Oligo service. Primer 
pair  efficiency  (E)  was  determined  by  real-time  PCR  over  a  set  of  10-fold  standard 
dilutions and calculated according to the formula E = 10
1/slope (an example is shown in 
Figure 4.2). 100% primer 
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efficiency would generate a value of 2 and represents a doubling of fluorescence (DNA 
product) during each amplification cycle A 10-fold dilution series should result in a 3.3 
cycle difference in PCR product for every 10-fold change in starting cDNA concentration 
(a doubling of product would occur after 1 cycle). Primer efficiency is shown in (Table 
4.1).  
 
Table 4.1: Primer details of selected genes used for quantitative PCR analysis 
 
Gene Name  Gene 
Symbol 
Accession 





Reference Genes             
18 s ribosomal RNA  18s  NR_003278  CTCAACACGGGAAACCTCAC  CGTCCACCAACTAAGAACG  110  2.02 
Hypoxanthine guanine 
phosphoribosyl  Hprt1  NM_013556  TCCTCCTCAGACCGCTTTT  CCTGGTTCATCATCGCTAATC  90  1.97 
Phosphoglycerate kinase 1  Pgk1  NM_008828  TACCTGCTGGCTGGATGG  CACAGCCTCGGCATATTTCT  65  1.99 
Peptidyl prolyl isomerase B  Ppib  NM_011149  TTCTTCATAACCACAGTCAAGACC  ACCTTCCGTACCACATCCAT  92  1.95 
Succinate dehydro-genase 
complex, subunit A  Sdha  NM_023281  TGTTCAGTTCCACCCCACA  TCTCCACGACACCCTTCTGT  66  1.99 
TATA box binding protein  Tbp  NM_013684  GGGAGAATCATGGACCAGAA  GATGGGAATTCCAGGAGTCA  90  1.94 
Tubulin  -1  Tuba-1  NM_011653  CTGGAACCCACGGTCATC  GTGGCCACGAGCATAGTTATT  114  1.95 
Pluripotency Genes             
Nanog homeobox gene  Nanog  NM_028016.1  TGCTTACAAGGGTCTGCTACTG  GAGGCAGGTCTTCAGAGGAA  76  1.99 
POU domain, class 5, 
transcription factor 1  Oct4  NM_013633.2  GTTGGAGAAGGTGGAACCAA  CTCCTTCTGCAGGGCTTTC  61  1.89 
SRY-box containing gene 2  Sox2  NM_011443.3  TGGGCTCTGTGGTCAAGTC  TGATCATGTCCCGGAGGT  105  1.92 
Differentiation Genes             
S100 calcium binding 
protein A4   S100a4  NM_011311.1  GGAGCTGCCTAGCTTCCTG  TCCTGGAAGTCAACTTCATTGTC  102  1.88 Chapter 4 
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Figure 4.2: Nanog dilution series data for calculating primer pair efficiency. 
(A) Opticon Monitior v3.1 output from real-time PCR amplification of ES cell cDNA 
using Nanog specific primer sequences over a serial 10-fold dilution.  Each cDNA 
concentration was run in triplicate. The dotted line represents the cycle threshold, C(t) 
where  the  fluorescence  signal  exceeded  background  fluorescence.  (B)  Standard 
curve used to calculate primer efficiency (E), E = 101/slope. 
 
Data analysis of reference genes 
Absolute  data  from  qPCR  experiments  can  be  highly  variable  due  to  the  multiple 
processing steps involved prior to and during the procedure (Pfaffl, 2001). It is therefore 
essential  to  normalize  absolute  expression  values  of  a  gene  of  interest  to  control 
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reference  genes  to  allow  precise  comparison  between  treatments.  Reference  genes 
selected  for  normalization  must  also  show  stable  expression  levels  and  must  not  be 
influenced  by  experimental  treatment.  To  meet  all  of  these  requirements,  analysis  of 
seven commonly used reference genes was performed using the geometric averaging 
normalization approach as described by Vandesompele et al.(2002).  
Cycle  threshold  (C(t))  values,  representing  the  specific  cycle  where  the  fluorescence 
signal of the amplifying product exceeded background fluorescence, were exported to 
Microsoft  Excel  from  Opticon  Monitior  v3.1  software.  Fluorescence  signals  were 
regarded positive when the fluorescence intensity reached 10x standard deviation of the 
threshold.  C(t)  values  were  converted  into  relative  quantities  (RQ)  corrected  for 
PCR/primer efficiency (E) using the following formula:     
RQ = (E)
 C(t)  
Where,   C(t)  =    C(t)  of  sample  –  minimum  C(t)  value  (i.e.  sample  with  highest 
expression; cDNA concentration correlates inversely to C(t) value). 
RQ  values  were  processed  using  geNorm  software  to  determine  the  stability  of  the 
reference genes. The geNorm program is a Visual Basic application for Microsoft Excel, 
which facilitates intra- and inter-set comparisons in expression of candidate reference 
genes and calculates a gene stability measure (M) for each individual gene. Gene stability 
is calculated by determining average pairwise variation of each gene sample set against 
all other reference genes studied. Those genes exhibiting the lowest stability values show 
low  intra  and  inter-set  variation  and  thus  the  highest  expression  stability.  Reference 
genes were ranked in order of stability according to systematic exclusion of the least 
stable genes by the geNorm applet to give the most stable genes. 
Relative expression of each individual reference gene was determined from the geNorm 
output by calculating the geomean (normalization factor) of all genes. Normalization of 
the  genes  was  achieved  by  dividing  the  raw  RQ  values  for  each  sample  by  the 
corresponding normalization factor. 
Data processing for relative gene expression analysis 
Sample sets were prepared as described above from the same batch of cDNA as used for 
geNorm analysis of the selected reference genes.  Relative expression values for specific 
genes of interest were normalized to the two most stable reference genes as determined 
by geNorm analysis. In this instance, normalization factors were determined for the two Chapter 4 
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most stable reference genes only and normalized expression levels for specific genes of 
interest  were  calculated  by  dividing  the  raw  RQ  values  for  each  sample  by  the 
normalization factors. 
Statistical testing 
Statistical analysis was performed in Minitab 16.1.0. Data was analyzed for normality by 
using the Anderson-Darling test and variance homology was tested using Fishers F-test. 
Mean expression values between dietary treatments were compared using a 2-sample t-
test. Data are expressed as mean ± SEM.  
4.2.3 Karyotype analysis.  
Karyotype  analysis  was  carried  out  in  collaboration  with  Congshan  Sun.  Actively 
growing cultures of ES cells were harvested with 0.05% trypsin-EDTA. Pelleted cells 
(300g  for  5  minutes)  were  resuspended  in  a  hypotonic  KCL  solution  (0.75  M)  and 
incubated at 37ºC for 5, minutes at room temperature. Cells were centrifuged (300g, 5 
minutes) and fixed by resuspension with glacial acetic acid in methanol (1:3) for 20 min 
at  -20°C.  This  was  repeated  an  additional  three  times.  Chromosome  spreads  were 
prepared by dropping the cells onto humidified ethanol-treated glass slides at a distance 
and  were  allowed  to  air-dry.  Chromosomes  were  stained  with  Giemsa  stain  (Sigma, 
G500;  1:25  dilution)  for  10-20  minutes  and  coverslips  were  mounted  using  Depex 
mounting medium (BDH labs). Spreads were analysed using a brightfield microscope 
with a CCD camera to obtain the frequency of 2n=40 metaphases. 
4.2.4 Sex determination of ES cell lines 
Sample preparation 
ES cells lines were quick-thawed and cultivated on MEFs for at least one passage. For 
sex  determination  ES  cells  were  purified  from  MEF  cells  by  preplating  and  grown 
feeder-free in 96 well plates until confluent (3-4 days). 
DNA extraction 
Cells were washed twice with PBS and 50  l lysis buffer added per well. Plates were 
incubated overnight at 55°C. The following day, lysates were transferred to a 1.5 ml 
eppendorf tubes and two volumes of cold ethanol (absolute) was added. The tubes were 
left  undisturbed  at  room  temperature  until  the  precipitated  nucleic  acid  was  visible. 
Tubes were centrifuged at 2000 rpm for 5 min and supernatant was discarded by gentle 
inversion. Pellets were washed twice in 70% ethanol and allowed to air-dry for 15-20 Characterisation of ES cells 
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min. 30-50  l (depending on pellet size) of water was added and left overnight to allow 
resuspension.  DNA  was  quantified  using  the  Nanodrop  ND-100-  spectrophotometer 
(protocol modified from Ramirez-Solis et al., 1992) 
Multiplex PCR 
Primers amplifying the Sry (Gubbay et al., 1990) and Zfy (Mardon and Page, 1989) genes 
located in sex-determining regions of the Y chromosome were used to verify male ES 
cell lines. Primers targeting the DXNds3 (Love et al., 1990) sequence on X chromosome 
were used as a control. Primers were synthesised by Sigma using sequences identical to 
those described by Kunieda et al. (1992), and are detailed in Table 4.2 
For sexing ES cell DNA, multiplex PCR (Greenlee et al., 1998; Kunieda et al., 1992) 
reactions were prepared as described in section 2.4.2 in a total volume of 25  l. PCR was 
performed  on  a  DNA  Engine®  Peltier  Thermal  Cycler  (BioRad,  UK).  Reaction 
conditions are shown in section 2.4.2. Male and female controls (from tail lysates) and a 
water blank (no DNA) were also subjected to the multiplex PCR procedure along with 
the  ES  cell  samples.  Amplified  DNA  products  (10   l)  were  separated  by  gel 
electrophoresis  using  a  3%  agarose  gel  with  TBE  buffer,  at  70  V  for  2-3  h.  
Amplification was visualised under UV light. 
 
Table 4.2: Sex specific primer details 
Sequences of primers used for sex determination of ES cell lines. Primers designed to 
amplify Sry and Zfy genes, located on the Y chromosome were used to identify male 
ES cell lines. Primers targeting DXNds3, located on the X chromosome, were used as 
a control to verify female cells. 
Gene Name 
Forward Primer 
Sequence 5’ to 3’ 
Reverse Primer 














TTAGTTGC  244 
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4.3 Results 
4.3.1 Qualitative pluripotency expression analysis  
Expression  of  transcription  factors  associated  with  pluripotency  is  indicative  of  an 
undifferentiated state and can therefore be used as cellular markers for defining ES cell 
status.  Qualitative  assessment  of  pluripotency  marker  (Nanog,  Oct4  and  Sox2) 
expression by immunohistochemistry was therefore used to characterise ES cell status. 
Immunofluorescence microscopy revealed nuclear staining of Oct4 (Figure 4.3A; LPD 
n=10; NPD, n=13) Nanog (Figure 4.3C), and SOX2 (Figure 4.3D) markers within all ES 
cell lines tested. Staining was not present in feeder cells (counterstained with nuclear 
marker, DAPI). ES cells derived from R1-129/SvJ mice, which have previously been 
shown to contribute to the germ-line in chimeras, were used as a control to confirm 





Figure 4.3: Pluripotency marker immunofluorescence analysis 
Immunofluorescence  labelling  of  pluripotency  markers  Oct4  (A,  B),  SOX2  (C)  and 
Nanog (D) in ES cells derived from C57BL/6 blastocysts using our LPD model (A, C, 
D), and in control germline competent ES cells derived from 129/ Sv mice (B). (A-B) 
Markers  were  not  expressed  in  underlying  MEFs.  Nuclei  were  stained  with  DAPI 
(blue). Scale bar = 50  m. 
 
In order to quantitatively compare ES cell pluripotency status between treatment groups, 
we also compared expression at the mRNA transcript level by real-time PCR. 
4.3.2 Quantitative pluripotency expression analysis 
The most widely applied technique to detect and quantify mRNA expression, quantitative 
PCR (qPCR; Bustin, 2002), is highly sensitive. It is able to analyze gene expression 
down to the single cell level (Stahlberg et al., 2009) and can discriminate against closely Chapter 4 
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related  mRNA.  However,  variation  may  occur  using  this  method  due  inconsistencies 
during the multiple processing steps involved in RNA extraction, reverse transcription 
and  the  qPCR  reaction  itself  (Pfaffl,  2001;  Stahlberg  et  al.,  2004).  This  means  that 
absolute data from qPCR experiments can be highly variable. It is therefore essential to 
normalize absolute expression values of a gene of interest to a control reference gene to 
allow precise comparisons between samples. It is important that reference genes used for 
normalization  show  stable  expression  levels  that  are  not  influenced  by  experimental 
treatment. It is clear however that many of the reference genes used for normalization can 
be  influenced  by  conditions  such  as  dietary  manipulations  (Janovick-Guretzky  et  al., 
2007). It has therefore been suggested that selection of multiple reference genes should 
be tailored to specific experimental conditions. Vandesompele et al. (2002) generated a 
normalization  approach  based  on  the  geometric  averaging  of  expression  levels  of 
multiple reference genes which are subsequently ranked by stability. 
To accurately study gene expression by qPCR using our dietary undernutrition model in 
ES cells, we analysed seven commonly used reference genes (18s, Hprt1, Ppib, Pgk1, 
Sdha, Tbp, and Tuba1; Table 4.1) based on their reported stability in other models and 
tissues (Boda et al., 2009; Mamo et al., 2007; Meller et al., 2005). geNorm software was 
used to determine the most stable genes for normalization (Vandesompele et al., 2002). 
ES cell samples were then characterized for expression of a triad of pluripotency markers 
(Nanog, Oct4 and Sox2) to confirm an undifferentiated status in all samples. 
RNA quality 
All ES cell RNA samples were analyzed for concentration, purity and integrity. Based on 
Nanodrop analysis, 260 to 280 nm absorbance ratios were greater than 1.9 and hence 
RNA  was  considered  pure  and  protein  free.  RNA  integrity  was  also  considered 
acceptable as determined by gel electrophoresis (Figure 4.1). The intact total RNA shows 
sharp 28S and 18S rRNA bands. A 2:1 ratio (28S:18S) in band intensity being taken as a 
good indication that the RNA is intact. Partially degraded RNA would show a general 
smear,  will  lack  the  sharp  rRNA  bands,  or  will  not  exhibit  a  2:1  ratio.  Completely 
degraded RNA would show as a very low molecular weight smear. 
Selection of reference genes for normalization  
Amplification of each target reference gene was quantified by qPCR using SYBR-green 
fluorescent signals generated during each PCR cycle. A melting curve was generated for 
each gene to verify amplification of a specific product. The melting temperature (Tm) of Characterisation of ES cells 
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an  oligonucleotide  is  determined  by  the  base  composition  and  length.  Similar  PCR 
products should melt at the same temperature. At the melting point DNA strands separate 
and  fluorescence  dramatically  decreases  revealing  information  about  any  products 
amplified. This allows contamination or mispriming to be exposed. All genes showed a 
single  peak  on  the  melting  curve  at  the  correct  Tm.  Product  specificity  was  further 
confirmed by running PCR products on a 2% agarose gel (Appendix II.iv). 
Gene expression stability in ES cells from our maternal dietary model was determined by 
geNorm  software  (Vandesompele  et  al.,  2002),  which  calculates  a  gene  expression 
stability value (M) based on pairwise variation within each sample set compared against 
all other genes analysed. 
All seven of the selected reference genes showed high expression stability with low M 
values (M<0.5), which were below the stability cut-off limit of 1.5 in the geNorm applet.  
Figure 4.4A displays M of each gene and ranking of the least and most stable reference 
genes.  Tbp  and  Sdha  were  identified  as  the  most  stable  genes.  In  addition  to  gene 
stability, geNorm also calculates a normalisation factor used to calculate the optimal 
number  of  reference  genes  for  normalisation.  A  pairwise  variation  V  between  two 
sequential normalisation factors is generated between increasing number of genes, i.e. the 
normalisation factor generated by the two most stable genes versus the normalisation 
factor generated for the three most stable reference genes (V2/3) (Figure 4.4B). A large 
variation (>0.15) indicates that the added gene should be considered for normalising 
against in any relative gene expression analysis. Figure 4.4B shows that V2/3 is less than 
0.15 (0.097) and the V value did not essentially increase with the inclusion of further 
reference genes. Therefore using either the two (Tbp, Sdha) or three (Tbp, Sdha, Tuba) 
most stable reference genes was taken as being acceptable for normalisation. 
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Figure 4.4: geNorm output showing reference gene expression stability in ES 
cell samples. 
(A)  geNorm  analysis  showing  average  gene  expression  stability  M,  calculated  by 
comparing average pairwise variation in expression between genes. M was calculated 
for each gene and the least stable gene was then excluded from the next round of 
calculations. This stepwise exclusion enabled gene stability to be ranked as indicated 
in the x-axis. The two most stable genes are shown on the right and cannot be further 
ranked.  (B)  Shows  optimal  number  of  reference  genes  for  normalisation. 
Normalisation  factors  were  calculated  for  an  increasing  number  of  genes  and  the 
pairwise variation V between normalisation factors was calculated. Generally, a V less 
than  0.15  indicate  that  additional  reference  genes  are  unnecessary  for  accurate 
normalisation. Therefore no more than two genes are required for normalisation in ES 
cell gene expression profiling. 
Comparison of reference gene expression between ES cell treatments 
Relative expression of each reference gene was calculated to ensure that the most stable 
genes were also stable between treatments. For both treatments, relative expression of 
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each gene was normalised to the expression of all seven reference genes used by the 
calculation of the geometric mean (Vandesompele et al., 2002). For each gene, LPD 
expression was made relative to NPD samples (value of one). There was no statistical 
difference  in  expression  levels  between  treatments  in  ES  cell  samples  (Figure  4.5). 
Details of cell lines used are shown in Appendix II. iii. 
 
Figure  4.5:  Relative  expression  of  the  selected  reference  genes  in  ES  cells 
derived using our undernutrition diet model. 
Relative  expression  of  each  individual  reference  gene  was  normalised  against  the 
expression  of  all  seven  reference  genes  by  calculation  of  the  geometric  mean. 
Normalised expression values were calculated for each treatment group. Expression 
within ES cell lines (PN 9-10) from the LPD treatment group is displayed relative to 
NPD treatments and is from 11 LPD (lines 1, 2, 4, 6, 11, 12, 13, 20, 24, 39, 40), and 
14 NPD (lines 7,8,9,15,21,35,37,38,42,44,46,48,51,52) ES cell lines. Vertical bars are 
SEM. 
 
Quantitative analysis of pluripotency markers in undifferentiated ES cells 
derived using our undernutrition model.  
Amplification of each target genes Nanog, Oct4 and Sox2 was quantified by qPCR using 
SYBR-green fluorescent signals. A melting curve was generated for each gene to check 
product specificity showed a single dissociation peak at the correct Tm of each amplicon. 
Product specificity was further confirmed by electrophoresis on a 2% agarose gel (Figure 
4.6). 
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Figure 4.6: Pluripotency gene real-time PCR product specificity  
(A-C) Melting curves of Nanog (a), Oct4 (B) and Sox2 (C) for all ES cell samples. 
Single  peaks  show  that  the  real-time  PCR  products  are  dissociating  at  a  similar 
temperature and the product is specific. This is marked by a rapid decrease in SYBR-
green  fluorescence  as  double  stranded  DNA  separates.  Change  of  relative 
fluorescence units (RFU) with time (T) (-d (RFU)/dT) is plotted against temperature 
and in all cases show peaks at the melting temperature (Tm) of the specific amplicon. 
(h)  PCR  products  for  each  gene  show  single  bands  at  the  correct  amplicon  size 
(Nanog, 76 bp; Oct4, 61 bp; Sox2, 105 bp) when run by electrophoresis on a 2% 
agarose gel. S100a4 was used as a fibroblast specific marker to ensure no MEF DNA 
contamination in ES cell samples. 
 
ES cell samples were prepared feeder-free to prevent any MEF product being amplified 
in  any  gene  expression  analysis.  To  check  for  MEF  contamination,  ES  cell  cDNA 
samples from both dietary treatment groups were compared against MEF control cDNA 
for expression of a fibroblast specific marker, S100a4 (Figure 4.7) (Strutz et al., 1995). 
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Relative S100a4 expression in ES cell samples was highly variable in both treatments 
(0.08 ± SEM 0.04 in LPD vs. 0.15 in NPD ± SEM 0.06), but was far lower than that of 
MEF controls (20.6). 
 
Figure 4.7: Quantitative analysis of fibroblast marker S100a4 in undifferentiated 
ES cells 
Real-time PCR analysis of fibroblast specific marker S100a4. Relative expression of 
S100a4 was calibrated against the normalisation factor of the most stable reference 
genes (Tbp and Sdha), as determined by geNorm analysis. Expression within ES cells 
(PN  9-10)  from  LPD  and  NPD  treatment  groups  is  made  relative  to  MEF  control 
samples. n = 11 LPD (lines 1, 2, 4, 6 , 11 , 12, 13, 20, 24, 39, 40), and 14 NPD (lines 
7, 8, 9, 15, 21, 35, 37, 38, 42, 44, 46, 48, 51, 52) ES cell lines. Error bars indicate 
mean ± SEM. 
 
Relative  expression  of  established  pluripotency  markers  was  analysed  to  confirm  the 
differentiation state of the ES cell samples. Data was normalised to the expression of the 
two most stable reference genes as determined by geNorm analysis (Tbp and Sdha). LPD 
expression was calculated relative to NPD samples. All three markers were expressed in 
ES cell samples and revealed no significant differences between the treatment groups 
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Figure 4.8: Quantitative analysis of pluripotency markers in undifferentiated ES 
cells 
Real-time  PCR  analysis  of  three  pluripotency  markers  (Oct4,  Nanog  and  Sox2). 
Specific  genes  of  interest  were  normalized  to  Tbp  and  Sdha  as  determined  by 
geNorm analysis. LPD expression is relative to NPD samples. n = 11 LPD (lines 1, 2, 
4, 6 , 11 , 12, 13, 20, 24, 39, 40), and 14 NPD (lines 7, 8, 9, 15, 21, 35, 37, 38, 42, 44, 
46, 48, 51, 52) ES cell lines (PN 9-10). Error bars indicate mean ± SEM. 
 
4.3.3 Karyotype assessment 
In addition to assessing expression of pluripotency markers, it is necessary to determine 
the  karyotype  of  all  ES  cell  lines  as  fully  competent  stem  cells  require  a  normal 
chromosome number. 
Chromosome spreads were prepared at passage number 14-17 to ensure that individual 
ES cell lines maintained a normal karyotype through extensive culture. Suspended cells 
were treated with hypotonic KCL that causes cells to swell before fixing. The proportion 
of ES cell lines displaying a euploid karyotype of 40 chromosomes and the number of 
aneuploid spreads were recorded (Appendix II.v) At least 30 chromosome spreads were 
counted per cell line. Cell lines were considered to have a normal karyotype if more than 
50 percent of metaphase spreads had 40 chromosomes present (Figure 4.9). The vast 
majority of cell lines tested showed a euploid karyotype (75.9%) for more than 50% of 
the  metaphase  spreads  counted  (Table  4.3).  Diet  treatment  had  no  statistically 
demonstratable  effect  on  chromosome  number,  although  there  were  slightly  more 
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abnormal  cell  lines  from  the  LPD  group  (28.6%  vs.  20.0%  in  controls)  (Table  4.3). 
Representative examples of euploid and aneuploid ES cells are shown in Figure 4.9.  
Table 4.3: Summary of karyotype analysis of ES cell lines 
Showing  the  percentage  of  ES  cell  lines  used  in  this  study  displaying  a  euploid 
karyotype of 40 chromosomes. ES cell lines with > 50 % of metaphase spreads with 
40 chromosomes present were considered euploid. 
  % Aneuploid  
ES cell lines 
% Euploid ES cell  
lines (2n=40) 
LPD  28.58  71.42 
NPD  20.00  80.00 
Total  24.14  75.86 
 Chapter 4 
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Figure 4.9: Karyotype analysis of ES cell lines 
(A) Example metaphase spread of a euploid ES cell line (2n = 40; green bar)). 30 
chromosome spreads were counted. (B, C) Images showing aneuploid karyotype with 
reduced chromosome number (B) and an example of polyploidy (C). Chromosomes 
were stained with Giemsa stain. 
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4.3.4 Sexing of embryonic stem cell lines 
Sex determination is also of relevance for later investigations within this study. Maternal 
diet has been shown to affect postnatal phenotype and genotype in a gender specific 
manner. Gender specific differences in growth and physiology are demonstrated in male 
and female rats fed a LPD (Kwong et al., 2000). Male rats show altered expression of 
genes  implicated  in  hypertension  and  insulin  resistance  in  blastocysts  (Kwong  et  al., 
2006) and in foetal liver (Kwong et al., 2007). Altered cardiovascular physiology has 
also been observed in male mice (Watkins et al., 2010; 2008a). Therefore it is possible 
that the characteristics of diet derived ES cell lines may also be variable between sexes.   
Sex was determined for each individual ES cell line by amplifying Sry and Zfy genes 
located  in  sex-determining  regions  of  the  Y  chromosome  by  multiplex  PCR.  The  X 
chromosome specific gene DXNds3 was amplified as a control for female ES cell lines. 
Sex  specific  reactions  are  shown  in  Figure  4.10.  PCR  of  male  ES  cell  lines  show 
amplification of all three genes as expected and revealed three bands (Zfy, 617 bp; Sry, 
404bp, DXNds3, 244 bp) when run on agarose gels (lanes containing samples M, 1, 4, 5, 
7,  8,  12,  24).  Female  ES  cell  lines  resulted  in  one  band,  DXNds3  (lanes  containing 
sample F, and 3). Chapter 4 
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Figure 4.10: Products of multiplex PCR for sexing DNA isolated from ES cell 
lines 
Lane B: sample without DNA; Lane M: 50ng of purified DNA from male mouse; Lane 
F: 50ng of purified DNA from female mouse.  Numbered lanes refer to ES cell line ID: 
Each lane contains 50 ng DNA from ES cell line, all of which were determined as male; 
Band sizes were determined using a Bioline Hyperladder II DNA size marker. 
 
Table 4.4 shows the number of male and female ES cell lines for each treatment group. 
The number of male lines isolated was very much higher than the number of female lines 
across treatments (76.20% total male). 
 
Table  4.4:  Results  of  PCR  sex  analysis  of  ES  cell  lines  separated  by  diet 
treatment. 
Diet 
Number of ES 
cell lines 
Male (%)  Female (%) 
LPD  17  12 (70.6)  5 (29.4) 
NPD  25  20 (80.0)  5 (20.0) 
Total  42  32 (76.2)  10 (23.8) 
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4.4 Discussion 
Validation of any putative ES cell lines is essential to ensure that the cells retain all of the 
characteristics  of  their  in  vivo  counterparts  within  the  blastocyst.  Gene  and  protein 
expression studies can confirm the identity of ES cells. Oct4 and Nanog mRNAs are 
exclusively expressed in future ICM cells at compaction of the morula, and in the ICM of 
the blastocyst. Expression is also maintained in pluripotent stem cell populations derived 
from ICM (Mitsui et al., 2003; Nichols et al., 1998; Palmieri et al., 1994). Oct4 and 
Nanog  appear  to  inhibit  differentiation  in  early  development,  whereas  Sox2  is  a 
coactivator  of  Oct4  activity  and  synergistically  regulates  transcription  of  target 
pluripotency factors (Ambrosetti et al., 1997). Oct4 and Nanog upregulation have been 
shown to initiate differentiation, however, this is transient and expression of all markers 
is downregulated in differentiated cell types (Palmieri et al., 1994; Tanaka et al., 2002). 
ES cell lines from both of our treatment groups showed expression of Oct4, Nanog and 
Sox2 by immunofluorescence showing similar expression patterns to control R1-129/ SvJ 
ES  cells,  which  have  been  shown  to  be  germ-line  competent  and  therefore  fully 
pluripotent.  As  discussed,  expression  levels  of  cell  lineage  markers  are  important  in 
determining  cell  fate.  In  order  to  quantify  expression  levels  between  treatments,  we 
looked at the levels of mRNA expression by real-time PCR. As discussed in section 4.3.2 
it is necessary to normalise absolute gene expression data to control reference genes. 
These  genes  must  be  stably  expressed  and  must  not  be  affected  by  experimental 
conditions.  We  used  the  geNorm  approach  to  select  suitable  reference  genes  for 
normalisation (Vandesompele et al., 2002). The reference gene expression was shown to 
be remarkably stable in ES cells from our undernutrition model, and expression levels 
did  not  differ  between  LPD  and  NPD  treatments.  It  has  however  been  shown  that 
stringent  testing  of  suitable  reference  genes  is  required  when  searching  for  subtle 
differences in gene expression by qPCR. Studies have shown that expression levels of 
many  commonly  used  reference  genes  can  be  highly  variable  between  experimental 
treatments and tissue type. For example, expression of two commonly used reference 
genes  glyceraldehyde-3-phosphate  dehydrogenase  (GAPDH)  and  beta-actin  was 
significantly  upregulated  in  invasive  melanoma  cells  compared  to  non-invasive 
melanoma cells from the same patient (Goidin et al., 2001). Serum stimulation in NIH 
3T3  fibroblasts  also  showed  increased  expression  on  reference  genes  beta-actin  and 
GAPDH  (Schmittgen  and  Zakrajsek,  2000).  Dietary  restriction  and  glucocorticoid Chapter 4 
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treatment also leads to variable reference gene expression in rat cortex and hippocampus. 
Here  GAPDH  and  beta-actin  are  very  stable  but  18s  and  cyclophilin  B  (cypB)  are 
variable in expression between structures (Tanic et al., 2007). Expression of multiple 
reference genes also altered in bovine liver under physiological stress and with dietary 
manipulation (Janovick-Guretzky et al., 2007).  Furthermore, when comparing reference 
gene expression in many adult and foetal tissues using our undernutrition model we have 
found that the most stable reference genes varied by tissue. In addition, reference gene 
expression  was  also  shown  to  vary  between  sexes  in  this  model  of  preimplantation 
maternal low protein diet in the blastocyst (Cleal et al., 2010; Lucas et al., 2011). The use 
of  less  stable  reference  genes  for  normalising  expression  of  Oct4  and  Nanog  in 
blastocysts and mouse ES cells has been shown to have a significant impact on data 
interpretation  (Willems  et  al.,  2006).  Relative  expression  of  these  genes  was  highly 
variable and expression levels did not correlate when normalised with the least stable 
reference  genes  compared  to  the  most  stable  reference  genes  (Willems  et  al.,  2006).  
These  findings  confirm  the  importance  of  validating  reference  genes  according  to 
experimental models and on a tissue-specific basis. The expression of the reference genes 
themselves should also be examined as even the most stable genes across samples can 
vary in expression between treatments (Lucas et al., 2011). In this study pluripotency 
gene expression was normalised to the two most stable reference genes for this treatment 
as determined by geNorm analysis (Tbp and Sdha). 
Pluripotency marker analysis in our ES cell samples showed relatively high expression of 
all three genes demonstrating that they do indeed remain undifferentiated and maintain 
pluripotent characteristics in culture in both dietary treatments, through many passages.  
In addition, very low level expression of fibroblast specific marker, S100a4 (Strutz et al., 
1995) was observed in ES cell samples in comparison to MEF control samples which 
verifies that there was little MEF cell contamination in ES cell sample preparations. This 
may further indicate that there has been little differentiation within the samples. 
Sex determination of our ES cell lines showed a gender bias towards male ES cell lines, 
which was not influenced by dietary treatment (70.6% male in LPD, n=17 vs. 80.0% in 
NPD, n=25). This is not unusual and the vast majority of established ES cell lines have a 
40XY karyotype. A female (XX) ES cell karyotype has been shown to cause frequent 
loss of one chromosome leading to abnormal cellular functioning, arrested proliferation 
and loss of clones (Hadjantonakis and Papaioannou, 2001; Robertson et al., 1983). In Characterisation of ES cells 
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somatic  cells,  dosage  differences  of  X-linked  genes  between  XX  and  XY  cells  are 
adjusted by transcriptional inactivation of one of the two female X chromosomes. X 
inactivation  is  a  multistep  process,  in  which  the  cell  counts  the  number  of  X 
chromosomes, chooses one to be active, and silences the other (Boumil and Lee, 2001). 
X-inactivation occurs shortly after implantation or after differentiation of female ES cells. 
Therefore, in XX ES cells, as in the EPI, both chromosomes are active, a situation that 
appears to be unstable and unfavourable for ES cell propagation (Rastan and Robertson, 
1985).  This  X-chromosome  instability  is  thought  to  be  due  to  hypomethylation  that 
commonly occurs in XX ES cells relative to XY and XO cells (Zvetkova et al., 2005). 
There are also increased growth rates and metabolism in mammalian preimplantation 
male  embryos,  which  appear  proliferate  to  the  blastocyst  stage  faster  than  female 
embryos (Erickson, 1997; Sato et al., 1995; Xu et al., 1992; Zwingman et al., 1993), 
which may cause a reduction in the number of pluripotent cells available from female 
embryos at the time of ES cell isolation. This makes it difficult to make comparisons 
between genders from our treatments due to the low number of female cell lines (5 per 
diet group). However it is possible to analyse the effects of diet on male ES cells where 
appropriate. 
We  also  assessed  chromosome  number  in  our  ES  cells  lines.  For  ES  cells  to  be 
considered pluripotent they must reintegrate fully into embryogenesis. A normal euploid 
karyotype is a good indication that ES cells are fully functional and generally, more than 
50% of metaphase spreads must contain a normal diploid chromosome number to be 
considered  for  making  chimeras.  Chromosome  numbers  are  susceptible  to  change  in  
culture. Trypsin passaging often induces abnormalities on ES cell lines (Baker et al., 
2007). ES cells can gain, or lose a chromosome; these mutations generally appear by 
incident  and  are  not  heritable.  However,  there  are  circumstances  where  heritable 
mutations  occur,  and  occupy  a  whole  population  of  cells  by  selective  pressure.  An 
abnormal  karyotype  may  influence  pluripotency  (Buzzard  et  al.,  2004),  but  typically 
those  mutations  leading  to  accelerated  growth  and  adaptations  to  culture  conditions 
might result in dominance of cultures (Prokhorovich et al., 2007). Chromosome counts in 
this study showed that most cell lines maintained a stable karyotype (above the 50% 
threshold) over prolonged culture. Aneuploid ES cell lines were excluded from further 
analysis in the subsequent chapters of this thesis. Chapter 4 
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Our  dietary  derived  ES  cells  appear  to  be  morphologically  normal  and  express 
pluripotency  markers  and  a  euploid  karyotype.  Therefore  they  appear  to  retain  the 
characteristics of the ICM cells from which they were derived.  
  113 
Chapter 5:  Analysis of functional characteristics 
of ES cell lines 
5.1 Introduction 
Having  isolated  ES  cells  using  our  undernutrition  model,  and  confiming  stem  cell 
identity by maintenance of pluripotency markers and karyotype stability after prolonged 
in  vitro  culture,  we  have  established  a  novel  model  to  study  the  phenomenon  of 
developmental programming in the blastocyst.  
It  has  previously  been  suggested  that  the  adaptations  that  occur  in  the  foetus  as  a 
consequence of developmental environment, are likely to contribute to DOHaD-related 
disorders  -  perhaps  by  altering  growth  characteristics,  postnatal  metabolism,  and 
physiology  of  the  offspring  (Barker,  1994).  Therefore,  our  initial  aims  were  to 
characterise the effects of maternal undernutrition on basic cellular processes such as cell 
growth, proliferation, metabolism, and apoptosis in these cells. 
During normal development, appropriate cell number and organ size are determined by 
coordinated  cell  growth,  cell  proliferation,  and  apoptosis  (reviewed  by  Danial  and 
Korsmeyer, 2004; Murray, 2004). Suboptimal developmental conditions may affect the 
balance of these processes. Indeed, maternal LPD during preimplantation development 
can have long-term effects on foetal and postnatal growth, cardiovascular physiology and 
organ allometry in offspring (Eckert et al., 2012; Kwong et al., 2000; Watkins et al., 
2008a).  The  long-term  response  to  LPD  treatment  in  such  a  small  window  of  early 
development  prompted  investigation  of  blastocyst  phenotype  to  gain  insight  into  the 
mechanisms of change, although this has proved difficult due to the small size and low 
cell number at this stage. However, in rodents, it has been shown that cell proliferation 
within the lineages of the preimplantation embryo is slowed by maternal undernutrition 
(Eckert et al., 2012; Kwong et al., 2000; Mitchell et al., 2009). Increased glucose and 
reduced insulin levels in maternal serum, generating a mild hyperglycaemic environment 
in  undernourished  mothers,  were  suggested  as  a  possible  mechanism  for  retarded 
proliferation  and  cell  numbers  during  preimplantation  development.  Elevated  glucose 
reduces proliferation in ICM and TE cells and alters metabolic state of the embryo (De 
Hertogh et al., 1991; Moley et al., 1996). Reduction in essential amino acids in the serum 
was also suggested as a contributory mechanism for slower proliferation as this may Chapter 5 
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decrease biosynthesis of proteins and alter the embryo’s metabolism and so change its 
growth (Kwong et al., 2000). 
Reduced  blastocyst  cell  number  or  altered  function  in  response  to  maternal 
undernutrition  is  associated  with  disproportionate  growth  of  specific  organs  in  rats 
(Kwong et al., 2000). In mice, LPD treatment results in smaller kidneys and a lower 
number of nephrons suggesting that alterations in ICM cells have a profound effect on 
adult  physiology  (Watkins  et  al.,  2008a).  Further,  experimental  manipulations  of  the 
mouse  blastocyst,  reducing  ICM  cell  number  reduces  the  size  of  the  embryo  post-
implantation and delays gastrulation (Power and Tam, 1993). In this study, reduced ICM 
cells  in  the  blastocysts  resulted  in  an  apparent  compensatory  growth  with  increased 
proliferation  during  late  gestation  restoring  foetal  size.  Catch-up  has  been  observed 
following LPD treatment in mice (Langley-Evans et al., 2011). Also, in vitro culture 
reduces blastocyst cell number and causes large offspring syndrome (LOS) in sheep and 
cattle, a result of abnormal foetal growth (Young et al., 2001). These findings suggest 
that changes in cell growth occur within the embryo as a result of its developmental 
environment, altering the developmental trajectory. This is consistent with the DOHaD 
hypothesis,  where  inappropriate  embryonic  adaptations  to  the  environment  lead  to 
adverse physiological effects in later gestation or in adult life. These observed changes 
within preimplantation development have a considerable impact on cellular function and 
physical  characteristics  of  the  cell  lineages  within  the  blastocyst.  Hence  it  is 
hypothesized that there may also be changes in the physical and functional properties of 
our LPD blastocyst-derived ES cells. Importantly, our ES cell model enables in depth 
investigation of cellular physical and functional characteristics, which is difficult to study 
in the embryo itself. . 
Here, we compare cell proliferation, cell cycle kinetics and cellular metabolism in ES 
cells derived using our undernutrition model. Functional analysis of ES cells 
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5.2 Materials and methods 
5.2.1 Cell proliferation assay 
Proliferation  assays  were  performed  on  isolated  ES  cell  firstly  during  initial  cell 
expansion at passage number 4-5, i.e. before cells were frozen, and secondly after cell 
expansion and freezing (passage number (PN) 9-11). This enabled us  to characterise 
possible short-term effects of diet on cell activity and also to analyse maintained changes 
within the embryo’s stem cells. 
ES cells were cultivated as described in section 2.2.2. At the chosen passage number, ES 
cells were harvested and seeded at 2500 cells/ well onto 96-well plates containing freshly 
prepared MEFs. Cells were cultured in ES medium (150  l/ well) for up to 96 h. Medium 
was replaced daily. 
Cell numbers were determined using conventional haemocytometer counts. Simply, cells 
were dissociated with trypsin (45  l/ well) and cell number in a 0.1  l volume was 
visualised using a phase-contrast microscope. Cell counts were performed in triplicate at 
24 h intervals over a total of 96 h.  The mean number of cells per well was calculated at 
each assay time-point. 
5.2.2 Cell viability assay 
Viable cells present in a population can be determined using dye exclusion assays. This 
is  based  on  the  principle  that  live  cells  possess  intact  cell  membranes  that  exclude 
cellular  dyes.  Cell  viability  was  determined  using  the  trypan-blue  exclusion  method 
(Mesner et al., 1992; Songyang et al., 1997). Cells were plated at 2500 cells per well in 
96-well  plates  and  cultured  as  described  above  (section  5.2.1).  Cells  were  then 
trypsinised, gently triturated, and mixed with an equal volume of trypan blue solution 
(Sigma). Triplicate samples were counted on a Neubauer haemocytometer. 
5.2.3 Cell cycle analysis 
Cell cycle distribution 
Distinct phases of the cell cycle can be differentiated by measuring fluorescence intensity 
(DNA content) of individual PI-labelled cells. Cells in gap 2 (G2) phase have double the 
amount of DNA and therefore twice the fluorescence than cells in the gap 1 (G1) phase. 
To compare cell cycle status between ES cell lines, 4 x 10
4 cells were seeded cells at a 
standardised  passage  number  and  cultured  as  described  in  section  2.2.2.  After  24  h, Chapter 5 
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asynchronously  growing  ES  cells  were  fixed  with  70%  ethanol  and  labelled  with  PI 
(section 2.6.1). Flow cytometric analysis was carried out on 10, 000 gated events. FSC 
(cell size) vs. SSC (cell granularity) plots were used to identify ES cell populations, 
which were gated to exclude MEF cells and cell debris. Cell doublets were excluded by 
pulse processing in order to avoid double positive results. Pulses, generated by scattered 
light  or  fluorescence  of  cells,  are  electronically  analysed  for  their  height  and  width, 
therefore  plotting  pulse  width  vs.  pulse  area  enables  separation  of  single  cells  and 
aggregates  (which  emit  a  larger  pulse)   Data  acquisition  was  performed  on  a 
FACSCalibur (BD Biosciences) and the proportion of cells in G0/G1, S phase, and G2/M 
phase  distribution  was  analysed  by  mathematical  deconvolution  of  DNA  histograms 
using FlowJo 7.6.5 software (TreeStar, Inc., San Carols, CA).  
Cell cycle kinetics - BrdU incorporation 
To investigate cell cycle kinetics between ES cell lines, the level of BrdU incorporation 
was assessed together with DNA content. 1 x 10
5 ES cells were seeded in triplicate on 6 
well plates. 24 h after plating, cells were pulsed with 10  M BrdU for 20 or 60 min. Cells 
were  harvested  and  fixed  in  70  %  ethanol.  The  percentage  of  cells  in  S  phase  was 
determined by immunodetection of incorporated BrdU using mouse anti-BrdU antibody 
and secondary anti-mouse Alexa Fluor 488, followed by PI staining and flow cytometry 
analysis (section 2.6.2). 10,000 gated cell events were recorded for each sample using a 
FACSCalibur flow cytometer (BD Biosciences) as above. To determine the S-phase cells 
(DNA replication), samples were subjected to two-parameter dot plot histogram analysis 
(BrdU  incorporation  FL-1  vs.  DNA  content  PI  FL-2)  using  FlowJo  7.6.5  software 
(TreeStar, Inc., San Carols, CA).  
Cell cycle synchronisation 
To  gain  further  insight  into  the  cell  cycle  dynamics  of  ES  cell  lines,  cell  cycle 
progression was monitored in synchronised cell populations. Cells were arrested in G2/M 
phase  by  treating  with  nocodazole,  an  antimitotic  agent  that  reversibly  disrupts 
microtubule polymerisation, stopping cell division: During the cell cycle, cells replicate 
their contents at interphase, and divide in two at the M phase. The segregation of the 
replicated  chromosomes  is  mediated  by  the  mitotic  spindle,  a  complex  and  dynamic 
cytoskeletal structure made up of microtubules (polymer filaments formed from globular 
protein subunits of  - and  -tubulin). At concentrations equal to or higher than tubulin, 
nocodazole rapidly associates to (and dissociates from)  -tubulin (Hoebeke et al., 1976; Functional analysis of ES cells 
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Lee  et  al.,  1980),  inhibiting  polymerisation.  At  high  concentrations,  cells  rapidly 
depolymerise their microtubules and are prevented from proceeding through mitosis by 
failure to properly attach their chromosomes to the mitotic spindle, blocking cell cycle 
progression at the transition from metaphase to anaphase (Jordan and Wilson, 1998). 
4 x 10
4 cells per well were seeded in quadruplet (triplicate experimental wells and one 
vehicle control well) on 12 well plates and cultured as described in section 2.2.2. After 
18 h, cells were synchronised in mitosis by addition of 80 ng/ ml nocodazole (Sigma) or 
DMSO (vehicle control) to media for 6 h. After nocodazole release (by washing), cells 
were cultured in untreated ES medium. At 0, 2, 3, 4, 5, 6, 7, 9, 11, and 13 h post release, 
cells  were  harvested  and  fixed.  Cells  were  then  PI-labelled  and  analysed  by  flow 
cytometry (section2.6.1). The proportions of G0/G1, S, and G2/M cells were determined 
by  manually  applying  marker  gates  to  DNA  histograms  based  on  PI  fluorescence 
intensity using the FlowJo 7.6.5 software (TreeStar, Inc., San Carols, CA). 
5.2.4 Cell metabolism 
A colorimetric assay was used to assess metabolic activity of ES cell populations. This is 
based  on  the  ability  of  mitochondrial  dehydrogenase  from  viable  cells  to  cleave  the 
tetrazolium ring of pale yellow 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl tetrazolium 
bromide  (MTT;  Sigma,  M5655)  and  formation  of  a  dark  blue  formazan  crystal 
(Mosmann, 1983). 
ES cells were cultured on MEFs in ES medium. To measure metabolic activity in ES 
cells it was necessary to eliminate MEFs from culture. At the correct passage number ES 
cells were purified as described in 2.2.3. ES cells were seeded at 2000 cells/ well on 96-
well plates and cultured fibroblast-free in ES medium (150  l/ well). ES medium was 
replaced every 24 h. 
Cellular metabolic activity was measured at 24 h time-points over a total of 96 h. At the 
indicated time-points, cells were incubated with MTT (final concentration 1 mg/ml) for 2 
h at 37°C. Following solubilisation in DMSO and liberation of the formazan crystals, 
absorbance was determined on a multiwell scanning spectrophotometer at 570 nm using 
a  reference  wavelength  of  620  nm.  Metabolic  activity  for  each  ES  cell  line  was 
determined from triplicate repeats (negative controls without MTT labelling were also 
included). In conjunction with the MTT assay, ES cells were plated fibroblast-free in Chapter 5 
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triplicate, and cell counts were recorded at each assay time-point (as detailed in 5.2.1). 
This enabled metabolic activity per cell to be calculated for each ES cell line. 
 
Details of the cell lines and passage numbers used for all experiments are shown in 
Appendix II. iii. 
5.3 Results 
A number of methods were used to attempt to assess the potential effects of a low protein 
diet during pre-implantation development on growth characteristics of ES cells derived 
from blastocysts subjected to this type of environmental challenge. Firstly, we examined 
the  effects  of  a  dietary  challenge  during  blastocyst  formation  on  proliferation  and 
survival characteristics of the blastocysts ES cell populations. 
5.3.1 Cell counts as a measure of cell proliferation rate and cell viability 
LPD-challenge during pre-implantation development does not affect 
subsequent ES Cell proliferation rates but does appear to reduce cell 
viability 
To determine optimal cell growth for proliferation assays, male ES cell lines were seeded 
at various starting cell densities and cell growth was determined over a 96 h period. 
Proliferation rate showed a general decrease over the culture period. There was a higher 
percentage  increase  in  cell  number  at  lower  starting  cell  densities  (Appendix  II.vi). 
Therefore for comparisons between treatment groups, ES cells were plated at starting cell 
densities of 2500 cells per well. Cell proliferation was determined by triplicate counts at 
24 h intervals over a total 96 h (Figure 5.1A). 
Figure 5.1 and 5.2 compare short-, and long-term effects of a dietary-challenge during 
blastocyst  formation  on  proliferation  of  the  ES  cells  derived  from  the  blastocysts 
subjected to these dietary changes. Early passage proliferation rates (measured at the 
earliest possible opportunity after ES cell isolation, PN 4-6) were not different between 
treatment  groups  over  a  96  h  growth  period  (Figure  5.1)  as  determined  by 
haemocytometer counts. Likewise, diet-treatment had no impact on later passage (PN 
9/10) ES cell proliferation rates (Figure 5.2) over a 96 h timecourse. 
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Figure 5.1: Early passage ES cell proliferation assay. 
Proliferation rate of ES cells (4-6), as determined by haemocytometer counts at 24hr 
intervals over a total of 96hrs. (A) Growth of LPD ES cells on MEFs over 96 hrs. (B) 
Mean total number of cells at each assay time-point. (C) Mean percentage increase in 
cell number between each assay time-point. Values are means for 7 LPD ES cell lines 
(lines 1, 2, 4, 6, 24, 39, 40) from 6 mothers vs. 8 NPD ES cell lines (lines 7, 8, 9, 15, 
48, 51, 52, 55) from 6 mothers, with standard errors represented by vertical bars. Chapter 5 
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Figure 5.2: LPD treatment has no effect on (late passage) ES cell proliferation. 
Proliferation rate of ES cells (P 11-13) were determined using a trypan blue exclusion 
assay. Live cells (trypan negative) were counted at 24hr intervals over a total of 96hrs 
using a haemocytometer. (A) Mean total cell number at each assay time-point. (C) 
Mean percentage change in cell number at each assay time-point. Values are means 
for 8 LPD ES cell lines (lines 1, 2, 4, 6, 11, 12, 24, 40) from 8 mothers vs. 9 NPD ES 
cell lines (lines 8, 10, 15, 18, 19, 21, 36, 48, 51) from 7 mothers ± SEM (represented 
by vertical bars). Functional analysis of ES cells 
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The trypan blue exclusion assay was used to determine live: dead cell ratios. Cells were 
counted at 24hr intervals over a total of 96hrs using a haemocytometer Figure 5.3 shows 
the  percentage  of  non-viable  at  each  time-point.  Using  this  method  LPD-ES  cells 
consistently  show  increased  proportions  of  dead  (trypan  +)  cells  at  each  time-point, 
which were significantly higher than control (NPD) cell lines at 48 h (10.01% ± 0.331 in 
LPD vs. 6.93% ± 0.552 in NPD; P=0.003) and 96 h time-points (10.71% ± 1.256 in LPD 
vs. 7.64% ± 0.5716 in NPD).  
 
 
Figure 5.3: LPD treatment reduces ES cell viability. 
The trypan blue exclusion assay was used to determine live: dead cell ratios. Live and 
dead cells (PN 11-13) were counted at 24hr intervals over a total of 96hrs using a 
haemocytometer. The percentage of non-viable (trypan +) cells is shown. Values are 
means for 8 LPD ES cell lines (lines 1, 2, 4, 6, 11, 12, 24, 40) from 8 mothers vs. 9 
NPD ES cell lines (lines 8, 10, 15, 18, 19, 21, 36, 48, 51) from 7 mothers ± SEM, 
represented by vertical bars. * Mean values were significantly different from that of the 
NPD group. ***P<0.001, *P<0.05. 
 
5.3.2 Cell cycle analysis of ES cells lines 
LPD-challenge during pre-implantation development does not affect cell 
cycling of ES cells derived from diet-challenged embryos  
To provide a more precise comparison of growth and proliferation characteristics of our 
ES cell lines, cell cycle status was analysed in exponentially growing cells at 24 h after 
seeding.  
 Chapter 5 
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G1,  S,  and  G2/M  cell  cycle  distributions  in  asynchronous  ES  cell  populations  were 
determined  by  PI-staining  cells  (1   g/ml),  and  measuring  DNA  content  (based  on 
fluorescence intensities) using flow cytometry (Figure 5.4). The mean percentage of cells 
in each distinct cell cycle phase was comparable between LPD and NPD ES cell lines, 
with 21.75% ± 0.92 G1, 50.26% ± 2.04 S-phase, 27.03% ± 1.68 G2/M cells, and 23.15% 
± 0.83 G1, 52.03% ±2.35 S-phase, 23.68% ± 1.90 G2/M cells in LPD and NPD lines 
respectively. Functional analysis of ES cells 
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Figure  5.4:  LPD  treatment  has  no  effect  on  cell  cycle  distribution  in 
asynchronous ES cell populations. 
(A)  Cell  cycle  distribution  of  exponentially  growing  ES  cell  lines  (PN  10-12)  was 
determined  by  measuring  DNA  content  of  cells  by  PI  staining  samples.  G1  peak 
(green) is approximately half the fluorescence intensity (and half the DNA content) of 
the G2/M peak (blue). Representative cell cycle profiles of LPD (left) and control (right) 
ES cells are shown 24 h after seeding. Samples were analysed by flow cytometry and 
cell  cycle  distributions  were  calculated  using  FlowJo  software.  (B)  Percentages  of 
cells in G1, S, and G2/M phases of the cell cycle are shown. Values are means ± 
SEM of 10 LPD (lines 1, 2, 4, 6, 12, 13, 20, 24, 32, 40) (9 mothers) and 10 NPD (lines 
7, 15, 18, 19, 21, 35, 36, 48, 51, 52) (7mothers) ES cell lines. Each individual ES cell 
line was analysed from triplicate wells. 
 
To  analyse  cell  cycle  kinetics, a nd  as  a  further  measure  of  proliferative  capacity  a 
combined  BrdU-incorporation  and  PI  staining  protocol  was  used.  BrdU,  a  thymidine Chapter 5 
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analog, is incorporated into cells actively synthesizing DNA and therefore can accurately 
separate replicating s-phase cells from gap phase cells, defined by PI staining intensities. 
We first compared the levels of BrdU incorporation in our ES cell lines from (3 LPD-, 
and 4 NPD ES cell lines) by continuous pulse labelling of asynchronous ES cells over a 
duration of 24 h (5 min – 24 h) to give some idea of the rate of BrdU incorporation and 
DNA synthesis (Figure 5.5A).  
This method of cell cycle analysis accurately captures very late and early S-phase cells, 
and BrdU incorporation was detectable even after a 5 min pulse and showed a rapid 
linear  increase  in  BrdU  incorporation,  which  began  to  plateau  after  ~60  min.  We 
observed  no  significant  difference  in  BrdU  incorporation  between  LPD  ES  cells  and 
controls (Figure 5.5B) over this time-course. BrdU incorporation was analysed in this 
exponential phase more extensively in our ES cell lines, by comparing the percentage of 
actively replicating cells after a 20 min and 60 min BrdU pulse (Figure 5.6A). There was 
no  significant  difference  in  the  percentage  of  BrdU  incorporation  between  treatment 
groups (Figure 5.6B). 
 Functional analysis of ES cells 




Figure 5.5: Flow cytometric analysis of BrdU incorporation in diet derived ES 
cells. 
Cells were labelled with BrdU (10 µM) for different times over 24 h. S phase cells are 
show  by  incorporation  of  BrdU  which  was  measured  by  flow  cytometry  using  a 
monoclonal anti-BrdU. (A) BrdU + cells are displayed in the upper gate of the scatter 
plots  showing  fluorescence  intensities  of  BrdU  incorporation  (y-axis)  against  DNA 
content (x-axis). (B) Shows the mean percentage of S-phase cells (positive for BrdU 
incorporation) over the first 8 h time-course for LPD and NPD ES cell lines. Values 
represent means of 3 LPD and 4 NPD individual ES cell lines ± SEM. Chapter 5 




Figure 5.6: LPD treatment has no effect on cell cycle rate. 
Levels of BrdU incorporation after 20’ and 60’ incubation in BrdU were assessed to 
determine the rate of cell cycle progression in LPD and NPD ES cells. (A) Scatter 
plots  show  representative  flow  cytometry  staining  for  LPD  (upper  panel)  and  NPD 
(lower) ES cell lines for each BrdU incubation time. Shows fluorescence intensities of 
BrdU  incorporated ( y-axis)  vs.  DNA  content  (x-axis).  Gates  separate  S-phase 
populations  (BrdU+)  and  are  positioned  based  on  no  BrdU  treated,  and  negative 
antibody  control  samples.  (C)  Histogram  showing  fluorescence  measurements  for 
controls  against  an  experimental  sample  (in  green).  (B)  Percentages  of  cells  in  S 
phase (BrdU positive) of the cell cycle after 20’ and 60’ BrdU incorporation. For 20’ 
BrdU assay, values represent mean percentage of BrdU positive cells for 7 ES cells 
lines per treatment (LPD lines 1, 4, 6, 11, 12, 24, 40; NPD lines 10, 18, 19, 21, 36, 45, 
51) (from 6 mother) ± SEM. For 60’ BrdU pulse experiment means are from 9 LPD-ES 
cell lines (lines 1, 2, 4, 6, 12, 13, 20, 24, 32) (from 9 mothers) ±SEM and 10 control 
lines (lines 7, 8, 15, 18, 19, 21, 48, 36, 51, 52) (7 mothers) ± SEM  Functional analysis of ES cells 
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To  kinetically  assess  the  progression  and  duration  of  cell  cycle  phases,  cells  were 
synchronised  by  nocodazole  treatment.  Nocodazole  reversibly  disrupts  microtubule 
polymerisation, stopping cell division, and arresting cells in the G2/M phase of the cell 
cycle. 
To determine the most suitable nocodazole treatment conditions, we first performed a 
nocodazole time-course experiment, followed by a dose-response experiment. ES cells 
were cultured in normal conditions for 24 h and nocodazole (80 ng/ml) was added for 
various  times  (1-10  h).  Cells  were  then  PI-stained  and  cell  cycle  distribution  was 
determined by flow cytometry (as above). Increased exposure to nocodazole was shown 
to have a cytotoxic effect on ES cells with 25% dead cells after 1 h treatment, increasing 
to more than 50% after 10 h incubation (Appendix II.viiB). Dead cells were determined 
by gating sub-G1 cells in DNA histogram plots (Appendix II.viiA). Appendix II.viiC 
shows that a 6 h nocodazole treatment was sufficient to G2/M arrest the majority of cells. 
Nocodazole concentrations of <60 ng/ml showed little change in cell cycle distribution 
(Appendix II.viii). Higher concentrations of nocodazole resulted in a higher number of 
cells in G2/M phase. 80 ng/ml showed >90% of cells in G2/M phase, which did not 
increase with increased nocodazole concentration (Appendix II.viii). 
To compare cell cycle progression between synchronized LPD- and control-ES cell lines, 
cells  were  grown  for  18  h  and  then  synchronized  by  replacing  media  with  media 
containing nocodazole (80 ng/ml). Following nocodazole release, cells were harvested at 
1-2 h periods over 13 h. The cells were PI-labelled, and analysed by flow cytometry 
(Figure 5.7A). The distribution of cells in cell cycle phases changed after nocodazole 
treatment, with approximately 85% of cells in G2/M phase, whereas untreated (DMSO 
vehicle  control)  retained  a  normal  cell  cycle  distribution.  The  majority  of  cells  had 
progressed to G1 cell cycle phase within 1 h of nocodazole release. Over time post-
nocodazole, LPD-ES cells and control ES cells progressed through the cell cycle phases 
at an equivalent rate showing no difference between treatments in cell cycle progression 
or proliferation rate (Figure 5.7B). Chapter 5 
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Figure 5.7: No changes in cell cycle progression in ES cells as a result of LPD 
treatment  
(A)  Flow  cytometry  images  showing  movement  through  the  cell  cycle  after 
synchronisation  by  nocodazole  (80ng/ml)  for  6h  assessed  by  PI  staining  and  flow 
cytometry.  Figure  represents  results  of  one  example  line  from  each  treatment. 
Triplicate measurements were taken for each individual line (PN 11-13). Gates were 
manually selected to determine the cell cycle phase and are shown by the coloured 
bars. (B) The fraction of cells in each cell cycle phase as assessed by PI staining over 
time,  after  release  from  synchronisation  with  nocodazole.  Mean  percentages  are 
shown for 7 LPD ES cell lines (lines 1, 2, 4, 6, 12, 24, 40) vs.6 NPD ES cell lines 
(lines 8, 15, 21, 36, 48, 51) ± SEM. Chapter 5 
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5.3.3 MTT Metabolic Assay to Assess Cellular Activity 
Metabolic activity in ES cell lines was analysed using the colorimetric MTT assay. To 
assess the MTT assay as a measure of metabolism, cells were plated onto a MEF feeder 
layer at various densities and the metabolic activity was determined by measuring the 
amount  of  blue  formazan  product  produced  following  MTT  conversion  using  a 
spectrophotometer. There was a general increase in metabolism over the assay duration. 
Higher starting cell densities began to plateau at 72 h, which was not observed with 
lower cell densities (Appendix II.ix). It was therefore decided to use 2500 cells per well.  
It was also hypothesised that the plateau effect may be a confounding factor of the feeder 
cells. Figure 5.8 shows a surprisingly high metabolic activity from feeder cells when they 
were grown independently of ES cells, which increased over the assay period. Feeder-
free growth of ES cell showed a much more linear correlation between cell number and 
metabolic  activity  (Figure  5.9).  Therefore  ES  cells  were  grown  feeder-free  for  MTT 
assay analysis at a starting cell density of 2000 cells per well. Functional analysis of ES cells 





Figure 5.8: MTT assay for MEF cells only 
Shows metabolic activity of MEF feeder cells only over 72 h. Cells were plated at the 




Figure 5.9: MTT assay optimisation without MEF cells. 
Metabolic activity of two ES cell lines grown feeder-free at a starting cell density of 
2000 cells per well. All measurements were taken in triplicate and included a control 
blank where no MTT was added (lysis buffer only). Vertical bars indicate SEM. Chapter 5 
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Mean OD per cell was significantly elevated in ES cells derived from the LPD treatment 
after 96 h in culture (P=0.04) (Figure 5.10). Over the MTT assay period, LPD ES cells 
showed a higher absorbance value per cell in comparison with the NPD treatment. Mean 
optical density (OD; at 570 nm) per cell was used as a measure of metabolism. 
 
Figure 5.10: Effect of maternal diet on ES cell metabolism 
(A) ES cells were grown feeder-free over 96 hr. ES cell metabolism (PN 8-10) was 
determined  by  the  MTT  assay,  where  pale  yellow  MTT  is  converted  to  a  purple 
formazan  crystal  in  viable  cells.  (B)  MTT  conversion  in  ES  cells  treated  with  MTT 
(+MTT)  for  2  h,  which  show  a  dark  blue  colour  within  the  cells  (in  PBS  solution). 
Untreated  cells  (in  DMEM  medium)  are  also  shown  (-MTT).  (C)  Overall  metabolic 
activity for each treatment group is represented as mean optical density (OD) per cell. 
LPD, n = 7 (lines 2, 6, 4, 12, 13, 20, 24) from 7 mothers; NPD, n = 13 (lines 8, 9, 15, 
18, 19, 21, 35, 36, 38, 45, 48, 51, 52) from 8 mothers. Vertical bars = SEM.. Functional analysis of ES cells 
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5.4 Discussion 
The  impact  of  embryo  environment  during  the  preimplantation  period  on  later 
development  or  postnatal  phenotype  suggests  that  permanent  alterations  are  initiated 
within the preimplantation embryo. Specifically, embryos may be able to regulate growth 
rate or metabolism to maximize the chance of survival under reduced nutrient availability. 
Here we used ES cells derived from the ICM of diet-challenged blastocysts as a model to 
investigate these short-term effects. Detailed analysis of the ES cell cycle demonstrated 
that mild undernutrition during preimplantation development has no immediate effect on 
cell  proliferation  rate.  Assuming  that  the  derived  ES  cells  in  this  model  retain  the 
characteristics  of  their  in  vivo  progenitor  cells,  this  suggests  that  the  growth 
characteristics of the ICM cells in the blastocyst are not altered in response to the nutrient 
availability in utero, which is contradictory to some previous reports in rodents, where 
ICM cell numbers are reduced following maternal undernutrition (Kwong et al., 2000; 
Mitchell  et  al.,  2009).  Preliminary  analysis  of  ES  cell  viability  in  culture  showed 
increased cell death in LPD-ES cells proposing that this may instead drive the responses 
previously shown in the embryo and possibly in later development and adult life. 
It has been suggested that a reduced proliferative capacity of embryos developed in a 
suboptimal intrauterine environment or in culture, showing reduced embryo cell number 
and altered lineage allocation, may be responsible for longer–term health changes. For 
example,  in  the  rat,  feeding  a  LPD  throughout  preimplantation  development  reduced 
ICM and TE cell numbers in the blastocyst (Kwong et al., 2000). Although this was 
attributed to a slower proliferation rate and not increased levels of apoptosis, the mitotic 
indexes only differed from controls (18% casein) under more severe protein restriction 
(6%),  but  not  when  fed  a  mild  LPD  (9%  casein).  They  argue  that  the  conditions 
generated in utero by the LPD (elevated glucose and reduced insulin, with reduced levels 
of free amino acids) are capable of slowing cell proliferation. Indeed, high levels of 
glucose have been shown to slow embryo growth and alter metabolic activity in rats and 
mice (De Hertogh et al., 1991; Moley et al., 1996), whilst insulin and IGFs stimulate 
proliferation in the blastocyst (Kane et al., 1997). However, it has also been shown that 
elevated glucose levels increases the levels for apoptosis both in vitro, and in vivo using a 
diabetic mouse and rat models (Keim et al., 2001; Moley et al., 1998; Moley et al., 1991; 
Pampfer et al., 1997b), and that IGFs have a major antiapoptotic role in the blastocyst 
(Colon et al., 2007; Lin et al., 2003). It may be that reduced cell numbers in blastocyst Chapter 5 
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may result from increased cell death, and not a slowing of cell proliferation. The data 
from our ES cell model supports this concept, suggesting that there is not an immediate 
effect  on  cell  proliferation.  The  recent  study  by  Eckert  et  al.  (2012),  where  similar 
intrauterine conditions develop from a LPD in mice, in fact shows no effect of diet on 
ICM cell numbers but an impact on the TE lineage, highlighting species differences in 
the blastocyst response. This is partially in agreement with the data from in our ES cells. 
The intrauterine milieu has not been investigated in the C57BL/6 mouse model used here 
and there may also be strain differences in the response to maternal undernutrition. In 
chapter 3 we showed substantial reduction in ES cell isolation potential following LPD 
treatment. It is also possible that slower proliferation in these blastocysts may play a role 
here,  and  that  the  blastocysts  that  actually  generated  ES  cell  lines  represent  a  small 
proportion that were less affected by LPD treatment, and therefore display characteristics 
similar to control blastocysts. Thus, these ES cells may possess comparable proliferative 
characteristics as control cells, and may not be representative of the LPD treatment group 
as a whole. 
It is possible that changes in proliferative capacity do occur as a result of maternal diet, 
yet these changes are not immediately evident in the blastocyst (or its derived ES cells). 
Indeed it has been suggested that embryo environmental factors (such as nutrition) may 
affect  epigenetic  regulation  of  gene  expression  with  short-term  and  long-term 
consequences on foetal growth and development. Differentiated cell types possess their 
own fixed epigenetic signature; however, at discrete stages of development and in some 
disease states, cells undergo major reprogramming and modulation of epigenetic marks. 
The blastocyst is thought to be particularly vulnerable to epigenetic regulation of foetal 
growth due to remodelling that occurs here. After fertilisation, DNA methylation patterns 
are erased in order to restore totipotency (Mayer et al., 2000; Okamoto et al., 2004). The 
initiation of de novo methylation and establishment of epigenetic patterns coincides with 
the  first  differentiative  event  in  development  -  blastocyst  formation,  and  persists 
throughout implantation (Watanabe et al., 2002). Imprinted genes (many of which are 
involved in growth) are largely protected from demethylation/ remethylation processes, 
retaining the methylation profile of the parent-of origin (Brandeis et al., 1993; Howell et 
al., 2001). 
Due to this instability of the epigenome around the time of implantation it is probable 
that changes in the epigenetic status of genes regulating cell growth and proliferation Functional analysis of ES cells 
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may well initiate during preimplantation development, however, physical changes may 
only  become  apparent  postimplantation,  once  epigenetic  patterns  have  been  re-
established.  Indeed  it  has  been  shown  that  compensatory  growth  occurs  late  in 
development, often postnatally (Watkins et al., 2010; Watkins et al., 2011; Watkins et al., 
2008a).  Although  allelic  patterns  of  imprinted  genes  are  generally  methylated  in  the 
blastocyst, some imprinted genes (e.g. IGF-II) (Brandeis et al., 1993) acquire their foetal 
levels of methylation after implantation (Frank et al., 1991; Kafri et al., 1992; Monk et al., 
1987). These genes may be particularly susceptible to epigenetic alterations. 
Despite  no  changes  in  cell  division,  we  did  observe  a  higher  metabolic  rate  after 
prolonged culture, as determined by the MTT assay. MTT is converted by succinate 
dehydrogenases, which are involved in maintenance of the respiratory transport chain 
and proton extrusion therefore giving an indication of metabolic activity in the cell. Our 
study suggests increased mitochondrial activity and therefore ATP production. Mitchell 
et  al,  (2009)  showed  that  periconceptional  exposure  of  female  mice  to  a  LPD  also 
resulted in mitochondrial defects and a reduced number of ICM cells. While their study 
showed a reduced mitochondrial/ nuclear clustering, they also had increased levels of 
cellular ATP in the 2-8 cell stage in embryo. The increased levels of ATP may be due to 
a decreased usage as well as a raised production. Our data suggests the latter may be the 
case. Further, reduced nuclear clustering in the embryo and in ES cells is associated 
differentiation  and  senescence  (Barnett  and  Bavister,  1996).  Differentiation  is  also 
associated with increased mitochondrial metabolic activity (Lonergan et al., 2006). It has 
been shown in ES cells that the increase in mitochondrial activity and ATP production 
results  in  a  higher  production  of  reactive  oxygen  species  (ROS)  (Cho  et  al.,  2006). 
Oxidative  stress  causes  damage  to  macromolecules  within  the  cell  and  has  been 
associated  with  the  onset  of  the  metabolic  syndrome.  Levels  of  oxidative  stress  are 
usually  controlled  by  antioxidants,  which  maintain  the  redox  state  of  the  respiratory 
chain. In diabetics, there can be an altered redox balance, generating more ROS (Rolo 
and Palmeira, 2006). IUGR pups in rats display increased oxidative stress and impaired 
mitochondrial  function  in   -cells,  liver  and  skeletal  muscle  leading  to  a  T2D-like 
phenotype  (Selak  et  al.,  2003;  Simmons  et  al.,  2005).  Other  studies  also  associated 
deficiencies in blastocyst development with altered mitochondrial activity after excessive 
nutrient exposure (Igosheva et al., 2010). Maternal diet-induced obesity in these mice led 
to an increase in mitochondrial membrane potential, mitochondrial DNA content and Chapter 5 
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biogenesis. ROS were raised generating conditions of oxidative stress, which were linked 
to possible increases in cell death in these embryos. Although we saw differences in 
mitochondrial activity in our study, this was seen only after four days in culture and 
cultured in feeder-free conditions. Our ES cells are generally maintained on fibroblasts, 
and passaged routinely after 2-3 days. It is arguable whether these changes would have a 
detrimental impact during normal ES cell maintenance, or within the blastocyst itself. 
Levels of ATP or ROS were not measured in this study, but the increase in mitochondrial 
activity may suggest that LPD-ES cells may be more sensitive to differentiation and cell 
death and it is possible that increased ROS may induce long-term metabolic dysfunction. 
Although previous studies have suggested that changes seen in the early embryo are due 
to changes in cell proliferation, the role of other factors, such as differentiation and cell 
death in early development have been largely overlooked. This and other recent studies 
(Eckert et al., 2012) suggest that proliferation does not play an immediate role in early 
development in response to maternal undernutrition, at least within the ICM cells. There 
is however good evidence to suggest that changes in the early embryo do have longer-
term effects on foetal growth and development. These changes may occur as a result of 
proliferation, but the role of cell death has been not been studied despite the importance 
of this process during blastocyst development. 
Our ES cell model has enabled us to assess cell proliferation and cell cycling in more 
depth than has previously been possible in the blastocyst. The growth rates were almost 
identical between treatment groups showing similar distributions of cells in each phase of 
the cell cycle. Cells progress quickly through the S-phase of the cell cycle, as determined 
by BrdU incorporation. This is characteristic of pluripotent cells. Cell synchronisation at 
the  G2/M  phase  by  nocodazole  treatment  confirmed  comparable  cell  cycle  kinetics. 
Whether  the  characteristics  of  these  cells  are  maintained  during  differentiation  is 
unknown and is an interesting avenue to investigate.  
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Chapter 6:  Cell death analysis of ES cell lines 
6.1 Introduction 
Our  data  suggests  that  cell  proliferation  and  metabolism  are  not  altered  by  a 
preimplantation maternal undernutrition treatment. This is contradictory to some data 
that  attributes  a  reduced  cell  number  in  the  blastocyst  following  such  treatments  to 
slower  proliferation  rates  (Eckert  et  al.,  2012;  Kwong  et  al.,  2000).  However,  it  is 
possible that maternal undernutrition at this stage of development may increase levels of 
cell death, causing the reduced blastocyst cell number. Such changes in cell death may 
also explain the reduced ES cell isolation potential from blastocysts of mothers fed a 
LPD shown in this study.  
Cell death is highly regulated in the preimplantation embryo and plays an important role 
in  ensuring  that  incompetent,  damaged,  or  superfluous  cells  are  eliminated.  Possible 
causes  of  cell  death  during  early  stages  of  development  include  chromosomal 
abnormalities (Liu et al., 2002), or imbalance of growth or ‘survival’ factors (Byrne et 
al., 2002; Fabian et al., 2004). If damaged cells are allowed to progress in the ICM, and 
post-implantation  into  the  developing  foetus,  this  could  be  detrimental  for  later 
development  and  offspring  health.  At  the  same  time,  the  preimplantation  embryo 
contains very few cells; therefore tight regulation of this process is essential to avoid loss 
of  viable  cells.  Apoptosis  allows  a  regulated  cell  loss  by  elimination  of  only  single 
aberrant cells (Jacobson et al., 1997). Nonetheless, levels of cell death are high in the 
preimplantation  embryo  (Brison,  2000;  Van  Blerkom  et  al.,  2001)  highlighting  the 
importance  of  ensuring  that  inadequate  cells  are  not  replicated.  The  embryo  is 
particularly sensitive to environmental stressors. For example in vitro culture, maternal 
age, and oocyte age increase death of blastomeres and early embryo viability (Brison and 
Schultz,  1997;  Jurisicova  et  al.,  1998a;  Jurisicova  et  al.,  1998b;  Rappolee,  2007). 
Hyperglycaemic conditions in vitro and in vivo have been shown to induce PCD through 
the death effector pathways (Keim et al., 2001; Moley et al., 1998), and there are reduced 
ICM  cells  and  increased  apoptosis  in  rodent  models  of  diabetes  (Lea  et  al.,  1996; 
Pampfer et al., 1997a). Mice fed a high protein diet show increased cell death in the ICM 
of blastocysts due to increased exposure to ammonium (Gardner et al., 2003; Lane and 
Gardner, 2003). It is possible that cell death occurring as a result of maternal diet may Chapter 6 
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affect cell number in the blastocyst, and subsequent lineage allocation. Such changes 
may regulate tissue structure and physiology during development. 
Levels  of  cell  death  in  the  blastocyst  following  a  maternal  LPD  have  not  been  well 
studied. Our ES cell model provides a method to study potential effects of maternal 
undernutrition  on  cell  death  in  the  blastocyst.  Indeed,  ES  cells  enable  in  depth 
investigation of the biochemical and molecular changes that occur within the cell as cell 
death initiates, which is difficult in the blastocyst itself. 
One way of studying cell death is to compare expression of key proteins involved in 
initiating  and  mediating  the  apoptotic  pathway.  As  discussed  in  detail  in  chapter  1, 
apoptosis is mediated by BCL-2 proteins which are considered the key regulators of cell 
death (Adams and Cory, 1998). BCL-2 proteins regulate release of cytochrome c and 
other  factors  from  the  mitochondria,  triggering  the  activation  of  caspases  and 
subsequently cell death. This is a complex system, involving interactions between BCL-2 
family proteins and other related targets, which function to promote, or block cell death, 
depending  on  the  nature  of  these  associations,  and  to  determine  the  localisation  and 
activity  of  the  proteins.  The  BCL-2  family  is  divided  into  two  major  groups,  the 
inhibitors of apoptosis (pro-survival), and the inducers of cell death (pro-apoptotic). The 
proapoptotic proteins required for initiation of apoptosis includes the BAX death family 
(pore formers), which are essential to induce mitochondrial disruption during apoptosis, 
and BH3-only proteins, involved in suppression of pro-survival BCL-2 proteins (Cory 
and Adams, 2002). 
When studying cell death, it is also important to consider the expression and activity of 
the  upstream  regulatory  pathways  involved.  As  the  death  machinery  exerts  such  a 
profound effect on the cell, its constituents are tightly regulated. In order to achieve this, 
cells integrate external signals via The Ras/ MEK/ ERK, PI3K/ AKT, and JAK/ STAT 
signaling pathways. Constitutive expression of these pathways in healthy cells regulates 
cell survival by active inhibition of cell death machinery. This is mediated either directly 
by phosphorylating components of the apoptotic machinery, or indirectly by changing the 
expression levels of these genes. While these pathways have a cytoprotective role, stress-
related MAPKs, JNK and p38 MAPK can promote apoptosis due to reduced activation of 
pro-survival pathways in response to stress stimuli (Wagner and Nebreda, 2009; Xia et 
al., 1995). The mechanisms by which these pathways regulate apoptosis are complicated 
and vary depending on cell type and the stimulus the cell receives. Cell death analysis 
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Here we compared levels of cell death in our diet ES cell lines, the expression levels of 
key  components  of  the  cell  death  machinery,  and  the  upstream  regulatory  signalling 
pathways that control cell death/ survival. 
6.2 Materials and methods 
6.2.1 Cell death assay 
One of the most common methods of identifying apoptotic cells is by using Annexin V to 
detect  membrane  asymmetry.  Annexin  V  binds  specifically  to  PS  phospholipids  that 
ordinarily reside on the inner leaflet of the cells plasma membrane. During the early 
stages  of  apoptosis,  PS  is  externalized  without  loss  of  membrane  integrity.  A 
fluorescently conjugated Annexin V marker used in combination with an exclusion dye 
such as PI can distinguish apoptotic from necrotic cells (Figure 6.1a). 
 
Figure 6.1: Principles of Annexin V-PI cell death assay. 
(A)  Phosphatidyl  serine  (PS)  lipid  externalisation  from  the  inner  to  outer  plasma 
membrane  occurs  during  the  early  stages  of  apoptosis  without  loss  of  membrane 
integrity. Annexin V binds with high affinity to PS lipid and can be used to detect early 
apoptotic cells. Using in conjunction with an exclusion dye such as PI, that can enter 
cells with compromised membrane integrity can distinguish between early and late 
apoptotic/ necrotic cells. This can be assessed by measuring fluorescence intensity by 
flow cytometry. (B) Viable cells exclude both markers (Q3). Early apoptotic cells, with 
intact membranes are positive for Annexin V and negative for PI (Q4). Late apoptotic/ 
necrotic cells stained positive for PI are shown in upper quadrants.  
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Annexin V staining was used to define the basal levels of apoptosis for each ES cell line. 
4 x 10
4 cells were plated in triplicate on mitomycin treated feeder cells on a 12-well plate 
and cultured as described in section 2.2.2. Cells were harvested as single cell suspensions 
(with  media)  by  trypsinisation  at  24  h,  48  h,  and  72  h  time-points  and  stained  with 
Annexin V-FITC and PI (section 2.6.3.). For flow cytometric analysis, 20,000 cell events 
were  recorded  using  a  FACSCalibur  flow  cytometer  (BD  Biosciences).  Data  was 
acquired as detailed in section 2.6.4. FSC and SSC gates were used to exclude MEF cell 
populations  and  cell  debris.  The  percentage  of  apoptotic  cells  was  determined  by 
generating a dual-colour dot plot (Annexin V-FITC (FL-1) vs. PI (FL-2)) and then setting 
a quadrant marker based on unstained and single-labelled control samples. Electronic 
compensation was used to eliminate bleed-through fluorescence. Quadrant settings were 
set so that the negative control allowed less than 1% positivity.  Lower left quadrants 
show the live cells, which exclude PI and are negative for Annexin V-FITC. Upper right 
quadrant  contains  the  non-viable,  late  apoptotic  cells  -  positive  for  Annexin  V-FITC 
binding and for PI uptake, whilst the lower right quadrants represent the apoptotic cells - 
Annexin V-FITC positive and PI negative, demonstrating plasma membrane integrity 
(Figure 6.1b). 
As a positive control, ES cells were induced with 10 µg/ml etoposide (Sigma) for 8 h to 
undergo apoptosis.  
6.2.2 Expression analysis by western blotting 
3  x  10
5  cells  were  seeded  and  grown  feeder-free  on  gelatin-coated  6  cm  plates  at  a 
standardised passage number. Cells were harvested (with culture media) at 24 h, 48 h, 
and 72 h time points. Whole cell lysates were prepared in onyx lysis buffer supplemented 
with phosphatase and protease inhibitors (section2.7.1). Samples were quantified using a 
BCA protein assay (Thermo) as described in section 2.7.2, 25  g of total protein per 
sample were separated by SDS-PAGE (as described in section 2.7.3) and transferred to 
PVDF membranes (section 2.7.4). Membranes were blocked for 1 h at room temperature 
with 5% non-fat dry milk in 0.05% TBS-T, and incubated with the relevant primary 
antibody (Table 6.1) in 5% BSA in 0.05% TBS-T overnight at 4 °C. After washing with 
TBS-T, the membrane was incubated for 1 h at room temperature with secondary goat 
anti-rabbit IRDye 800CW (1:10,000; LICOR) in 5% BSA, 0.05% TBS-T for 1 h at room 
temperature.  Bands  were  visualized  using  LICOR  Odyssey  IR  imager  (LICOR)  and 
analysed as described in section 2.7.4.  
 
Table 6.1. Primary antibodies used for western blotting procedures 
Antigen  Species  Company  Cat # 
Working  
Dilution 
Band Size  
(kDa) 
Bim  Rabbit  Cell Signaling Technology   2819  1:700    23, 15, 12 
Cleaved-caspase  Rabbit  Cell Signaling Technology  9661  1:1000    17, 19 
Caspase 3  Rabbit  Cell Signaling Technology  9662  1:1000    17, 19, 35 
Phospho-AKT (Ser473)  Rabbit  Cell Signaling Technology  4060  1:1000    60 
Phospho-ERK (Thr202/Tyr204)  Rabbit  Cell Signaling Technology  9101  1:1000    42, 44 
Phospho-JNK (Thr183/Tyr185)  Rabbit  Cell Signaling Technology  4668  1:1000    49, 55 
Phospho-p38 (Thr180/Tyr182)  Rabbit  Cell Signaling Technology  4631  1:1000    38 
Phospho-Stat3 (Tyr705)  Rabbit  Cell Signaling Technology  9131  1:1000   79, 86 
Total-AKT  Rabbit  Cell Signaling Technology  9272  1:1000    60 
Total-ERK  Rabbit  Cell Signaling Technology  4695  1:1000    42, 44 
Total-p38  Rabbit  Cell Signaling Technology  9212  1:1000    42, 44 
Puma  Rabbit  In house  NT  1:500    23 
Stat3  Rabbit  Cell Signaling Technology  9132  1:1000    79, 86 
 -Tubulin  Rabbit  Cell Signaling Technology  2144  1:1000    50 Chapter 6 
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6.3 Results 
To  compare  basal  levels  of  cell  death  in  our  ES  cell  lines,  cells  were  fluorescently 
labelled with Annexin V-FITC conjugate and PI, and analysed by flow cytometry (as 
described  in  section  6.2.1).  To  correctly  determine  apoptotic  cells  and  avoid  false-
positive measurements, unstained samples were analysed as an autofluorescence control, 
and  populations  were  positioned  within  the  lower  left  hand  quadrant  of  the  dot  plot 
(Figure 6.2a). Cell samples individually labelled for each fluorochrome marker were then 
run, and compensation (electronic subtraction of unwanted signal) was adjusted so that 
positively stained cells were directly in line with unstained background cells and parallel 
with the appropriate axis (Figure 6.2b and c), correcting for spectral overlap between 
fluorochromes.  Two-colour  analysis  was  then  performed  on  experimental  samples  in 
order to determine levels of apoptosis (Figure 6.2d). Cell death analysis 
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Figure  6.2:  Compensation  controls  for  determination  of  apoptotic  cells  by 
Annexin V and PI staining. 
(A-C)  Dot  plots  used  as  compensation  controls  for  flow  cytometry  analysis  of 
untreated ES cell samples. (A) Unstained (autofluorescence) control. (B-C) Samples 
individually stained with Annexin V-FITC (B) or PI (C) used to compensate for spectral 
overlap between fluorescence detectors. (D) Exemplary plot of ES cell sample dual-
stained  with  Annexin-FITC  and  PI.  Quadrants  were  set  based  on  compensation 
controls enabling accurate separation of viable, apoptotic and necrotic cells. 
 
As a positive control ES cells were induced with 10 µg/ml etoposide for 8 h to undergo 
apoptosis  (Figure  6.3).  Etoposide  can  cause  double-stranded  DNA  breaks  leading  to 
activation of the terminal apoptotic cascade and culminating in cell death (Walker and 
Nitiss, 2002). Here, etoposide treatment results in a substantially increased proportion of 
Annexin V and Annexin V-PI positive cells (50.3% vs. 17.83% in untreated control) 
(Figure 6.3a). This treatment also induces activation of (Cleaved-) Caspase 3, an enzyme 
that plays a central role in the execution-phase of apoptosis (Figure 6.3b), indicating that 
these Annexin V positive ES cell populations are indeed apoptotic. 
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Figure 6.3: Etoposide induced apoptosis in ES cells. 
(A) Dot plots of etoposide treated (lower panel) and untreated (upper) ES cells stained 
with Annexin V-FITC and/ or PI indicating levels of live (Q4), apoptotic (Q2, Q3) and 
necrotic (Q1) cells. Percentages of cells in each quadrant are shown. (B) Western blot 
of untreated vs. etoposide treated ES cells. Shows protein levels of active and inactive 
Caspase 3.  -Tubulin was used as a loading control. 
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To assess levels of cell death in diet-ES cell lines, cells were counterstained for Annexin 
V and PI, and analysed by flow cytometry using the parameters set above. Basal levels of 
apoptosis were compared at 24, 48, and 72 h after seeding. There were no significant 
changes in the levels of cell death at 48 h (Figure 6.4). However, the proportion of viable 
cells (Annexin V -/ PI -) was reduced in LPD-ES cells compared to control NPD cells at 
both 24 h (71.52% ± 1.33 in LPD vs. 76.40% ± 1.460 in control, P = 0.0272), and 72 h 
(59.36%  ±  1.41  vs.  65.32%  ±  1.12,  P  =  0.008)  time-points  (Figure  6.4B).  The 
percentages  of  cells  at  different  phases  of  the  apoptotic  pathway  were  also  different 
between the 24 and 72 h time-points. At 24 h, LPD-ES cell populations showed increased 
percentages of Annexin V+/PI+ late apoptotic cells (7.17% ± 0.45 in LPD-ES cells vs. 
5.08% ± 0.48 in controls, P = 0.007), and Annexin V-/PI+ dead/necrotic cells (3.82% ± 
0.4228 in LPD-ES cells vs. 2.52% ± 0.40 in controls, P = 0.0406), whereas at 72 h, there 
was a significant increase in Annexin V+/PI- early apoptotic cells (22.45% ± 1.29 in 
LPD-ES  cells  vs.  18.87%  ±  0.80  in  controls,  P  =  0.0458)  however  the  increase  of 
Annexin V+/PI+ late apoptotic cells (13.68% ± 0.76 in LPD-ES cells vs. 11.65% ± 0.48 
in controls, P = 0.0535) was not statistically significant (Figure 6.4). These differences 
may reflect the duration of stress signals being transmitted, or in the type of stimuli being 
received at these time-points. Chapter 6 
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Figure 6.4: Basal levels of apoptosis are enhanced in LPD-ES cells 
ES  cell  lines  (P11-12),  harvested  at  24,  48,  and  72  h  time  points  were  stained  with 
Annexin  V  and  PI.  Discrimination  between  live,  apoptotic  and  necrotic  cells  was 
determined by flow cytometric analysis. (A) Dot plots show representative AnnexinV-PI 
staining for LPD (upper panel) and NPD (lower) ES cell lines at each time-point. (B) Bar 
chart shows mean percentages of cells in each representative quadrant for LPD (solid 
bars) and NPD (hatched bars) ES cell lines, at 24 h (black), 48 h (grey), and 72 h (red) 
time-points. Values are means for 8-10 (24 h), 6-9 (48 h), 7-6 (72h), LPD and NPD cell 
lines respectively ± SEM. Triplicate wells were analysed for each cell line at each assay 
time point. **P<0.01, *P<0.05, #P<0.1. 
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We hypothesized that the increased levels of apoptosis at 24 h and 72 h time-points, but 
not at 48h may reflect the levels of stress signals being in received at these times. For 
example, at 24 h, there may be an effect from passaging the cells, while at 72 h, there 
may be an effect from confluence of the cells and nutrient deprivation. The unchanged 
levels of cell death at 48 h may reflect optimal culture conditions at this time. In order to 
test for potential sensitivity to cellular stress, cells were grown for 48 h (where we saw 
no change in basal levels of cell death) and serum-deprived (10%, 0.5% 0.1%) for 12 h 
prior to assay. Levels of cell death were analysed by Annexin V-PI assay as described 
above and analysed by flow cytometry. Reduced serum concentration led to a modest 
increase in the proportion of apoptotic cells. However, levels of cell death in LPD-ES 
cells were comparable with control ES cell lines for all serum concentrations (Figure 6.5). Chapter 6 
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Figure 6.5: Serum-deprivation doesn’t alter levels of apoptosis in diet ES cells  
Serum-depleted medium (10%, 0.5%, and 0.1% serum) added at 36 h, and cultured 
for a further 12 h did not alter levels of cell death in LPD-ES cells compared to control 
cells. (A) Dot plots show representative AnnexinV-PI staining for LPD (upper panel) 
and NPD (lower) ES cell lines at each serum concentration. (B) Bar chart shows mean 
percentages of apoptotic cells (Annexin+) for LPD and NPD ES cell lines at each 
serum  concentration.  Values  are  means  for  5  LPD  and  4  NPD  cell  lines  ±  SEM. 
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As described in section 1.5, regulation of cell death is controlled by key components of 
pro-survival signal transduction pathways. Continuous activation of the core modules in 
these pathways (ERK, AKT, JAK/ Stat) function to suppress cell death machinery in the 
absence of apoptotic stimuli. Cellular stress can be transmitted via stress-related MAPK 
signalling to initiate cell death by activating pro-apoptotic components of the cell death 
machinery, and inhibiting pro-survival signalling. To determine if the increased levels of 
cell death seen in ES cells derived from the blastocysts of dietary challenged mothers 
corresponded  with  activity  (phosphorylation)  of  these  pathways,  cells  were  harvested 
(with  media)  24,  48,  and  72  h  after  plating,  and  the  levels  of  phospho-ERK 
(Thr202/Tyr204),  phospho-AKT  (Ser473),  phospho-Stat3  (Tyr705),  and  phospho-p38 
(Thr180/Tyr182) were determined by western blotting. 
ES cells from blastocysts of diet-challenged mothers showed reduced phosphorylation of 
ERK1/2 compared to NPD controls at 24, 48, and 72 h time-points (showing 1.79-, 1.48-, 
and 1.90-fold reductions respectively) (Figure 6.6; Figure 6.7). Levels of phosphorylated 
AKT, Stat3, and p38 were similar between treatments (Figure 6.7). Chapter 6 




Figure 6.6: Phosphorylated-ERK1/2 is reduced in LPD-ES cells. 
ES  cell  lines  were  harvested  at  24,  48,  and  72  h  time-points.  Whole  cell  protein 
lysates  were  prepared  and  analysed  by  western  blotting  (A)  for  phosphorylated-
ERK1/2 (Thr202/Thy204). (B) Quantitative analysis of phospho-ERK1/2 normalised to 
total-ERK1/2  for  ES  cells  derived  from  blastocysts  of  diet-challenged  mothers  is 
shown as the fold change relative to NPD controls. Values are representative of at 
least  two  individual  experiments  comparing  at  least  7  ES  cell  lines  per  treatment 







Figure 6.7: Reduced ERK activation in LPD-ES cells is independent of other key cell survival pathways 
(A-C) Western blot analysis of components of the signal transduction pathways involved in cell survival and apoptosis. (D-E) Quantitative analysis of 
phosphorylated (activate) protein normalised to total protein. Protein extracts were harvested at 24 (A, D), 48 (B, E), and 72 h (C, F) time-points after 
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ERK1/2  directly  regulates  expression  and/  or  activity  of  certain  components  of  the 
apoptotic pathway suppressing aberrant cell death. We looked to see if expression levels 
of some of these key proteins were altered as a consequence of reduced ERK activation 
and in correspondence to increased levels of cell death. Active (cleaved) Caspase3 is 
considered the most important executioner caspase as it is cleaved by all of the initiator 
caspases (Walsh et al., 2008), and is activated in most cases of PCD. The BOPs, Bim and 
PUMA  are  upregulated  or  activated  in  response  to  certain  apoptotic  stimuli.  Bim  in 
particular is tightly regulated by ERK (Balmanno and Cook, 2009; Dijkers et al., 2000; 
Ewings et al., 2007a; Gillings et al., 2009). Bim and Puma interact with (suppress) all 
pro-survival  proteins  to  initiate  intrinsic  cell  death  and  therefore  exhibit  potent  pro-
apoptotic activity (Chen et al., 2005; Kuwana et al., 2005; Merino et al., 2012). Western 
blot analysis of whole cell lysates prepared at 24, 48, and 72 h after seeding cells showed 
little or no changes in expression of Bim, intact or cleaved caspase3, or PUMA in LPD 
ES cells compared with controls (Figure 6.8).  
 
 
Figure 6.8: Expression analysis of key initiators and executioners of the apoptotic pathway. 
(A-C) Western blot analysis of components of the apoptotic machinery. Protein extracts were harvested at 24 (A, D), 48 (B, E), and 72 h (C, F) time-
points after seeding cells. (D-E) Quantitative analysis protein levels normalised to tubulin loading control. Values represent the fold change of LPD-ES 
cells compared with NPD controls from at least 7 ES cell lines from two experiments. 
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6.4 Discussion 
Cell death mechanisms are tightly regulated during pre-implantation development. ICM 
and ES cells are almost unique in lacking regulatory checkpoints in the cell cycle; this 
enables a rapid rate of cell division during early cleavage and blastocyst formation but 
also means that high levels of cell death must occur to ensure that aberrant cells are not 
incorporated into the developing foetus. This ensures effective removal of damaged cells 
but means that the blastocyst is particularly sensitive to environmental changes causing 
cell  stress.  This  is  evident  in  models  such  as  the  diabetic  mouse,  where  severe 
hyperglycaemia has a teratogenic effect on embryo development with increased levels of 
cell death, particularly within the ICM. This can explain the lower pregnancy rates seen 
in this strain. Other metabolic stresses, for instance a HPD have also been shown to cause 
increased mouse blastocyst apoptosis (Gardner et al., 2003). ES cells also exhibit high 
levels of apoptosis with suboptimal culture conditions such as omission of growth factors 
or nutrients, which induces apoptosis far more readily than in differentiated somatic cells 
(Rawson et al., 1990).  
As a model of determining possible mechanisms regulating embryo growth in response 
to nutritional changes, we were interested to see if the sensitivity of ES cells in vitro were 
altered by a maternal LPD during preimplantation development. We find that levels of 
apoptosis in ES cells derived from blastocysts of mothers fed a LPD are higher than in 
control cell lines. LPD during pregnancy increases glucose levels in utero (Eckert et al., 
2012; Kwong et al., 2000). Whilst this has not been well studied, it may induce cell death 
in the peri-implantation embryo. Counter-intuitively high extracellular glucose causes 
cellular glucose starvation and activation of apoptotic pathways due to reduced glucose 
transporter expression (Chi et al., 2000a; Hinck et al., 2003), explaining the reduction in 
rodent blastocyst cell number. Similar responses to high glucose have been identified in 
bovine embryos (Jimenez et al., 2003). LPD only produces mild hyperglycaemia and it 
remains to be seen if the increased levels of glucose have a pro-apoptotic effect on the 
blastocyst. Previous work investigating the effect of a LPD on rat blastocyst development 
failed to show increased apoptosis (Kwong et al., 2000), but was not investigated in 
depth. In agreement with our findings maternal LPD during gestation has been associated 
with increased apoptosis in key organs during foetal and postnatal development. This 
may  indicate  that  changes  induced  in  the  embryo’s  stem  cells  are  maintained  in 
differentiated cells and provides some clues to the mechanisms that link foetal nutrition Cell death analysis 
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to  the  permanent  physiological  changes  that  promote  disease.  For  example,  in  rats 
maternal  LPD  (9%)  during  mid-late  gestation  (Langley-Evans  et  al.,  1999;  1996c; 
Vehaskari et al., 2001), produce increased apoptosis in E13 metanephric mesenchyme 
resulting in offspring with fewer glomeruli and higher systemic blood pressures than 
controls. A similar response is shown in the offspring of food restricted pregnant rats 
(Tafti  et  al.,  2011).  Maternal  diet  also  appears  to  play  a  crucial  role  in  promoting 
apoptosis  in  foetal  liver  with  offspring  of  Wistar  rats  fed  a  LPD  (5%)  showing  an 
increased  number  of  apoptotic  hepatocytes  (Ramadan  et  al.,  2012).  LPD  throughout 
gestation, reduced pancreatic  -cell mass and insulin content, with smaller islets and a 
decrease in  -cell proliferation in young rat offspring. There were more apoptotic islet 
cells in the endocrine pancreas of LPD-offspring while the number of cells positive for 
IGF-II, a survival factor preventing apoptosis, was decreased (Petrik et al., 1998; 1999; 
Snoeck  et  al.,  1990).  As  the  majority  of  these  studies  subject  mothers  to  a  LPD 
throughout gestation, these LPD-induced changes in organ structure may occur later in 
development during sensitive periods of organ development. It remains to be seen if LPD 
treatment exclusively during preimplantation embryos will have a similar apoptotic effect. 
However, as a LPD exclusively during preimplantation development induces changes in 
kidney and liver weights in the rat (Kwong et al., 2000), and LPD during mouse oocyte 
maturation decreases kidney weight (Watkins et al., 2008b) it is highly possible.  
Basal levels of apoptosis were increased in ES cells isolated from blastocysts of LPD 
treated mothers at 24 h and 72 h after plating. ES cells undergo significant cell death 
upon  dissociation  into  single  cells.  Likewise  ES  cells  are  sensitive  to  pH  changes, 
overcrowding and absence of survival factors, which may contribute to the high cell 
death seen in cells harvested 72 h after plating. The fact that there were no changes in 
apoptotic rates between treatment groups at 48 h, when ES cells are growing optimally, 
suggests that ES cells derived from LPD-challenged blastocysts are more vulnerable to 
environmental stressors. Inducing cellular stress by serum starvation after 48 h of cell 
culture  had  no  added  effect  on  cell  death  in  LPD-ES  cells  compared  to  controls. 
Discrepancies in the proportion of cells at each apoptotic stage at 24 h and 72 h time 
points  may  reflect  differences  in  the  duration  or  type  of  apoptotic  stimulus  in  these 
cultures. 
In  addition  to  increased  apoptosis  in  LPD-ES  cells,  there  were  reduced  levels  of 
phosphorylated ERK. No difference was shown in the phosphorylation of AKT, Stat3, or Chapter 6 
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p38 MAPK suggesting that the cell death response was independent of these signalling 
pathways, and that apoptosis in these cells may be mediated by ERK. Little is known 
about  the  signalling  pathways  regulating  cell  survival  in  ES  cells.  Pharmacological 
inhibition of PI3K/ AKT signalling in mouse ES cells (and in vitro cultured blastocysts) 
induces  apoptosis,  whereas  MEK/  ERK  inhibition  has  no  impact  on  cell  survival  as 
measured by DNA fragmentation (Gross et al., 2005). MEK inhibitor specificity may 
explain this variation to our results as these inhibitors block all ERK isoforms (Kamakura 
et al., 1999). The activation and response of ERK isoforms other than ERK1/2 must be 
considered in the cell survival response. Further there is a degree of pathway crosstalk, 
which compensates for such pharmacological interventions. Cell survival is not affected 
in  most  cell  types  subjected  to  MEK  inhibition  for  these  reasons  and  there  may  be 
inappropriate dismissal of ERK in survival signalling. ERK (and p38 MAPK) activation 
has been shown to induce apoptosis in ES cells treated with nitric oxide (Lee et al., 2012). 
These  responses  to  altered  ERK  activity  may  be  due  to  differences  in  the  apoptotic 
stimuli. 
Although reduced ERK activity appears to correlate with increased cell death in our cells, 
ERK has many functions and can have opposing roles. Indeed there are many examples 
demonstrating that ERK activation contributes to the regulation of both cell survival and 
apoptosis. For example, studies using pharmacological inhibitors of MEK or dominant 
interfering MEK mutants have shown a role for MEK/ ERK dependent cell death in some 
cell types (Bhat and Zhang, 1999; Pavlovic et al., 2000; Sinha et al., 2004; Wang et al., 
2000), whereas in others such treatments block apoptosis (Bonni et al., 1999; Boucher et 
al., 2000; Hong et al., 2001; Jost et al., 2001). 
There are a number of regulatory mechanisms that enable distinct cellular responses to 
occur from activation of the same signalling molecules (Schaeffer and Weber, 1999). 
Differences in the duration and magnitude of ERK activity as well as localisation can 
determine  signalling  specificity  (Ebisuya  et  al.,  2005).  In  PC12  cells,  treatment  with 
epidermal  growth  factor  (EGF)  stimulates  transient  ERK  activation  and  induces  cell 
proliferation (Gotoh et al., 1990; Marshall, 1995), while stimulation with nerve growth 
factor (NGF) causes sustained ERK activation, its nuclear accumulation, and promotes 
differentiation. In fibroblasts, sustained activation of ERK is required for quiescent cells 
to enter S-phase of the cell cycle and to proliferate (Balmanno and Cook, 1999), which 
does not occur under transient ERK activation (Murphy et al., 2002). However, high Cell death analysis 
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levels  of  ERK  phosphorylation  can  lead  to  cell  cycle  arrest  (Coleman  et  al.,  2003; 
Roovers and Assoian, 2000; Sewing et al., 1997; Woods et al., 1997). Signal strength and 
duration are interpreted, at least in part, by phosphorylation of immediate early genes 
(Murphy  and  Blenis,  2006).  Transient  ERK  activation  initiates  transcription  of  such 
genes, but ERK is inactivated before their accumulation. High levels of ERK or sustained 
ERK  activity  are  required  for  phosphorylation  and  stabilisation  of  the  accumulated 
transcription factors, allowing expression of their target genes (Murphy et al., 2002; Vial 
and Marshall, 2003).  
It has been proposed that differential effects of ERK may depend on the specific receptor 
availability. EGF receptors are downregulated rapidly upon ligand binding in PC12 cells 
to  ensure  only  transient  ERK  activation,  while  NGF  and  receptor  expression  is 
maintained (Marshall, 1995). LPD during preimplantation development may permanently 
alter expression of receptors that are involved in signalling through the ERK pathway, 
affecting  ERK  stimulation.  A  number  of  peptide  growth  factors  signal  via  the  ERK 
pathway to control cell survival (Vincent and Feldman, 2002), and receptor expression 
changes occur in suboptimal conditions. For example, maternal diabetes impairs IGF-I 
and  insulin  receptor  expression  in  rabbit  blastocysts  inducing  apoptosis  through 
decreased  BCLXL  gene  expression  (Ramin  et  al.,  2010).  Hyperglycaemic  conditions 
causes downregulation of IGF-I receptors in mouse blastocysts and induces apoptosis 
(Chi et al., 2000b). A LPD has not been shown to alter growth factor receptor expression 
in  the  blastocyst.  However,  a  maternal  LPD  during  preimplantation  development 
downregulates IGF-2 receptor expression in rat foetal liver (Kwong et al., 2006) and 
increases insulin and IGF-I receptor expression in retroperitoneal fat in mice (Watkins et 
al., 2011). 
Further,  spatial  regulation  of  ERK  is  important  in  determining  cell  fate  by  directing 
signals to specific downstream targets. In resting cells components of the ERK cascade 
are maintained mostly in the cytoplasm (Chuderland and Seger, 2005; Kondoh et al., 
2005;  Murphy  and  Blenis,  2006).  Upon  stimulation,  ERK  molecules  are  directed  to 
various  compartments  and  the  site  of  ERK  cascade  initiation  determines  substrate 
specificity (Casar et al., 2009; Inder et al., 2008). After phosphorylation, 50-70% of ERK 
molecules  translocate  to  the  nucleus  (Chen  et  al.,  1992;  Lenormand  et  al.,  1993; 
Rubinfeld  et  al.,  1999).  More  than  half  of  ERK  substrates  identified  are  nuclear 
transcription factors (Yoon and Seger, 2006). ERKs have been shown to interact with Chapter 6 
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several distinct scaffold proteins on endosomes (Luttrell et al., 2001; Nada et al., 2009). 
These interactions allow signal propagation from this vicinity, and regulate trafficking of 
the endosome, and internalised receptor function. ERK localization to the surface of the 
Golgi  apparatus  prevents  nuclear  translocation  and  ERK-dependent  transcription  via 
interactions with the scaffold protein Sef1 (Torii et al., 2004), promoting cytoplasmic 
specific  signalling.  ERK  localisation  in  the  mitochondria  regulates  processes  such  as 
survival/  apoptosis,  modulation  of  steroid  synthesis,  and  more  (Dagda  et  al.,  2008; 
Poderoso et al., 2008). The large numbers of ERK molecules per cell (~10
7 molecules per 
cell)  suggests  that  distinct  pools  mediate  distinct  functions.  Compartmentalisation  of 
subgroups  of  molecules  at  different  organelles  may  ensure  specific  interactions  with 
desired substrates. Determining ERK localisation may indicate function. 
This  complex  regulation  of  ERK  is  required  for  signalling  specificity  but  makes  it 
difficult to determine molecular mechanisms underlying ERK function in studies such as 
this one, especially where ERK performs multiple functions within the cell at the same 
time.  The  enhanced  basal  levels  of  apoptosis  and  corresponding  decrease  in 
phosphorylated ERK in our ES cells suggests that there may be a loss of survival factors 
as oppose to a response to apoptotic stimuli. A threshold of continuous ERK activity may 
be  required  to  maintain  cell  survival,  and  levels  of  phosphorylated  ERK  below  this 
threshold may increase cell death. ERK is known to promote cell survival by actively 
blocking apoptotic pathways. It is possible that ERKs role in the regulation of these 
pathways is disrupted in LPD-ES cells. However, it is also possible that crosstalk from 
other signalling pathways may be actively destabilising ERK. 
Mitochondria have a pivotal role in survival and cell death decisions. In response to a 
variety of apoptotic stimuli, apoptogenic proteins (such as cytochrome c) are released 
from the intermembrane space of the mitochondria to the cytosol and/or the nucleus; 
subsequent activation of caspases and nucleases, or neutralization of cytosolic inhibitors 
of these processes promotes apoptosis (Du et al., 2000; Liu et al., 2000; Susin et al., 1999; 
Verhagen et al., 2000). Mitochondrial and cytosolic pro-apoptotic BOPs (e.g. PUMA, 
Bim)  interact  with  anti-apoptotic  BCL2  proteins  (e.g.  BCL2,  MCL1)  to  control 
dimerization  and  activation  of  BAX-like  ‘pore-formers’  (BAX,  BAK)  and  release  of 
apoptogenic agents from the mitochondria (Adams, 2003; Willis et al., 2007; Yamaguchi 
and Wang, 2002). ERK promotes cell survival by targeting this machinery in a way that 
blocks these interactions and the release of apoptogenic agents (Bonni et al., 1999). This Cell death analysis 
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is a potential point of integration by which ERK signalling cascades may act to promote 
cell survival in our ES cells.  
Bim is one of the few BOPs that interacts with all pro-survival BCL2 proteins as well as 
the effector BAX-like proteins and therefore exhibits potent pro-apoptotic activity (Chen 
et al., 2005; Chipuk et al., 2010; Kuwana et al., 2005; Merino et al., 2012). Further, Bim 
in particular is tightly regulated by ERK (Balmanno and Cook, 2009; Dijkers et al., 2000; 
Ewings et al., 2007a; Gillings et al., 2009). For example, phosphorylation of BimEL by 
ERK on Ser69 marks it for ubiquitination and degradation (Ley et al., 2003; Luciano et 
al., 2003). Phosphorylation of Bim at Ser65 by ERK is also thought to antagonise its 
function  by  preventing  interactions  with  the  pro-survival  proteins  MCL1  and  BCLXL 
(Ewings et al., 2007b), and pro-apoptotic BAX (Harada et al., 2004).  
Cell  survival  in  TS  cells  is  maintained  through  ERK-mediated  phosphorylation  and 
degradation  of  Bim  (Yang  et  al.,  2006).  Removal  of  growth  factor  FGF4  reduces 
phosphorylated ERK and stabilizes Bim. We saw no differences in the Bim expression 
between  LPD-ES  cells  and  control  cell  lines,  though  it  was  not  possible  to  detect 
phosphorylated levels. However, localisation of Bim is important in determining function 
and may not involve changing the levels of Bim. Upon Bim expression in healthy cells, it 
is neutralised by binding to the microtubular dynein motor complex (Puthalakath et al., 
1999). Phosphorylation of Bim at Ser87 causes it to be sequestered in the cytoplasm by 
14-3-3 proteins, preventing localisation with its BCL2 targets at the mitochondria (Qi et 
al., 2006). 
ERK also controls expression and activity of other BCL2 family proteins regulating cell 
survival  by  similar  post-translational  modifications  (Datta  et  al.,  1997;  Fueller  et  al., 
2008;  Schmelzle  et  al.,  2007;  Zha  et  al.,  1996).  Further,  many  ERK  substrates  are 
transcription factors which are involved in upregulating expression of pro-survival BCL2 
proteins  (Boucher  et  al.,  2000;  Wang  et  al.,  1999).  It  is  possible  that  reduced  ERK 
activation may disrupt the activation of these survival mechanisms leading to increased 
levels of apoptosis in our ES cells.  
We did not look at levels of the stress-activated MAPK, JNK in this study, and it is 
possible that JNK may counteract ERK-mediated survival signals to promote apoptosis 
in our cells. For example, JNK promotes cell death by phosphorylation of pro-apoptotic 
BOPs, releasing them from sequesterisation and enabling activation of BAX/ BAK, and 
initiation of the caspase cascade (Lei and Davis, 2003; Letai et al., 2002). JNK also Chapter 6 
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neutralises the activity of pro-survival BCL2 proteins (Cai et al., 2006; Puthalakath et al., 
1999; Puthalakath and Strasser, 2002; Sunayama et al., 2005). Importantly, JNK can 
negatively regulate ERK and there may be crosstalk between these signalling pathways 
(Black et al., 2002; Shen et al., 2003; Zuluaga et al., 2007). 
Further, there was no correlation between increased cell death and expression levels of 
the executioner caspase-3 in our cells. Active (cleaved) caspase-3 is considered the most 
important effector caspase. It is cleaved by all of the initiator caspases (Walsh et al., 
2008), and is activated in most cases of PCD, where it is involved in initiating proteolytic 
dismantling of cellular components (Slee et al., 2001). In apoptosis, activation of the 
effector  caspases  (caspase-3/  6/  7)  occurs  before  many  of  the  biochemical  and 
morphological  events  characteristic  of  apoptosis  including  our  measure  of  apoptosis, 
phosphatidylserine  externalisation  (Annexin  V  binding).  Optimal  caspase  (and  Bim) 
activity may have preceded the time-points used here explaining why differences were 
not detectable. A much shorter time-course may be necessary to detect differences in 
initiating apoptotic events. Although caspases play a crucial role in cell death, caspase-
independent  death  can  occur  (Belmokhtar  et  al.,  2001;  Cummings  and  Schnellmann, 
2002; Subramaniam and Unsicker, 2006; Tait and Green, 2008). Caspase-independent 
cell  death  is  mediated  by  the  disruption  of  the  mitochondrial  membrane  and  the 
translocation of AIF and endonuclease G to the nucleus, where they induce chromatin 
condensation and/or large-scale DNA fragmentation, characteristic of apoptosis (Cregan 
et al., 2004; Jaattela and Tschopp, 2003; Susin et al., 2000). ERK plays a crucial role in 
necroptotic  forms  of  caspase-independent  cell  death,  which  display  characteristics 
resembling both apoptosis and necrosis (Subramaniam et al., 2004). 
These  findings  provide  clues  to  the  adaptations  occurring  within  the  preimplantation 
embryo as a result of maternal LPD and may have implications in determining possible 
molecular  mechanisms  involved  here.  Changes  in  ERK  during  the  peri-implantation 
period may affect lineage allocation and organ development. Sustained changes in ERK 
expression would further impact on later development and may be causative of the long-
term health implications that occur as a result of LPD during early pregnancy. 
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Chapter 7:  General discussion 
7.1 Conclusions 
The DOHaD hypothesis proposes that embryonic environment (e.g. altered nutrition) can 
influence  developmental  pathways  and  induce  permanent  changes  in  metabolism, 
resulting in enhanced long-term disease risk (Gluckman et al., 2009; Hales and Barker, 
2001). Further, environment during critical periods of gestation are sufficient to alter 
organ development and homeostasis, and disease susceptibility in adults. This is best 
studied in animal models; for example, a LPD through gestation induces hypertension 
and vascular dysfunction (Langley-Evans et al., 1996c; Torrens et al., 2009a; 2009b). 
However, human epidemiological observations such as the Dutch (Painter et al., 2006; 
Roseboom et al., 2001) and Chinese famines (Li et al., 2010) also show that nutritional 
challenges during pregnancy increases susceptibility to adult onset of CVD (Painter et al., 
2006) and T2D (Li et al., 2010; Ravelli et al., 1998). Evidence from rodent models show 
that  the  preimplantation,  and  even  pre-fertilisation  periods  are  critically  sensitive  to 
maternal nutrition (Watkins et al., 2010; 2008a; 2008b). The adaptations observed in 
offspring here mirror the changes seen in gestational undernutrition. This provides strong 
evidence to suggest a degree of programming within these early embryonic cells. It is 
therefore necessary to further these studies and to determine mechanisms of the changes 
occurring in very early embryos. 
Previous studies have used embryos from outbred MF-1 mice to study the effects of 
periconceptional  maternal  undernutrition  (Eckert  et  al.,  2012;  Watkins  et  al.,  2011; 
2008b). Due to genetic variability in these mice it is difficult to study subtle molecular 
changes that may occur under these conditions. We have used a highly inbred C57BL/6 
mouse model to investigate such nutritional challenges thus removing genetic variability. 
Another intrinsic problem of studying such changes in the very early embryo is the small 
amounts of tissue available. The ability to now isolate the stem cells of the blastocyst and 
expand them in culture, whilst retaining their in vivo characteristics, has provided new 
avenues to alleviate such problems. Therefore, we have generated a novel ES cell model 
to  investigate  the  effects  of  maternal  LPD  on  the  blastocysts  ICM  cell  populations 
(progenitors of all foetal tissues), with the aim of determining potential origins of long-
term changes in offspring phenotype.  Chapter 7 
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Although using C57BL/6 removes genetic variability, there are difficulties in obtaining 
ES  cells  from  this  strain,  and  it  has  only  become  possible  since  the  introduction  of 
defined media (Cheng et al., 2004; Kawase et al., 1994). Even under these conditions 
these ES cells experience loss of pluripotency, and differentiate more readily than in 
more permissive 129 strains (Sato et al., 2009). Indeed our initial attempts to isolate ES 
cells from C57BL/6 blastocysts were unsuccessful and required optimisation of other 
widely  used  protocols.  We  found  that  ICM-derived  cells  of  blastocyst  outgrowths 
appeared to differentiate sooner than in other strains. Reducing the culture period of 
blastocyst  outgrowths,  before  dissociating  ICM-derived  clumps  enabled  much  more 
efficient isolation of ES cell lines. The advantages of this model however also have some 
limitations.  Prolonged  in  vitro  culture  of  ES  cells  can  lead  to  aberrations  affecting 
pluripotency and growth (Dean et al., 1998; Longo et al., 1997). Therefore changes in 
these  cells  may  be  an  artefact  of  the  in vitro  culture  process  itself.  Although  direct 
comparisons can be drawn between our LPD- and control-ES cell lines, whether these 
changes are present in the embryo itself, and whether they would persist through normal 
development  remains  to  be  seen.  Having  said  this,  our  ES  cells  do  maintain 
characteristics of their in vivo progenitor cells; all cell lines express pluripotency markers, 
and  the  majority  maintain  a  euploid  karyotype  over  many  passages.  Further,  it  is 
common to generate male ES cell lines more frequently than females due to an unstable 
karyotype in these cells. This was also the case in this study with approximately 75% of 
our ES cell lines derived from male blastocysts. This is of particular relevance in this 
study as it has been shown that maternal undernutrition induces sex-specific phenotypes 
in offspring. It was not possible to compare the effects of maternal diet on female ES cell 
lines due to the low numbers of lines generated. Given more time to generate more lines 
this may be possible, but would require a large number of embryos. 
Similar  to  other  work,  maternal  protein  undernutrition  had  no  impact  on  blastocyst 
formation  in  this  study.  Others  have  shown  that  LPD  does  not  compromise  foetal 
viability;  but  rather  LPD  induces  subtle  changes  in  embryo  development.  Our  study 
shows no effect of LPD on blastocyst development in utero; cell numbers and lineage 
distribution  were  the  same.  However  blastocyst  morphology  analysis  showed  slower 
growth in unfavourable (few feeders) culture conditions, and although LPD blastocyst 
outgrowth was comparable to controls under more favourable growth conditions, there 
was a significant effect on ES cell isolation rates in these conditions, with less than 20% General discussion 
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of blastocysts from LPD-treated mothers producing ES cell lines compared to over 40% 
from control diet blastocysts. 
We hypothesized a number of potential causes for the reduced ES cell isolation potential. 
A reduction in the number of pluripotent cells following LPD may occur due to changes 
in  cellular  proliferation,  differentiation,  and  cell  death  either  in  the  blastocyst  itself, 
within blastocyst outgrowths in vitro, or in the ES cells following isolation. 
Proliferation was not measured in the blastocyst. However, as cell numbers were not 
different  between  treatments,  and  there  were  similar  rates  of  blastocyst  outgrowth 
development in favourable conditions, this suggests that proliferation rates are not altered 
by diet and that other factors must be involved in reduced ES cell isolation potential.  
In the blastocyst there were no differences in lineage marker expression between diet 
treatment groups however, blastocyst outgrowths did show changes in the number of 
pluripotent cells and this may explain the reduced efficiency in ES cell line derivation 
from LPD derived blastocysts. However this may have arisen from the different culture 
conditions generated between these experiments and the initial ES cloning. The absence 
of feeder fibroblasts in outgrowth cell lineage experiments may make it difficult to draw 
conclusions as to whether the cell lineage allocation/ differentiation is the cause of the 
reduced efficiency in ES line isolation from LPD derived blastocysts. Currently it is also 
unclear whether changes in proliferation or cell death may be contributory, as these were 
not measured in blastocyst outgrowths. 
In an attempt to determine mechanisms regulating changes in blastocyst development as 
a  result  of  maternal  LPD,  we  analysed  functional  characteristics  mediating  ES  cell 
growth. Further, this provided some insight into other possible causes of reduced ES cell 
isolation  from  LPD-blastocysts.  Analysis  of  cell  proliferation  and  cell  cycling  in 
asynchronous and synchronised cell cultures were almost identical between treatment 
groups. The similar proliferation rates shown here agrees with our blastocyst data and 
another  recent  study  showing  no  changes  in  blastocyst  cell  numbers  or  outgrowth 
development following a maternal LPD (Eckert et al., 2012), but is not in agreement with 
previous data shown in the rat (Kwong et al., 2000). It is possible that isolated ES cells 
are not representative of the LPD treatment group as a whole. Reduced ES cell isolation 
potential following a LPD could result from reduced proliferation, but the individual 
blastocyst that give rise to ES cells are perhaps less affected by LPD than the majority. 
As mentioned in chapter 3, it is possible that changes in proliferative capacity do occur as Chapter 7 
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a result of maternal diet, yet these changes are not immediately evident in the blastocyst 
(or its derived ES cells). The ICM cells in the blastocyst are largely demethylated due to 
epigenetic remodelling events that occur during cleavage (Mayer et al., 2000; Okamoto 
et al., 2004). Epigenetic changes may occur during de novo methylation that is initiated 
in  the  late  blastocyst/  post-implantation,  and  changes  in  gene  regulation  induced  by 
maternal LPD may only become evident at this stage. ES cells are isolated during the 
time of demethylation and exist in a largely demethylated state thus may not possess all 
the epigenetic marks regulating proliferation at this stage. Investigating cell proliferation 
in  blastocyst  outgrowths,  especially  under  suboptimal  conditions  where  growth  rates 
appear to be differentially affected could provide further insight into the reduced ES cell 
isolation  efficiency  from  LPD-blastocysts,  and  proliferative  potential  following 
differentiation. 
As with ICM-derived cells of blastocyst outgrowths (and potentially in the blastocyst 
itself),  ES  cells  isolated  from  the  blastocysts  of  mothers  fed  a  LPD  appeared  more 
sensitive  to  cellular  stresses  than  control  ES  cells.  Basal  levels  of  apoptosis  were 
enhanced in LPD-ES cells compared to controls, which correlated with reduced ERK 
activity. This was independent of PI3K/ AKT, and JAK/ Stat survival pathways and 
stress-activated  p38-MAPK  signalling.  Since  ERK  is  involved  in  cell  survival,  it  is 
possible that enhanced cell death is a result of decreased survival signalling rather than 
an increase in apoptotic stimuli per se.  
ERK controls cell survival through regulation of apoptotic initiator proteins that mediate 
activation of the apoptotic cascade. Though we found no evidence in this study to link 
these pathways to the changes in our ES cells, there are a huge number of potential 
targets,  and  a  number  of  ways  ERK  can  regulate  interactions  and  activity  of  these 
proteins. For example, ERK can phosphorylate pro-survival members of the apoptotic 
machinery to enhance function, or conversely ERK may target pro-apoptotic members, 
marking them for degradation or re-localising them away from the mitochondria, hence 
blocking release of apoptogenic agents and initiation of the caspase cascade. ERK also 
functions  to  regulate  expression  of  these  apoptotic  proteins  by  targeting  specific 
transcription factors. As these molecular events are early in the apoptotic process It is 
likely that altered expression and activity preceded our assay time-points. A much shorter 
time-course and a more comprehensive analysis of the BCL2 family proteins involved in 
apoptosis might be necessary to confirm ERK-mediated survival mechanisms. As well as General discussion 
  165 
cell  survival,  ERK  has  been  shown  to  promote  cell  death  after  certain  stimuli.  The 
distinguishing feature appears to be the duration or magnitude of the ERK response. For 
example, higher levels of ERK may be necessary to stabilise transcription factors and 
enable transcription of genes necessary to elicit the desired response. Altered expression 
of survival factor receptors can occur to alter the level of ERK stimulation. There is 
evidence  to  show  alterations  in  growth  factor  receptor  expression  in  response  to 
suboptimal  maternal  conditions.  For  example  a  hyperglycaemic  environment  impairs 
IGF-I  and  insulin  receptor  expression  the  blastocyst  leading  to  apoptosis (Chi  et  al., 
2000b; Ramin et al., 2010). Since LPD induces mildly hyperglycaemic conditions, it is 
plausible that receptor expression levels may be involved in the lack of ERK stimulation 
shown in our cells.  
A certain level of ERK activity appears necessary to maintain cell survival in our ES 
cells. If levels of phosphorylated ERK fall below the threshold required to maintain pro-
survival interactions, apoptosis would be initiated. This provides a possible model for the 
difference in levels of apoptosis between LPD-ES cell lines and controls. 
From  this  data,  it  is  possible  that  reduced  ES  cell  isolation  potential  from  LPD-
blastocysts is due to increased apoptosis within the ICM-derived cells. It may be that an 
enhanced  propensity  for  cell  death  occurs  in  the  preimplantation  embryo  itself  and 
throughout early development as a result of LPD. Certainly a sustained sensitivity to 
ERK-mediated  cell  death  throughout  development  would  have  a  long-term  effect  on 
organ structure and function, and may, at least partially explain some of the changes seen 
in offspring of undernourished mothers. Preliminary data in E8.5 embryos suggest that 
ERK activation is reduced in embryos subjected to a LPD. Long-term differentiation 
potential has not been studied in our ES cell and this would provide some insight into 
effects of LPD-induced cell death on the embryo’s stem cells developmental potential. 
These results provide insights into the important molecular changes occurring as a result 
of maternal LPD, which may be involved in mediating future developmental outcomes. 
The DOHaD hypothesis proposes that adaptations within the embryo are made to be 
advantageous to embryo development. It is suggested that changes made in response to 
embryo environment are predictive of the future environment and changes are made to 
cope with this.  
It  is  difficult  to  understand  how  increases  in  apoptosis  would  have  an  advantageous 
effect on embryo development rather that these occur as a consequence of the suboptimal Chapter 7 
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developmental  environment.  It  is  likely  that  the  embryo  may  then  respond  to  the 
enhanced  cell  death  and  possible  changes  in  cell  number  by  inducing  predictive 
adaptations to enhance immediate survival chances. This is not a new concept and it has 
been suggested as an explanation for the changes seen in organ structure in response to a 
suboptimal intrauterine environment. It is thought that protection of important organs 
occurs  during  development  at  the  expense  of  others,  with  long-term  impact  on  their 
function. 
7.2 Future directions 
Using our ES cell model to progress the understanding of the developmental changes 
involved in response to maternal undernutrition, it is first important for us to further 
explore the molecular pathways controlling ES cell fate decisions, and to investigate 
other changes that may occur in these cells as a response to maternal undernutrition. It is 
also  important  to  define  whether  the  changes  we  have  seen  are  applicable  to  in  the 
blastocyst in vivo, whether these changes are sustained throughout development, and if 
the longer-term changes in offspring can be linked to the changes seen in our ES cells. 
Firstly, it is important to confirm the apoptotic mechanisms involved in our ES cells by 
other  methods.  Caspase  activity  assays  and  mitochondrial  membrane  potentials  are 
alternative  measures  of  early  apoptotic  events,  whilst  PARP  assays, t erminal 
deoxynucleotidyl transferase dUTP nick end labeling (TUNEL), and DNA fragmentation 
assays could confirm the late apoptotic changes seen. To understand the mechanistic 
changes seen in our study it is necessary to determine upstream effectors of ERK activity 
as  well  as  downstream  substrates  that  mediate  the  apoptotic  response.  We  saw  no 
changes in protein expression of the downstream ERK substrates, but this study was 
limited in the number of targets analysed. A candidate gene approach targeting ERK-
mediated pro-survival and pro-apoptotic members of the BCL2 family may be useful. 
However due to the large number of proteins involved in cell death pathways, a real-time 
PCR  profiler  array  focused  on  a  panel  of  genes  related  to  apoptosis  may  be  more 
informative. Although transcriptional regulation of cell survival genes is an important 
mechanism in determining cell fate, post-translational modification also controls function 
of these proteins, and this will have also to be investigated. It is also possible that the 
timing of our analysis missed expression changes in the early stages of apoptotic events, 
and a more detailed study with earlier times points is necessary. General discussion 
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Determining  if  the  changes  seen  in  our  ES  cells  translate  to  the  blastocyst  itself  is 
important as the changes we see could be an artefact of the in vitro culture conditions and 
cell manipulations. Cell death analysis in blastocysts by TUNEL or AnnexinV staining 
may establish immediate effects of maternal undernutrition. The blastocyst outgrowth 
model is also useful in determining effects of maternal diet, especially when considering 
the differences we saw in outgrowths.  Similar cell death analyses can be applied to these 
outgrowths perhaps when grown in the presence of MEF feeder cells. Importantly this 
may provide further understanding of the reduced ES cell isolation potential from LPD-
blastocysts.  Determining  protein  levels  of  ERK  in  the  blastocyst  is  a  primary  focus, 
although difficult due to the small size. Investigating ERK localisation within the cells 
may  also  be  informative.  ERK  mediates  cell  survival  by  interacting  with  cell  death 
proteins at the mitochondria. The magnitude of the ERK signal can also determine its 
function.  It  is  possible  that  altered  ‘survival-receptors’  that  signal  through  the  ERK 
pathway  may  be  down-regulated  in  the  blastocyst  in  response  to  LPD.  Therefore 
establishing potential targets and analysing receptor expression in the blastocyst and our 
ES cells may provide mechanistic insight. Analysing ERK expression in the foetus later 
in development may also be useful to determine whether the changes are maintained 
throughout development. It would also determine whether the changes seen in our ES 
cells have relevance in vivo, and whether they may impact offspring in the long-term.  
In vitro differentiation models and in vivo studies may help to determine if the changes 
seen  in  our  ES  cell  are  sustained  and  whether  they  have  long-term  implications  for 
developmental  potential.  In vitro  differentiation  models  such  as  embryoid  body  (EB) 
formation  will  enable  us  to  assess  whether  cell  death  has  an  impact  on  further 
development.  EBs  are  large  three-dimensional  structures  formed  from  ES  cells  that 
spontaneously aggregate and differentiate in suspension cultures (Desbaillets et al., 2000). 
EBs possess the ability to generate all germ layers, providing a useful model to study 
many  aspects  early  development  and  will  provide  some  idea  of  the  differentiation 
potential  of  our  ES  cells.  To  test  developmental  potential  of  our  ES  cells  in  vivo, 
chimeras can be generated by introducing ES cells donor embryos. Increased levels of 
cell death in LPD-ES cells may prevent chimera formation; however incorporation of 
cells and generation of chimeras may provide insight into developmental potential of ES 
cells derived from the blastocysts of undernourished mothers compared to controls. Chapter 7 
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Our ES cell model also provides the potential for large-scale genomic studies, which is 
difficult in the embryo. Epigenetic changes have been suggested as a likely mechanism 
for  the  long-term  changes  induced  by  maternal  undernutrition.  There  is  significant 
epigenomic  remodelling  during  preimplantation  development.  Epigenetic  status  and 
methylation patterns become re-established in the late blastocyst/ postimplantation. The 
methylation  patterns  established  during  development  are  maintained  in  somatic  cells 
throughout life. Therefore, suboptimal environmental changes, such as LPD, during this 
period  could  potentially  alter  the  gene  methylation  patterns  and  may  have  extreme 
consequences. Comparisons of DNA methylation in undifferentiated and differentiated 
ES cells may provide insight into epigenetic mechanism affecting long-term development. 
Promoters in ES cells lack DNA methylation, as ES cells are derived from blastocysts 
after a global demethylation event. In vitro differentiation of mouse ES cells may provide 
an opportunity to compare methylation changes that occur as a result of undernutrition. 
One major limitation of our investigation was the lack of female ES cell lines isolated. 
This has made it impossible to study female-specific effects of maternal LPD. Maternal 
undernutrition  during  gestation  has  been  shown  to  have  gender-specific  effects  on 
offspring.  Generation  of  female  ES  cell  lines  is  therefore  necessary  to  study  such 
differences that may not be seen in male ES cells. 
In addition to isolation of ES cells, the multipotent TE cells, which enclose the ICM cells 
and blastocoel, can also be maintained in culture. The polar TE, adjacent to the ICM, 
maintains the potential to proliferate and contribute to a series of trophoblastic tissues 
including the ExE, the EPC and the TB component of the placenta. These cells can also 
be maintained in a proliferative, primary state in vitro and have been identified as TS 
cells (Oda et al., 2006; Rossant and Cross, 2001; Tanaka et al., 1998). 
The TB cell lineage plays a pivotal role in foetal-maternal interaction by contributing to 
the trophoblastic component of the placenta, mediating nutrient and gas supply to the 
foetus,  and  is  an  important  source  of  pregnancy  related  hormones.  Therefore 
extraembryonic lineages are likely mediators of response to maternal diet. Changes in the 
structure and properties of the extraembryonic tissues may act deleteriously and impact 
adult physiology. Importantly, changes to the TB may affect nutrient supply to the foetal 
tissues, and foetal adaptations may also occur but these may not be evident in the ICM 
cells of the blastocyst. TS cells from blastocysts of dietary- challenged mothers could be General discussion 
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analysed for epigenetic status, gene expression, differentiation and proliferative capacity, 
migration, and invasiveness.   
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Appendix I –Media 
Embryo media 
H6-BSA 
Stock B (stored at 4-8C for up to 2 weeks) 
Deionised water, sterile          10 ml 
Sodium hydrogen carbonate (NaHCO3)      0.2106 g 
Stock E (stored at 4-8C for up to 3 months) 
Deionised water, sterile          50 ml 
Hepes              2.9785 g 
Stock F (stored at 4-8C for up to 3 months) 
Sodium chloride (NaCl)          4.720 g 
Potassium Chloride (KCL)          0.110 g 
Sodium dihydrogen orthophosphate (NaH2PO4.2H2O)  0.060 g 
Magnesium chloride (MgCl2)        0.100 g 
D-glucose              1.000 g 
DL-lactic acid              3.4 ml 
Deionised water            Made up to 100 ml 
Stock G (stored at 4-8C for up to 2 weeks) 
Deionised water, sterile          10 ml 
Pyruvic acid              0.030 g 
Penicillin              0.060 g 
Streptomycin             0.050 g 
Stock H (stored at 4-8C for up to 3 months) 
Deionised water, sterile          10 ml 
Calcium chloride dehydrate (CaCl2.2H2O)      0.260 g 
20% Sodium Chloride 
Deionised water, sterile          10 ml 
Sodium Chloride (NaCl)          2.0 g 
 
To prepare 100 ml of H6-BSA: 
Deionised water, sterile          78 ml 
Stock B              1.6 ml 
Stock E              8.4 ml 
Stock F              10 ml   
Stock G              1.0 ml 
Stock H              1.0 ml      d  
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20% NaCl              0.6 ml 
BSA (Sigma, embryo culture tested, A3311)    0.4 g    
pH adjusted to 7.4; osmolarity adjusted to 270-280 mOsm; sterile filtered (0.22  M 
filter); aliquots stored at 4ºC. 
KSOM culture medium    
2x stock KSOM 
Sodium chloride (NaCl)          1.110 g 
Potassium chloride (KCl)          0.0095 g 
Magnesium sulphate7-hydrate (MgSO4.7H2O)    0.0099 g  
Lactic acid              0.362 ml 
Sodium pyruvate            0.0044 g 
Glucose              0.0072 g 
Sodium bicarbonate (NaHCO3)        0.420 g 
Penicillin              0.01256 g 
Streptomycin             1 ml 
EDTA               4 ml 
Tissue culture grade water          Made up to 100 ml 
5 ml aliquots stored at -80ºC for up to 2 months. 
1 x KSOM (10ml) 
The following was added to 5 ml of thawed 2x KSOM stock: 
Calcium chloride (CaCl2; 100x stock 25 mg/ml)    100  l 
Non-essential amino acids (100x stock; 10 mM)    50  l 
Essential amino acids (50 x stock)        100  l 
L-glutamine (200 mM)          50  l 
Deionised water, sterile          4.75 ml 
BSA                0.040 g 
Sterile filtered (0.22  m filter); osmolarity adjusted to 255 ± 5 mOsm with 20% NaCl; 
aliquots stored at 4ºC for up to 1 week. 
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Appendix II.i: Typical standard curve for BCA protein assay 
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Appendix II.ii: Background data of ES cell lines used in this study 
Details of the number of ES cell lines isolated per mother (mouse ID) relative to the 
number of blastocysts collected. Percentage of blastocysts yielding ES cell lines is 
shown for each mother and is summarised for each diet treatment group. Light grey 
rows show mothers fed a LPD, and white rows show mothers fed a NPD throughout 







No. ESC lines 
isolated 
Cell line ID 
% ESC deriving 
blastocysts 
1  LPD  7  1  1  14.3 
2  LPD  9  1  2  11.1 
3  NPD  6  0    0 
4  LPD  7  3  3,4,5  42.9 
5  LPD  8  0    0 
6  LPD  9  1  6  11.1 
7  NPD  8  0    0 
8  NPD  7  2  7,8  28.6 
9  NPD  8  2  9,10  25 
10  LPD  7  1  11  14.3 
11  LPD  7  0    0 
12  LPD  7  1  12  14.3 
13  LPD  6  1  13  16.7 




15  LPD  9  1  20  11.1 
16  NPD  7  2  21,22  28.6 
17  LPD  9  2  23,24  22.2 
18  NPD  8  6  25-30  75 
19  LPD  6  2  31  33.3 
20  LPD  7  3  32,33,34  42.9 
21  NPD  7  4  35,36,37,38  57.1 
22  LPD  8  2  39,40  25 




24  NPD  6  1  48  16.7 
25  NPD  8  4*  49,50,51  50 
26  NPD  7  4*  52,53,54  57.1 
Total 
NPD 
  94  40    41.1 
Total 
LPD 
  100  17    17.4 




Appendix II. iii: Cell lines and passage numbers used in ES cell characterisation experiments 
Summary of the range of experiments used to analyse the characteristics of our diet ES cell lines. Indicates which cell lines were used for each 
experiment at each time point, and the passage number (PN) the cell lines were used at. Table excludes all female and aneuploid cell lines and male 









































Figure Ref.  4.5; 4.7  5.1  5.2  5.4  5.5  5.6  5.6  5.7  5.10  6.4  6.4  6.4  6.6; 6.7  6.6; 6.7  6.6; 6.7 
NPD ES Cell lines 
7  PN10  PN5    PN10      PN10      PN12  PN12  PN13  PN13  PN13  PN13 
5 
8  PN10  PN5  PN11        PN10  PN13  PN9  PN12  PN12    PN12  PN12  PN12 
9  PN10  PN5              PN10             
6 
10      PN13      PN13              PN11  PN11  PN11 
15  PN10  PN5  PN12  PN12  PN16    PN12  PN13  PN10  PN12           
18      PN11  PN10    PN11  PN10    PN9  PN11  PN11  PN13  PN11  PN11  PN11  10 
19      PN13  PN12    PN13  PN10    PN11  PN11  PN12  PN12  PN11  PN11  PN11 
12  21  PN10    PN11  PN11      PN11  PN11  PN10  PN12  PN12  PN11       
35  PN10  PN6  PN12  PN10      PN10    PN10  PN12  PN12  PN13       
36        PN12  PN14  PN12  PN12  PN12  PN10  PN10      PN12  PN12  PN12  17 
37  PN10    PN12                         
38  PN10                PN10             
42  PN9                             
44  PN9                             
45                  PN10             
19 
46                               
48  PN10  PN6  PN12  PN10  PN16  PN12  PN10  PN12  PN9  PN12  PN12         
21 
51  PN10  PN6  PN11  PN10  PN14  PN11  PN10  PN11  PN9  PN10  PN10  PN11  PN11  PN11  PN11 
52    PN6    PN10      PN10    PN9  PN10  PN10    PN11  PN11  PN11 
22 
55  PN9                              
 






































WB 72 h 
LPD ES Cell lines 
1  1  PN9  PN5  PN13  PN10  PN16  PN13  PN10  PN12    PN10  PN10  PN11  PN10  PN10  PN10 
2  2  PN10  PN5  PN12  PN10  PN14    PN10  PN11  PN9  PN10  PN10  PN12  PN11  PN11  PN11 
3  4  PN9  PN5  PN13  PN11    PN13  PN11  PN12  PN10  PN10    PN12  PN12  PN12  PN12 
4  6  PN10  PN4  PN12  PN10    PN11  PN10  PN12  PN10  PN11  PN11  PN12  PN12  PN12  PN11 
7  11  PN8    PN11      PN11              PN11  PN11  PN11 
8  12  PN8    PN12  PN11    PN12  PN9  PN11  PN8  PN10      PN11  PN11  PN11 
9  13  PN8      PN11      PN9    PN8  PN10  PN11  PN11       
11  20  PN8      PN10      PN10    PN8  PN11  PN11  PN11  P11  PN11  PN11 
13  24  PN10  PN6  PN13  PN12  PN16  PN13  PN12  PN13  PN9  PN12      PN12  PN12  PN12 
16  32        PN12      PN12                 
39  PN10  PN5                           
18 
40  PN10  PN6  PN12  PN10    PN12    PN13      PN12  PN12  PN11  PN11  PN11 
Total number of cell line used per experiment 
NPD  14  8  10  10  4  7  10  6  15  10  9  6  8  8  8 
LPD  11  6  8  10  3  7  9  7  8  8  6  7  8  8  8 
Number of mothers 
NPD  9  6  7  8    6  7  6  8  7  6  5  6  6  6 
LPD  10  5  8  9    7  9  7  8  8  6  7  8  8  8 
 
  




    





Appendix II.iv: Reference gene real-time PCR product specificity 
(a-g) Melting curves of reference genes for all ES cell samples. Single peaks show 
that  the  real-time  PCR  products  are  dissociating  at  a  similar  temperature  and  the 
product is specific. This is marked by a rapid decrease in SYBR-green fluorescence 
as double stranded DNA separates. Change of relative fluorescence units (RFU) with 
time (T) (-d (RFU)/dT) is plotted against temperature and in all cases show peaks at 
the  Tm  of  the  specific  amplicon.  (h)  PCR  products  for  each  reference  gene  show 
single bands at the correct amplicon size  (18s, 110 bp; Hprt1, 90 bp; Pgk1, 65 bp; 
Ppib, 92 bp; Sdha, 66 bp; Tbp, 90 bp; Tuba 1, 114 bp) when run by electrophoresis on 
a 2% agarose gel. 
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Appendix II.v: Karyotype analysis of male ES cell lines. 
Showing the frequency of euploid and aneuploid chromosome spreads for each ES cell 
line at passage number 14-17. Euploid cell lines (lines with > 50% of metaphase counts 
with 40 chromosomes) were used for future analysis. Light grey rows show mothers fed a 
LPD, and white rows show mothers fed a NPD throughout preimplantation development. 
Cell line  <37  37  38  39  40  42  42<x<80  80  Total 
spreads  % Euploid 
1  2  3  1  0  27  0  0  0  33  81.8 
2  3  0  6  2  16  0  0  0  27  59.3 
3  5  0  4  9  18  0  0  0  36  50.0 
4  1  1  1  6  26  0  0  0  35  74.3 
5  2  2  3  3  12  5  1  2  30  40.0 
6  1  0  0  4  29  0  1  1  36  80.6 
7  5  3  7  4  22  0  0  0  41  53.7 
8  2  0  1  7  28  0  1  3  42  66.7 
9  2  0  2  6  24  0  1  4  39  61 
10  5  1  4  3  15  1  2  0  31  48.4 
11  4  2  1  10  18  1  0  0  36  50.0 
12  1  0  0  1  30  3  0  1  36  83.3 
13  1  0  2  2  32  0  0  2  39  82.1 
15  1  0  0  2  34  0  1  1  40  85 
16  1  1  5  15  5  0  2  0  29  17.2 
17  0  0  0  0  0  0  31  6  37  0 
18  0  0  0  1  31  0  1  3  36  86.8 
19  0  0  0  1  38  0  0  1  40  95.0 
20  1  0  4  1  28  4  1  0  39  71.8 
21  1  1  4  7  26  0  0  0  39  66.7 
24  3  1  1  3  22  1  3  0  34  64.7 
31  2  4  2  8  7  0  9  1  33  21.2 
32  1  0  0  4  35  1  0  0  41  85.4 
35  0  0  3  4  29  1  0  1  38  76.3 
36      2  0  34  0  0  1  37  91.9 
37  4  1  0  3  30  0  2  0  40  75.0 
39  6  2  9  13  15  0  0  0  45  33.3 
40  0  0  4  3  29  0  1  0  37  78.4 
42  3  0  4  0  27  0  0  1  35  77.1 
44  0  3  4  3  27  0  1  2  40  67.5 
45  2  0  4  2  28  0  2  2  40  70.0 
48  3  3  1  2  29  0  1  0  39  74.4 
49  4  5  5  8  10  0  10  1  43  23.3 
51  0  0  2  3  35  0  0  1  41  85.4 
52  0  0  4  4  24  4  0  0  40  65.0 
55  1  0  4  5  26  4  0  0  40  60.0 
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Appendix II.vi: Optimisation of cell proliferation assay 
(a) Shows general growth rate of ES cells over 96 h. (b) ES cells generally show a 
higher  proliferation  rate  when  plated  at  lower  cell  densities  as  indicated  by  the 
percentage increase in cell number between each assay time-point. ES cells were 
cultured on a MEF feeder layer in 96 well plates and cell counts were performed in 
triplicate at 24 h time-points.  




Appendix II.vii: Effect of Nocodazole treatment on ES cell status 
(A) PI stained cells analysed by flow cytometry. Histograms show DNA contents in ES 
cell  samples  treated  with  nocodazole  (80ng/ml)  for  varying  incubation  times  and 
indicate the numbers Sub-G1 (dead) cells and cell cycle distribution of live populations 
(indicated  by  gates  on  plots).  (B)  Shows  the  percentage  of  live  cells  after  various 
nocodazole  treatment  times.  Controls  were  treated  with  DMSO  only.  Live  cell 
populations were also determined 4 h after nocodazole release. (C) The percentage 
of cells arresting in the G2/M phase are shown at each nocodazole incubation time. 
G2/M peak is indicated on histograms by red line. 
  







Appendix II.viii: Effect of Nocodazole Concentration on ES cell status 
(A) PI stained cells analysed by flow cytometry. Histograms show DNA contents in ES 
cell samples treated with nocodazole (6 h) for varying concentrations and indicate the 
cell cycle distribution of cell populations. (C) The percentage of cells arresting in the 
G2/M phase are shown for each nocodazole concentration. G2/M peak is indicated on 
histograms by red line.  








Appendix II.ix: MTT assay optimisation 
ES  cells  grown  on  MEFs  at  various  starting  densities  show  increasing 
metabolic activity as cell number increases over 96 h. Activity determined by 
mitochondrial dehydrogenase mediated conversion of yellow MTT to a violet 
formazan  salt  following  2  h  MTT  incubation  prior  to  each  assay  point 
(measured by OD at 570 nm). Higher starting cell densities plateau at 72 h. 
Vertical bars indicate SEM. 